
<html lang="en"     class="pb-page"  data-request-id="29716cbe-1592-4e97-ab2b-a388a7af9a1c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-9;wgroup:string:ACHS website Group;article:article:10.1021/jm901713n;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors" /></meta><meta name="dc.Creator" content="Italo  Beria" /></meta><meta name="dc.Creator" content="Dario  Ballinari" /></meta><meta name="dc.Creator" content="Jay Aaron  Bertrand" /></meta><meta name="dc.Creator" content="Daniela  Borghi" /></meta><meta name="dc.Creator" content="Roberto Tiberio  Bossi" /></meta><meta name="dc.Creator" content="Maria Gabriella  Brasca" /></meta><meta name="dc.Creator" content="Paolo  Cappella" /></meta><meta name="dc.Creator" content="Michele  Caruso" /></meta><meta name="dc.Creator" content="Walter  Ceccarelli" /></meta><meta name="dc.Creator" content="Antonella  Ciavolella" /></meta><meta name="dc.Creator" content="Cinzia  Cristiani" /></meta><meta name="dc.Creator" content="Valter  Croci" /></meta><meta name="dc.Creator" content="Anna  De Ponti" /></meta><meta name="dc.Creator" content="Gabriele  Fachin" /></meta><meta name="dc.Creator" content="Ronald Dale  Ferguson" /></meta><meta name="dc.Creator" content="Jacqueline  Lansen" /></meta><meta name="dc.Creator" content="Jurgen Karl  Moll" /></meta><meta name="dc.Creator" content="Enrico  Pesenti" /></meta><meta name="dc.Creator" content="Helena  Posteri" /></meta><meta name="dc.Creator" content="Rita  Perego" /></meta><meta name="dc.Creator" content="Maurizio  Rocchetti" /></meta><meta name="dc.Creator" content="Paola  Storici" /></meta><meta name="dc.Creator" content="Daniele  Volpi" /></meta><meta name="dc.Creator" content="Barbara  Valsasina" /></meta><meta name="dc.Description" content="Polo-like kinase 1 (Plk1) is a fundamental regulator of mitotic progression whose overexpression is often associated with oncogenesis and therefore is recognized as an attractive therapeutic target..." /></meta><meta name="Description" content="Polo-like kinase 1 (Plk1) is a fundamental regulator of mitotic progression whose overexpression is often associated with oncogenesis and therefore is recognized as an attractive therapeutic target..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 16, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901713n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901713n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901713n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901713n" /></link>
        
    
    

<title>Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901713n" /></meta><meta property="og:title" content="Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0023.jpeg" /></meta><meta property="og:description" content="Polo-like kinase 1 (Plk1) is a fundamental regulator of mitotic progression whose overexpression is often associated with oncogenesis and therefore is recognized as an attractive therapeutic target in the treatment of proliferative diseases. Here we discuss the structure−activity relationship of the 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline class of compounds that emerged from a high throughput screening (HTS) campaign as potent inhibitors of Plk1 kinase. Furthermore, we describe the discovery of 49, 8-{[2-methoxy-5-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, as a highly potent and specific ATP mimetic inhibitor of Plk1 (IC50 = 0.007 μM) as well as its crystal structure in complex with the methylated Plk136−345 construct. Compound 49 was active in cell proliferation against different tumor cell lines with IC50 values in the submicromolar range and active in vivo in the HCT116 xenograft model where it showed 82% tumor growth inhibition after repeated oral administration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901713n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901713n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901713n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901713n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901713n&amp;href=/doi/10.1021/jm901713n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3532-3551</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901699j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901796s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of 4,5-Dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Italo++Beria">Italo Beria</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dario++Ballinari">Dario Ballinari</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+Aaron++Bertrand">Jay Aaron Bertrand</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Borghi">Daniela Borghi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto+Tiberio++Bossi">Roberto Tiberio Bossi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Gabriella++Brasca">Maria Gabriella Brasca</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Cappella">Paolo Cappella</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele++Caruso">Michele Caruso</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Ceccarelli">Walter Ceccarelli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonella++Ciavolella">Antonella Ciavolella</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cinzia++Cristiani">Cinzia Cristiani</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valter++Croci">Valter Croci</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++De+Ponti">Anna De Ponti</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriele++Fachin">Gabriele Fachin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+Dale++Ferguson">Ronald Dale Ferguson</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline++Lansen">Jacqueline Lansen</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jurgen+Karl++Moll">Jurgen Karl Moll</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Enrico++Pesenti">Enrico Pesenti</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helena++Posteri">Helena Posteri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Perego">Rita Perego</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maurizio++Rocchetti">Maurizio Rocchetti</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paola++Storici">Paola Storici</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Volpi">Daniele Volpi</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Valsasina">Barbara Valsasina</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39 0331581516. Fax: +39 03311581347. E-mail <a href="/cdn-cgi/l/email-protection#91f8e5f0fdfebff3f4e3f8f0d1fff4e3e7f8f0fffefce2bff2fefc"><span class="__cf_email__" data-cfemail="610815000d0e4f0304130800210f04131708000f0e0c124f020e0c">[email protected]</span></a></div><div class="corresp-fn" id="fn1">†Present address: Merck Co. & Inc., 126 E. Lincoln Avenue, Rahway, NJ 07065</div><div class="corresp-fn" id="fn2">‡Accelera, Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano (MI), Italy</div><div class="corresp-fn" id="fn3">§Present address: Sincrotrone Trieste S.C.p.A., Strada Statale 14, Area Science Park, 34149 Basovizza (TS), Italy</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901713n&amp;href=/doi/10.1021%2Fjm901713n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3532–3551</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 16, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 November 2009</li><li><span class="item_label"><b>Published</b> online</span>16 April 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901713n" title="DOI URL">https://doi.org/10.1021/jm901713n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3532%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DItalo%2BBeria%252C%2BDario%2BBallinari%252C%2BJay%2BAaron%2BBertrand%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D9%26contentID%3Djm901713n%26title%3DIdentification%2Bof%2B4%252C5-Dihydro-1H-pyrazolo%255B4%252C3-h%255Dquinazoline%2BDerivatives%2Bas%2Ba%2BNew%2BClass%2Bof%2BOrally%2Band%2BSelective%2BPolo-Like%2BKinase%2B1%2BInhibitors%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3551%26publicationDate%3DMay%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901713n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4002</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901713n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Italo&quot;,&quot;last_name&quot;:&quot;Beria&quot;},{&quot;first_name&quot;:&quot;Dario&quot;,&quot;last_name&quot;:&quot;Ballinari&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;Aaron Bertrand&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Borghi&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Tiberio Bossi&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Gabriella Brasca&quot;},{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Cappella&quot;},{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;Caruso&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Ceccarelli&quot;},{&quot;first_name&quot;:&quot;Antonella&quot;,&quot;last_name&quot;:&quot;Ciavolella&quot;},{&quot;first_name&quot;:&quot;Cinzia&quot;,&quot;last_name&quot;:&quot;Cristiani&quot;},{&quot;first_name&quot;:&quot;Valter&quot;,&quot;last_name&quot;:&quot;Croci&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;De Ponti&quot;},{&quot;first_name&quot;:&quot;Gabriele&quot;,&quot;last_name&quot;:&quot;Fachin&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;Dale Ferguson&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;Lansen&quot;},{&quot;first_name&quot;:&quot;Jurgen&quot;,&quot;last_name&quot;:&quot;Karl Moll&quot;},{&quot;first_name&quot;:&quot;Enrico&quot;,&quot;last_name&quot;:&quot;Pesenti&quot;},{&quot;first_name&quot;:&quot;Helena&quot;,&quot;last_name&quot;:&quot;Posteri&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Perego&quot;},{&quot;first_name&quot;:&quot;Maurizio&quot;,&quot;last_name&quot;:&quot;Rocchetti&quot;},{&quot;first_name&quot;:&quot;Paola&quot;,&quot;last_name&quot;:&quot;Storici&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Volpi&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Valsasina&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;3532-3551&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901713n&quot;},&quot;abstract&quot;:&quot;Polo-like kinase 1 (Plk1) is a fundamental regulator of mitotic progression whose overexpression is often associated with oncogenesis and therefore is recognized as an attractive therapeutic target in the treatment of proliferative diseases. Here we discuss the structure−activity relationship of the 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline class of compounds that emerged from a high throughput screening (HTS) campaign as potent inhibitors of Plk1 kinase. Furthermore, we describe the discovery of 49, 8-{[2-methoxy-5-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, as a highly potent and specific ATP mimetic inhibitor of Plk1 (IC50 = 0.007 μM) as well as its crystal structure in complex with the methylated Plk136−345 construct. Compound 49 was active in cell proliferation against different tumor cell lines with IC50 values in the submicromolar range and active in vivo in the HCT116 xenograft model where it showed 82% tumor growth inhibition after repeated &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901713n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901713n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901713n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901713n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901713n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901713n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901713n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901713n&amp;href=/doi/10.1021/jm901713n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901713n" /></input><a href="/doi/pdf/10.1021/jm901713n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901713n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901713n%26sid%3Dliteratum%253Aachs%26pmid%3D20397705%26genre%3Darticle%26aulast%3DBeria%26date%3D2010%26atitle%3DIdentification%2Bof%2B4%252C5-Dihydro-1H-pyrazolo%255B4%252C3-h%255Dquinazoline%2BDerivatives%2Bas%2Ba%2BNew%2BClass%2Bof%2BOrally%2Band%2BSelective%2BPolo-Like%2BKinase%2B1%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D9%26spage%3D3532%26epage%3D3551%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Polo-like kinase 1 (Plk1) is a fundamental regulator of mitotic progression whose overexpression is often associated with oncogenesis and therefore is recognized as an attractive therapeutic target in the treatment of proliferative diseases. Here we discuss the structure−activity relationship of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline class of compounds that emerged from a high throughput screening (HTS) campaign as potent inhibitors of Plk1 kinase. Furthermore, we describe the discovery of <b>49</b>, 8-{[2-methoxy-5-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide, as a highly potent and specific ATP mimetic inhibitor of Plk1 (IC<sub>50</sub> = 0.007 μM) as well as its crystal structure in complex with the methylated Plk1<sub>36−345</sub> construct. Compound <b>49</b> was active in cell proliferation against different tumor cell lines with IC<sub>50</sub> values in the submicromolar range and active in vivo in the HCT116 xenograft model where it showed 82% tumor growth inhibition after repeated oral administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mitotic cell cycle progression is tightly regulated through reversible covalent protein phosphorylation events coordinated by regulatory kinases, including members of the Polo subfamily.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Among the four Plk<a class="ref internalNav" href="#fn4" aria-label="a">a</a><div class="NLM_fn" id="fn4">a<p class="last">Abbreviations: Plk, Polo-like kinase; ABL, Abelson protein-tyrosine kinase; AKT, signal transducer and activator of transcription or protein kinase B; ALK, anaplastic lymphoma kinase; Aur, aurora; CDC, cell division cycle; CDK, cyclin dependent kinase; CK, casein kinase; CHK, Csk homologous kinase; EGFR, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; FGFR, fibroblast growth factor receptor; IGFR, insulin-like growth factor receptor; GSK, glycogen synthase kinase; IKK2, IκB kinase; IR, insulin receptor; LCK, lymphocyte-specific protein tyrosine kinase; MAP-KAPK2, mitogen activated proteinkinase-activatedprotein kinase-2; MET, high affinity tyrosine kinase receptor for hepatocyte growth factor; HGF, hepatocyte growth factor; NEK, NIMA-related kinase; NIMA, never in mitosis gene A; NIM, nim1/cdr1 protein; PAK, p-21 activated kinase; PKA, c-AMP-dependent kinase; PKC, protein kinase C; RET, receptor tyrosine kinase, STLK, serine-threonine like kinase; SULU, protein kinase 18; TRKA, catalytic receptor for the neurotrophin nerve growth factor; NGF, neurotrophin nerve growth factor; VEGFR, vascular endothelial growth factor receptor; AMP-PNP, adenylyl-imidodiphosphate tetralithium salt; NPM, nucleophosmin; TCTP, translationally controlled tumor protein; ADME, adsorption, distribution, metabolism, excretion; HLM human liver microsoms; <i>P</i><sub>app</sub>, apparent permeability; PAMPA, parallel artificial membrane permeation assay; EDC, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide; HOBT, 1-hydroxybenzotriazole; HOBT·NH<sub>3</sub>, 1-hydroxybenzotriazole ammonium salt ; (±)-BINAP, (±)-2,2′-bis(diphenylphosphino)-1,1′-binaphtalene; DMF-DIPA, <i>N</i>,<i>N</i>-dimethylformamide diisopropyl acetal; DTBAD, di-<i>tert</i>-butylazodicarboxylate; LiN(TMS)<sub>2</sub>, lithium bis(trimethylsilyl)amide; Pd<sub>2</sub>(dba)<sub>3</sub>, tris(dibenzylideneacetone)dipalladium(0); DMA, <i>N</i>,<i>N</i>-dimethylacetamide.</p></div> isoforms (Plk1−4), Plk1 is the best characterized and is recognized to be a key component of the cell cycle control machinery with important roles in the mitotic entry, centrosome duplication, bipolar mitotic spindle formation, transition from metaphase to anaphase, cytokinesis, and maintenance of genomic stability.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9">(5-9)</a> Plk1 is often overexpressed in many different tumor types including lung, colon, prostate, ovary, breast, head and neck squamous cell carcinoma, melanoma, and overexpression often correlates with poor prognosis.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16">(10-16)</a> In addition, interference with Plk1 activity and/or function by a variety of methods including antisense oligonucleotides, small interfering RNA, and various dominant negatives results in tumor cell apoptosis in culture and in vivo.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17-21)</a> Moreover, literature data report that normal cells survive Plk depletion, whereas tumor cells do not.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> All of this evidence supports Plk1 as a valid target for anticancer drug development. Although depletion of Plk1 is sufficient to induce G2/M cell cycle block, it is not clear whether it is important or indeed beneficial to inhibit all of the other Plk isoforms. In fact, less is known concerning the physiological roles of Plk2 and Plk3 that, in contrast to Plk1, are reported to be expressed in nonproliferating differentiated post mitotic cells, like neurons, indicating a potentially better safety profile for a Plk1 specific inhibitor.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Because of its essential role in cell proliferation there is a high level of interest and an increasing effort to identify and develop small-molecule inhibitors of Plks that has led to a number of different compounds which are currently under clinical investigation.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29">(24-29)</a></div><div class="NLM_p">In our effort to develop selective small-molecule Plk1 inhibitors, we identified a novel series of ATP-competitor 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline derivatives and herein we report their in vitro and in vivo characterization.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Starting from the unselective compound <b>1a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) that was fished out from a high throughput screening (HTS) campaign, we developed compound <b>49</b>, a highly potent (Plk1 IC<sub>50</sub> = 0.007 μM), selective, and orally bioavailable Plk1 inhibitor. Compound <b>49</b> showed good selectivity in a panel of more than 40 protein kinases and with more than 30-fold selectivity with respect to the Plk family members Plk2 and Plk3.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HTS pyrazoloquinazoline hit <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Structure−activity relationships (SAR) for this class together with data concerning the crystal structure of the selective inhibitor <b>49</b> in complex with the Plk1 kinase domain are reported below.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A versatile chemical strategy for the synthesis of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline derivatives involving the synthesis of flexible intermediates <b>5a</b>−<b>d</b> was established. Enaminones <b>5a</b>−<b>d</b> were prepared in 2/3 linear step process starting from the diketoester <b>2</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Cyclization of the diketoester <b>2</b> into the 1-substituted pyrazole derivatives <b>4a</b>−<b>c</b> was carried out in a regiospecific way by reacting suitable hydrazines <b>6a</b>−<b>c</b> in glacial acetic acid. Alternatively, reacting <b>2</b> with hydrazine hydrate followed by unselective base catalyzed alkylation of pyrazole derivative <b>3</b> with trityl chloride yielded a mixture of 1 and 2-trityl regioisomers wherein the desired intermediate <b>4d</b> was easily isolated by crystallization. Reaction of 7-oxo-tetrahydroindazole derivatives <b>4a</b>−<b>d</b> with <i>N</i>,<i>N</i>-dimethylformamide diisopropyl acetal yielded the versatile enaminones <b>5a</b>−<b>d</b>. Further elaboration of intermediates <b>5a</b>−<b>d</b> to obtain the final compounds modified at positions 1, 3, or 8 of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline scaffold was performed following the synthetic pathways reported in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a>−<a class="ref internalNav" href="#sch4" aria-label="4">4</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Cyclization of intermediates <b>5a</b>−<b>d</b> with phenyl guanidine carbonate at 110 °C in <i>N</i>,<i>N</i>-dimethylformamide allowed direct access to the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline scaffold decorated at position 8 with the desired anilino moiety (<b>7a</b>−<b>d</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Compound <b>7e</b> was then obtained from <b>7d</b> by acidic removal of the trityl protecting group. Conversion of <b>7a</b>−<b>c</b> and <b>7e</b> into the final compounds <b>1a</b>−<b>c</b> and <b>1e</b> was obtained in two steps by hydrolysis of esters <b>7a</b>−<b>c</b> or <b>7e</b>, followed by a reaction with 1-hydroxybenzotriazole ammonium salt and EDC to introduce the primary amide function. Compound <b>1e</b> was in turn used as starting material to synthesize compounds <b>1f</b>−<b>i</b> so as to complete the series of 1-substituted pyrazole derivatives. Alkylation of <b>1e</b> with the suitable alcohols proceeded regioselectively at the position 1 of pyrazole nucleus under Mitsunobu conditions using polymer-bounded triphenyl phosphine to facilitate the workup and purification of target compounds. As previously described by Brasca and co-workers,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> synthesis of derivatives <b>9</b>−<b>13</b> modified at the 3 position of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline template (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) was performed starting from ester <b>7a</b>. Modifications of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline scaffold at position 8 to afford compounds <b>19</b>−<b>49</b> were introduced by Buchwald−Hartwig coupling of the iodoamide <b>18</b> with suitable amines <b>50</b>−<b>76</b> or <b>85a</b>−<b>e</b> using palladium(II) acetate as catalyst and (±)-BINAP as ligand (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Iodoamide <b>18</b> was in turn obtained in four steps starting from enaminone <b>5a</b>, following the recently reported procedure (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Briefly, reaction of enaminone <b>5a</b> with guanidine carbonate afforded intermediate <b>15</b>, the amino group was then converted into iodo derivative <b>16</b> via diazonium salt, and finally the acid intermediate <b>17</b>, obtained from hydrolysis of ester <b>16</b>, was converted into the desired iodoamide <b>18</b>. An alternative synthesis of a limited number of derivatives (<b>80</b> and <b>81</b>) characterized by an amino or an amido residue at the position 2′ of the 8 anilino moiety was applied (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). According to this procedure, iodoester <b>16</b> was coupled with the <i>N</i>-Boc-<i>o</i>-phenylenediamine under Buchwald−Hartwig conditions, then the protecting group was easily removed with hydrochloric acid in dioxane, generating the aminoester <b>78</b> that was coupled with acetyl chloride to yield the corresponding amido esters <b>79</b>. The final conversion of <b>79</b> into target amide <b>81</b> was achieved in a straightforward manner with 30% NH<sub>4</sub>OH in a sealed tube at 70 °C. The same procedure was applied to the ester intermediate <b>78</b> to obtain the amide <b>80</b>. Preparation of disubstituted aniline intermediates <b>85a</b>−<b>e</b> is outlined in Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Compounds <b>85a</b>−<b>b</b> were prepared starting from the commercially available anilines <b>82a</b>−<b>b</b>. The amino group was first protected as an acetyl derivative simply by reaction with acetic anhydride, then the 4-methylpiperazin-1-yl residue was introduced by subjecting the bromo intermediates <b>83a</b>−<b>b</b> to a Buchwald−Hartwig coupling with 4-methylpiperazine using Pd<sub>2</sub>(dba)<sub>3</sub> as catalyst and 2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl as ligand. Final removal of the amino protecting group under acid conditions afforded intermediates <b>85a</b>−<b>b</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). An alternative approach was applied for the synthesis of <b>85c</b>−<b>d</b>. The first step (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) foresaw the installation of the 4-methylpiperazin-1-yl residue by reacting 4-methylpiperazine under either palladium catalyzed Buchwald−Hartwig coupling conditions, in the case of the less reactive 4-bromo-1-methoxy-2-nitro-benzene <b>83c</b>, or by high temperature nucleophilic substitution conditions for the more reactive 1-(2-chloro-6-nitro-phenyl)-ethanone <b>83d</b>. Final reduction of both nitro derivatives <b>84c</b>−<b>d</b> was carried out under catalytic palladium conditions, with hydrogen in a Parr apparatus under 35 psi presssure generating <b>85c</b> and under atmospheric pressure with cyclohexene as hydrogen source producing <b>85d</b>. Amine intermediate <b>85e</b> was prepared subjecting the commercially available 1-(4-fluoro-2-hydroxy-phenyl)-ethanone <b>86</b> to nucleophilic substitution with 4-methylpiperazine at high temperature (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Then, phenol derivative <b>87</b> was converted into the target aniline <b>85e</b> by a one-pot reaction with 2-bromo-2-methylpropionamide and NaOH in <i>N,N</i>-dimethylacetamide via a Smiles rearrangement.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds modified at the position <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesis of intermediate <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0017.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Enaminone Intermediates <b>5a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) hydrazine R<sub>1</sub>NHNH<sub>2</sub> (<b>6a</b>−<b>c</b>), AcOH glacial, rt, 36−55%; (b) hydrazine hydrate, EtOH, reflux, 70%; (c) tritylchloride, TEA, DCM, rt, 72%; (d) DMF-DIPA, DMF, 60 °C, 54−71%.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0018.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 1-Substituted 4,5-Dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline derivatives <b>1a</b>−<b>c</b>, <b>1e</b>, <b>1f</b>−<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) phenylguanidine carbonate, DMF, 110 °C, 67−72%; (b) 1.5 M KOH/EtOH, reflux, quant; (c) EDC, HOBt·NH<sub>3</sub>, DMF, DIPEA, rt, 56−78%; (d) TFA, DCM, rt, 80%; (e) DTBAD, Ph<sub>3</sub>P polyimer-bound, alcohol R<sub>1</sub>−OH (<b>8a</b>−<b>d</b>), THF, rt, 24−62%.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0019.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4,5-Dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline Derivatives <b>19</b>−<b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Pd(OAc)<sub>2</sub>, (±)-BINAP, K<sub>2</sub>CO<sub>3</sub>, amines (<b>50</b>−<b>76</b>; <b>85a</b>−<b>e</b>), DMF, 80 °C, 7−77%.</p></p></figure><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0020.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2′ Anilino Derivatives <b>79</b> and <b>81</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Pd(OAc)<sub>2</sub>, (±)-BINAP, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>-Boc-<i>o</i>-phenylenediamine, 61%; (b) 4N HCl/dioxane, DCM, rt, 96%; (c) acetyl chloride, DIPEA, rt, 72%; (d) 30% NH<sub>4</sub>OH, EtOH, sealed tube, 70 °C, 17−64%.</p></p></figure><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0021.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Amino Intermediates <b>85a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) acetic anhydride, rt, 42−51%; (b) Pd<sub>2</sub>(dba)<sub>3</sub>, 1 M LiN(TMS)<sub>2</sub>/THF, 4-methylpiperazine, 2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl, reflux, 53−91%; (c) HCl conc, EtOH, reflux, 45%-quant; (d) 4-methylpiperazine, Pd(OAc)<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, 2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl, THF, reflux, 55%; (e) 4-methylpiperazine, 120 °C sealed tube, 68%; (f) cyclohexene, 10% Pd/C, HCl conc, THF/H<sub>2</sub>O/EtOH, 70 °C, 95%; (g) 10% Pd/C, H<sub>2</sub>, 35 psi, MeOH, 90%.</p></p></figure><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0022.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Amino Intermediate <b>85e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 4-methylpiperazine, 130 °C, quant; (b) NaOH, DMA, 2-bromo-2-methylpropanamide, rt. then NaOH, 100 °C, 30%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the HTS campaign for the discovery of small-molecule inhibitors of Plk1, compound <b>1a</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> belonging to the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline class emerged as an interesting hit. Despite strong cross activity with others kinases, e.g., Aur-A and CDK2/A, inhibitor <b>1a</b> was selected for a chemistry expansion aimed at defining the structure activity relationship for this novel class and at improving both the selectivity profile and the pharmacokinetic properties. In particular, the effect of modifications at positions 1, 3, and 8 of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline scaffold will be discussed in more depth.</div><div class="NLM_p">Compounds modified at position 1 of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline template together with biochemical activity against Plk1, CDK2/A, Aur-A kinases and in vitro cell proliferation cytotoxicity on A2780 cell lines are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. According to this data, substitutions at position 1 of pyrazole ring did not improve the selectivity vs CDK2/A or Aur-A kinases. In contrast, the introduction of bulky groups in this position had dramatic effects on the Plk1 activity. Specifically, the compounds wherein the methyl substituent was removed (<b>1e</b>) or replaced with the cyclohexyl moiety (<b>1f</b>) showed a maintained or increased cytotoxicity (IC<sub>50</sub> = 0.10 and 0.55 μM, respectively), but a decreased Plk1 activity (Plk1 IC<sub>50</sub> = 0.248 and 0.143 μM, respectively) with respect to progenitor <b>1a</b> (Plk1 IC<sub>50</sub> = 0.068 μM). Replacement of methyl with a small flexible trifluoroethyl residue (<b>1b</b>) resulted in increased Plk1 activity (IC<sub>50</sub> = 0.006 μM) but decreased cellular activity (IC<sub>50</sub> = 2.75 μM) with respect to <b>1a</b>. A decrease from 6- to more than 100-fold in Plk1 biochemical activity was observed with the increase of the substituent’s complexity (<b>1c</b>, <b>1 g</b>−<b>i</b>). On the basis of these data, the methyl group was identified as the best residue at the position 1 of the 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline core in terms of biochemical and cellular activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR: Variation of R<sub>1</sub> Substitution<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0024.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0001.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the average of <i>n</i> ≥ 2.</p></div></div></div><div class="NLM_p">Exploration of the 3 position was performed with the synthesis of a set of compounds wherein the primary amide residue of hit <b>1a</b> was replaced with ethyl ester function (<b>7a</b>), carboxylic acid residue (<b>9</b>), or with secondary amides (<b>10</b>−<b>13</b>). Activity results reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> show that most of these modifications significantly decreased Plk1 activity. Even the simple methyl amide derivative <b>10</b> showed a 60-fold loss of activity in the Plk1 biochemical assay and 5-fold reduction in cell proliferation potency with respect to the parent compound <b>1a</b>. The only derivative that maintained the progenitor’s activity was the carboxylic acid <b>9</b>, however, its selectivity profile vs CDK2/A and Aur-A was not improved. Moreover, cellular activity of <b>9</b> was decreased 5-fold with respect to <b>1a</b>, probably due to the reduced capability of the carboxylic acid to cross the cellular membrane with respect to the primary amide as confirmed by the low value in the Caco-2 permeability assay of <b>9</b> with respect to <b>1a</b> (<i>P</i><sub>app</sub><b>1a</b> = 58.3 × 10<sup>−6</sup>cm/s; <i>P</i><sub>app</sub><b>9</b> = 2.7 × 10<sup>−6</sup> cm/s).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR: Variation of R<sub>2</sub> Substituent<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0002.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center" char=".">IC<sub>50</sub>, μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">Plk1</th><th class="colsep0 rowsep0" align="center" char=".">CDK2/A</th><th class="colsep0 rowsep0" align="center" char=".">Aur-A</th><th class="colsep0 rowsep0" align="center" char=".">A2780</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.068</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.251</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char=".">0.110</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">2.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">4.215</td><td class="colsep0 rowsep0" align="char" char=".">0.019</td><td class="colsep0 rowsep0" align="char" char=".">0.312</td><td class="colsep0 rowsep0" align="char" char=".">2.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">NHcyclopropyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.081</td><td class="colsep0 rowsep0" align="char" char=".">0.213</td><td class="colsep0 rowsep0" align="char" char=".">3.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">NHcyclopentyl</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">3.900</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">NHPh</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.574</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the average of <i>n</i> ≥ 2.</p></div></div></div><div class="NLM_p">Exploration at position 8 of the scaffold was initiated by evaluating the influence of substituents at positions 2′, 3′, or 4′ of the anilino residue. Analysis of the biochemical data reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> shows that in an homogeneous series, substitution at positions 3′ and 4′ of the phenyl ring was inefficient to increase Plk1 selectivity, especially against CDK2/A, as revealed by the substantially unmodified CDK2A/Plk1 ratio or Aur-A/Plk1 ratio for the compound pairs <b>20</b>−<b>21</b>, <b>23</b>−<b>24</b>, or <b>26</b>−<b>27</b> in comparison with <b>1a</b>. A unique behavior was shown by the nitro derivatives <b>29</b> and <b>30</b>, wherein despite a retention of activity on CDK2/A, a dramatic loss of activity was observed for Plk1 and Aur-A. As far as the 2′ substituted derivatives are concerned, the Plk1 activity was either maintained (<b>25</b>) or slightly decreased (<b>19</b>, <b>22</b>, <b>28</b>). However, more importantly, a general increase of selectivity against both CDK2/A and Aur-A was evident. In particular, the 2′-methoxy derivative <b>25</b> showed a marginal gain in terms of selectivity vs both CDK2/A (CDK2/A/Plk1 ratio from 0.03 to 0.97) and vs Aur-A (Aur-A/Plk1 ratio from 0.74 to 14.45) and a maintained cytotoxic activity on A2780 with respect to <b>1a</b>. An even more positive trend was shown by the 2′-acetyl derivative <b>22</b>, with an increased selectivity with respect to <b>1a</b> against both CDK2/A (CDK2/A/Plk1 ratio from 0.03 to 3.65) and Aur-A (Aur-A/Plk1 ratio from 0.74 to >28) but with loss of cytotoxicity on A2780. The high cytotoxicity shown by the unselective compounds <b>21</b>, <b>23</b>, <b>24</b>, and <b>27</b> (IC<sub>50</sub> = 0.25, 0.09, 0.04, and 0.05 μM, respectively) in comparison with <b>1a</b> (IC<sub>50</sub> = 0.5 μM) suggested that cellular activity of these compounds could be due to the inhibition by other kinases as, e.g., CDK2/A and Aur-A. The maintained cytotoxicity and the improved Plk1 selectivity shown by compound <b>25</b> in comparison with the unselective hit <b>1a</b> indicates that the ortho position is key for obtaining active and selective Plk1 inhibitors. In light of these positive results, a deeper investigation was performed to map the chemical space at position 2′ of the anilino moiety with the synthesis of a set of compounds differing in both electronic characteristics and steric bulk (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The data confirmed <b>25</b> as the most promising compound in terms of cellular activity on A2780 cell line, potency against Plk1 (IC<sub>50</sub> = 0.042 μM), and improved, but still low, selectivity vs Aur-A and CDK2/A with respect to progenitor <b>1a</b>. Compound <b>25</b>, however, did not show selectivity vs Plk2 and Plk3 isoforms. The lack of selectivity against Plk2 and Plk3 was shared by all compounds reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, indicating that this position is probably not suitable in achieving selectivity for Plk1 isoform; furthermore, all compounds, with the exception of <b>80</b>, demonstrated solubility at pH 7 below 30 μM. It is worth noting that introduction of medium/large moieties (<b>36</b>−<b>44</b> and <b>81</b>) in the 2′ position, with the exception of phenoxy derivative <b>40</b>, was detrimental not only for Plk1 inhibition (IC<sub>50</sub> ≥ 0.9 μM) but also for the others kinases (IC<sub>50</sub> > 0.4 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). On the contrary, small groups were well tolerated by Plk1 (<b>19</b>, <b>22</b>, <b>25</b>, <b>31</b>−<b>35</b>, and <b>80</b>) as confirmed by the only 6-fold loss of activity on the enzyme for <b>19</b> (IC<sub>50</sub> = 0.432 μM) and the 4-fold increased activity shown by <b>31</b> (IC<sub>50</sub> = 0.015 μM) when compared with <b>1a</b> (IC<sub>50</sub> = 0.068 μM). A significant modification in terms of potency and selectivity was achieved by the introduction of an additional substituent on the anilino moiety at position 8 (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Complete loss of biochemical activity for all the kinases and loss of cellular proliferation activity were obtained when the 4-methylpiperazino residue was introduced at the position 3′ of the 8-anilino substituent (<b>45</b>). However, encouraging results were obtained by introducing the 4-methylpiperazino substituent at the position 4′ of the anilino moiety (<b>46</b> and <b>48</b>). These derivatives not only maintained acceptable Plk1 activity but they also maintained or even improved the selectivity toward CDK2/A and Aur-A. In addition, improved selectivity against Plk2 and Plk3 was also achieved (compare <b>46</b> and <b>48</b> with <b>22</b> and <b>25</b>, respectively). Particularly interesting were the data for <b>47</b> and <b>49</b>, wherein the 4-methylpiperazino moiety was placed at the 5′ position of the 8-anilino appendix. Derivative <b>49</b> proved to be the best compound of the series, showing antiproliferative activity in the low nanomolar range in the A2780 cell line (IC<sub>50</sub> = 0.009 μM), good activity on Plk1 (IC<sub>50</sub> = 0.007 μM), and a high level of selectivity against Plk2, Plk3, CDK2/A, and Aur-A (0.238, 0.450, 0.355, and >10 μM, respectively). Furthermore, the introduction of 4-methylpiperazino residue also proved to be beneficial to the compound’s solubility that, in the case of <b>49</b>, resulted more than 50-fold with respect to <b>1a</b>. The high level of selectivity of compound <b>49</b> was also confirmed using a larger panel of more than 40 kinases, giving selectivity ratios that ranged from 16-fold to >1400-fold (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR: Variation of R<sub>3</sub> Substitution<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0003.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">Plk1 (IC<sub>50</sub>, μM)</th><th class="colsep0 rowsep0" align="center" char=".">CDK2/A (IC<sub>50</sub>, μM)</th><th class="colsep0 rowsep0" align="center" char=".">CDK2/A/Plk1 ratio</th><th class="colsep0 rowsep0" align="center" char=".">Aur-A (IC<sub>50</sub>, μM)</th><th class="colsep0 rowsep0" align="center" char=".">Aur-A/Plk1 ratio</th><th class="colsep0 rowsep0" align="center" char=".">A2780 (IC<sub>50</sub>, μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.068</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="char" char=".">0.740</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left"><i>o</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.432</td><td class="colsep0 rowsep0" align="char" char=".">0.306</td><td class="colsep0 rowsep0" align="char" char=".">0.708</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>23</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.051</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.118</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>196</td><td class="colsep0 rowsep0" align="char" char=".">1.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.872</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.270</td><td class="colsep0 rowsep0" align="char" char=".">0.310</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left"><i>o</i>-Ac</td><td class="colsep0 rowsep0" align="char" char=".">0.346</td><td class="colsep0 rowsep0" align="char" char=".">1.263</td><td class="colsep0 rowsep0" align="char" char=".">3.656</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>28</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-Ac</td><td class="colsep0 rowsep0" align="char" char=".">0.100</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.020</td><td class="colsep0 rowsep0" align="char" char=".">0.176</td><td class="colsep0 rowsep0" align="char" char=".">1.767</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-Ac</td><td class="colsep0 rowsep0" align="char" char=".">0.197</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.116</td><td class="colsep0 rowsep0" align="char" char=".">0.589</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left"><i>o</i>-OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td><td class="colsep0 rowsep0" align="char" char=".">0.969</td><td class="colsep0 rowsep0" align="char" char=".">0.607</td><td class="colsep0 rowsep0" align="char" char=".">14.452</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.135</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="char" char=".">0.158</td><td class="colsep0 rowsep0" align="char" char=".">1.164</td><td class="colsep0 rowsep0" align="char" char=".">1.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.256</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.128</td><td class="colsep0 rowsep0" align="char" char=".">0.499</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left"><i>o</i>-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.488</td><td class="colsep0 rowsep0" align="char" char=".">0.209</td><td class="colsep0 rowsep0" align="char" char=".">0.428</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">3.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left"><i>m</i>-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left"><i>p</i>-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.96</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the average of <i>n</i> ≥ 2.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR: Variation of R<sub>3</sub> Substitution<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0004.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="6" align="center" char=".">IC<sub>50</sub>, μM</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">Plk1</th><th class="colsep0 rowsep0" align="center">Plk2</th><th class="colsep0 rowsep0" align="center">Plk3</th><th class="colsep0 rowsep0" align="center" char=".">CDK2/A</th><th class="colsep0 rowsep0" align="center" char=".">Aur-A</th><th class="colsep0 rowsep0" align="center" char=".">A2780</th><th class="colsep0 rowsep0" align="center" char=".">solubility at pH 7, μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.068</td><td class="colsep0 rowsep0" align="left">0.009</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.432</td><td class="colsep0 rowsep0" align="left">0.109</td><td class="colsep0 rowsep0" align="left">0.095</td><td class="colsep0 rowsep0" align="char" char=".">0.306</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="char" char=".">0.346</td><td class="colsep0 rowsep0" align="left">0.261</td><td class="colsep0 rowsep0" align="left">0.103</td><td class="colsep0 rowsep0" align="char" char=".">1.263</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td><td class="colsep0 rowsep0" align="left">0.024</td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td><td class="colsep0 rowsep0" align="char" char=".">0.607</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="left">0.002</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.605</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">SMe</td><td class="colsep0 rowsep0" align="char" char=".">0.097</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.016</td><td class="colsep0 rowsep0" align="char" char=".">0.142</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">6.86</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">0.110</td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">2.900</td><td class="colsep0 rowsep0" align="char" char=".">7.54</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">0.125</td><td class="colsep0 rowsep0" align="left">0.027</td><td class="colsep0 rowsep0" align="left">0.037</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">1.181</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">0.365</td><td class="colsep0 rowsep0" align="left">0.509</td><td class="colsep0 rowsep0" align="left">0.146</td><td class="colsep0 rowsep0" align="char" char=".">0.358</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">1.117</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">1.448</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.076</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">2.746</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.733</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">1.120</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">8.30</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="char" char=".">1.565</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">1.347</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">OPh</td><td class="colsep0 rowsep0" align="char" char=".">0.278</td><td class="colsep0 rowsep0" align="left">2.666</td><td class="colsep0 rowsep0" align="left">0.051</td><td class="colsep0 rowsep0" align="char" char=".">1.900</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="char" char=".">0.943</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">0.571</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">NHPh</td><td class="colsep0 rowsep0" align="char" char=".">0.949</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">0.442</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">5.85</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">benzoyl</td><td class="colsep0 rowsep0" align="char" char=".">1.969</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">SPh</td><td class="colsep0 rowsep0" align="char" char=".">2.033</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.150</td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">2.497</td><td class="colsep0 rowsep0" align="char" char=".">2.92</td><td class="colsep0 rowsep0" align="char" char=".">190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left">NHAc</td><td class="colsep0 rowsep0" align="char" char=".">2.523</td><td class="colsep0 rowsep0" align="left">2.104</td><td class="colsep0 rowsep0" align="left">0.049</td><td class="colsep0 rowsep0" align="char" char=".">1.037</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">3.93</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the average of <i>n</i> ≥ 2. nd, not determined.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR: Variation of R<sub>3</sub> and R<sub>4</sub> Substitution<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0005.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="6" align="center" char=".">IC<sub>50</sub>, μM</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center" char=".">Plk1</th><th class="colsep0 rowsep0" align="center" char=".">Plk2</th><th class="colsep0 rowsep0" align="center" char=".">Plk3</th><th class="colsep0 rowsep0" align="center" char=".">CDK2/A</th><th class="colsep0 rowsep0" align="center" char=".">Aur-A</th><th class="colsep0 rowsep0" align="center" char=".">A2780</th><th class="colsep0 rowsep0" align="center" char=".">solubility at pH 7, μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.068</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.050</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="left">3′-(4-methyl-piperazin-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">2.051</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.121</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">170</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="left">4′-(4-methyl-piperazin-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.464</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.292</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">Ac</td><td class="colsep0 rowsep0" align="left">5′methyl-piperazin-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.109</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.762</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">4′-(4-methyl-piperazin-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.040</td><td class="colsep0 rowsep0" align="char" char=".">0.082</td><td class="colsep0 rowsep0" align="char" char=".">0.066</td><td class="colsep0 rowsep0" align="char" char=".">0.082</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.146</td><td class="colsep0 rowsep0" align="char" char=".">>225</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">5′-(4-methyl-piperazin-1-yl)</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">0.238</td><td class="colsep0 rowsep0" align="char" char=".">0.450</td><td class="colsep0 rowsep0" align="char" char=".">0.355</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">170</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the average of <i>n</i> ≥ 2.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Kinase Selective Profile of Compound <b>49</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub>, (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub>, (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Plk1</td><td class="colsep0 rowsep0" align="char" char="±">0.007 ± 0.003</td><td class="colsep0 rowsep0" align="left">CDK2/A</td><td class="colsep0 rowsep0" align="left">0.355 ± 0.167</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CK2</td><td class="colsep0 rowsep0" align="char" char="±">0.115 ± 0.045</td><td class="colsep0 rowsep0" align="left">Plk3</td><td class="colsep0 rowsep0" align="left">0.450 ± 0.101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK1/B</td><td class="colsep0 rowsep0" align="char" char="±">0.160 ± 0.029</td><td class="colsep0 rowsep0" align="left">VEGFR3</td><td class="colsep0 rowsep0" align="left">0.587 ± 0.230</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK5/p25</td><td class="colsep0 rowsep0" align="char" char="±">0.219 ± 0.092</td><td class="colsep0 rowsep0" align="left">PDGFR</td><td class="colsep0 rowsep0" align="left">0.954 ± 0.317</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Plk2</td><td class="colsep0 rowsep0" align="char" char="±">0.238 ± 0.043</td><td class="colsep0 rowsep0" align="left">KIT</td><td class="colsep0 rowsep0" align="left">1.904 ± 0.860</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2/E</td><td class="colsep0 rowsep0" align="char" char="±">0.347 ± 0.127</td><td class="colsep0 rowsep0" align="left">others<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>10 (31 kinases)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Data are reported as a mean ± standard deviation (<i>n</i> = 2).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">c-ABL, AKT1, ALK, Aur-A, Aur-B, CDC7, CDK7, CDK4/D1, CHK1, EGFR1, ERK2, FGFR1, IGFR1, GSK3β, IKK2, IR, LCK, MAP-KAPK2, MET, NEK-6, NIM, PAK4, PDK1, PKAα, PKCβ, P38α, RET, STLK2, SULU1, TRKA, and VEGFR2.</p></div></div></div><div class="NLM_p">A multiple construct approach was applied in order to obtain the crystal structure of the Plk1 kinase domain in complex with proprietary inhibitors. Specifically, out of 32 constructs that were cloned and tested for expression, 12 were purified on a large scale and subjected to extensive crystallization trials. However, initial efforts to obtain crystals of these constructs, both in the presence and absence of inhibitors, were unsuccessful. As a salvage approach, selected constructs were methylated and subjected to subsequent rounds of crystallization screening. In the end, this approach proved to be successful and crystals were obtained of methylated Plk1<sub>36−345</sub> bound to the nonhydrolyzable ATP analogue AMP-PNP. Interestingly, the crystal form that we obtained independently is the same as the one subsequently reported in the literature even though the crystallization conditions were different.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Remarkably, a zinc ion was observed in a crystal contact while no zinc was intentionally added to the solution providing these first crystals. A similar result concerning the unexpected presence of zinc in the crystals was also reported by Kothe and co-workers.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Moreover, among several structures subsequently solved, a methylated lysine could be unambiguously identified in only one structure (Lys257, data not shown). By soaking crystals of the methylated-Plk1<sub>36−345</sub>:AMP-PNP complex with compound <b>49</b>, we were able to replace the AMP-PNP with the inhibitor, as indicated by its well-defined electron density in the structure.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> As expected, <b>49</b> binds in the cleft between the N- and C-terminal lobes with the aminoquinazoline core, making three hydrogen bonds with the main chain atoms of Glu131 and Cys133 in the hinge region (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The glycine-rich loop folds down tightly over the inhibitor, with Leu59 sitting above the aromatic group in position 8 and Cys67 above the pyrazolo ring. More specifically, the aromatic group in position 8 is sandwiched between Leu59 (above) and Arg136 (below) and the substituents extend along the lower part of the hinge in opposite directions. The inhibitor’s amide moiety points toward the DFG motif of the enzyme (residues 194−196) and is part of an extensive network of hydrogen bonds (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The amide is directly bound to the side chains of Asp194 and Lys82 as well as to the main chain nitrogen of Asp194 through a bridging water molecule (W3). Interestingly, a conserved structural water molecule (W18)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> bridges together W3, the conserved Glu101 of αC helix and Phe195 and His105, two residues belonging to the regulatory spine of protein kinases.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Not suprisingly, the structural results, as elaborated below, are consistent with our key SAR findings that include the importance of the amide and the substituents on the aromatic group in position 8. Specifically, the amide hydogen bonding network and the shape of this region of the binding site can explain the decreased activity for compounds carrying an ester function (<b>7a</b>) or secondary amido residues (<b>10</b>−<b>13</b>) at position 3 of the template with respect to the primary amide derivative (<b>1a</b>). The 2′-methoxy group of <b>49</b> is accommodated in a small pocket close to the hinge residue Leu132, and this moiety is believed to play a critical role in obtaining selectivity against kinases bearing a residue bulkier than leucine in this position, such as those present in Aurora-A and CDK2/A. It is worth noting that a similar observation have been made for the methoxy group of the inhibitor BI-2536.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> A contribution to selectivity and to potency comes from the methylpiperazine moiety at position 5′ of the aniline residue (compare <b>22</b> with <b>47</b> and <b>25</b> with <b>49</b>). This substituent fits very well in a pocket lined mainly by residues of the kinase C-lobe, including Ser137 that forms the “floor” of this pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The corresponding amino acids in Aurora-A and CDK2/A are the larger Thr217 and Asp86, respectively. On the basis of the crystal structures of Aurora-A and CDK2/A with compounds of the same chemical class as <b>49</b> (proprietary data not shown), a clash would be likely to occur between these residues and the methylpiperazine substituent, explaining at least partially the observed selectivity against these two enzymes. Moreover, Glu140 of Plk1 is well positioned to establish a polar interaction with one of the piperazine nitrogens (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This, together with the optimal fitting of the methylpiperazine into its binding pocket, could explain the gain in potency given by this substituent. Interestingly, the amino acid corresponding to Glu140 of Plk1 is a histidine in both Plk2 and Plk3. Because the chemical properties of histidine are likely to hamper an interaction with a positively charged nitrogen, this feature might be the basis of the selectivity displayed by compounds <b>47</b> and <b>49</b> for Plk1 with respect to Plk2 and Plk3. A similar idea concerning the role of Plk1 residue Glu140 in the selectivity versus Plk2 and Plk3 has been recently proposed based on a homology model of Plk1 bound to a thiophene inhibitor.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>49</b> bound to Plk1. Hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hydrogen bonding network that links compound <b>49</b> to the regulatory spine residues His105 and Phe195.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding pocket of the methylpiperazino substituent of <b>49</b>, shown as a Connolly surface. The indicated distance for the interaction between Glu140 and <b>49</b> is in Ångstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of its favorable biochemical profile together with high potency in A2780 cell lines (IC<sub>50</sub> = 9 nM) and good solubility (170 μM at pH 7), compound <b>49</b> was selected for further in vitro and in vivo testing. In vitro antiproliferative activity of <b>49</b> was evaluated in a broad panel of cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Compound <b>49</b> proved to be a potent inhibitor of cell growth in vitro across a wide range of solid as well as hematological tumor cell lines. Compound <b>49</b> was also active in resistant cell lines like A2780 human ovarian adenocarcinoma cell line, which is resistant to <i>cis</i>-platinum (A2780/cis IC<sub>50</sub> = 0.011 μM), A2780 human ovary adenocarcinoma cell line ,which is resistant to adriamycin (A2780/ADR IC<sub>50</sub> = 0.057 μM), or the A2780 human ovary adenocarcinoma resistant to paclitaxel (A2780 1A9/PTX22 IC<sub>50</sub> = 0.016 μM), displaying comparable activity to that found in the parental cell line (A2780 IC<sub>50</sub> = 0.009 μM and A2780 1A9 IC<sub>50</sub> = 0.014 μM, respectively). The same behavior was observed in the LoVo human colon adenocarcinoma cell line resistant to doxorubicin (LoVo/Dx IC<sub>50</sub> = 0.078 μM) compared to the parental line (LoVo IC<sub>50</sub> = 0.066 μM). The mechanism of action of compound <b>49</b> was checked by flow cytometry analysis evaluating the percentage of cells with a 4N DNA content in A2780 cells. After 24 h treatment a clear G2/M block was observed by fluorescence activated cell sorting (FACS) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Analysis of cell cycle markers on A2780 cells at different dosages of <b>49</b> was also evaluated by Western blot. An increase in pSer10 histone H3 and pThr199 NPM in agreement with a mitotic block mechanism was observed in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The specific Plk1 mechanism of action of <b>49</b> was reinforced by the clear down-regulation of phosphorylation of Ser46 in TCTP, a reported substrate of Plk1.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Apoptosis induction was evaluated in two different cell lines, A2780 and HCT116 cells, which were treated at two different doses of <b>49</b> (0.5 μM and 1.5 μM) for 24 h followed by growth of cells for additional 24 h in the absence of compound. A G2/M cell cycle block was shown by flow cytometry after 24 h compound treatment, while after an additional 24 h of recovery in the absence of compound, a clear caspase-3 induction was observed. Also a high percentage of cells within the subG1 population, which is indicative of massive apoptosis, was observed at all tested doses. These data suggest that the compound acts by an initial prolonged mitotic block, followed by an induction of apoptosis through activation of caspases (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A,B).</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Flow cytometry analysis of <b>49</b> in A2780 cells. Cells were treated for 24 h with different doses of <b>49</b> (0.05 μM, 0.5 μM and 5 μM). DNA profile of untreated (C) and Nocodazole (N) treated cells are also reported.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0013.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Western blot analysis of <b>49</b> on A2780 cells. Cells were treated with <b>49</b> at two different doses (0.1 and 0.2 μM) for 24 h. Shown are untreated (C) and Nocodazole (N) treated cells. The Plk specific marker (pSer46 TCTP) as well as mitotic markers (pSer10 Histone H3 and pThr199 NPM) were evaluated. Total TCTP was used as loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0014.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Flow cytometry and Western blot analysis of A2780 (A) or HCT116 (B) cells treated for 24 h with 0.5 μM or 1.5 μM of <b>49</b> and after additional 24 h in the absence of compound. Expression of GAPDH was used as loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Antiproliferative Activity of Compound <b>49</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center">origin</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub>, (μM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center">origin</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub>, (μM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A2780</td><td class="colsep0 rowsep0" align="left">ovary</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="left">A431</td><td class="colsep0 rowsep0" align="left">epithelial</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A2780/cis</td><td class="colsep0 rowsep0" align="left">ovary resistant to cis platinum</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="left">MCF7</td><td class="colsep0 rowsep0" align="left">mammary</td><td class="colsep0 rowsep0" align="char" char=".">0.044</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A2780/ADR</td><td class="colsep0 rowsep0" align="left">ovary resistant to adriamycin</td><td class="colsep0 rowsep0" align="char" char=".">0.057</td><td class="colsep0 rowsep0" align="left">NCI-H929</td><td class="colsep0 rowsep0" align="left">myeloma</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A2780 1A9</td><td class="colsep0 rowsep0" align="left">ovary</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="left">OPM-2</td><td class="colsep0 rowsep0" align="left">myeloma</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A2780 1A9/PTX22</td><td class="colsep0 rowsep0" align="left">ovary resistant to patlitaxel</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="left">NHDF</td><td class="colsep0 rowsep0" align="left">human fibroblast</td><td class="colsep0 rowsep0" align="char" char=".">0.073</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PANC-1</td><td class="colsep0 rowsep0" align="left">pancreatic</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="left">KARPAS-299</td><td class="colsep0 rowsep0" align="left">lymphoma</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIA-PaCa-2</td><td class="colsep0 rowsep0" align="left">pancreatic</td><td class="colsep0 rowsep0" align="char" char=".">0.044</td><td class="colsep0 rowsep0" align="left">Jurkat</td><td class="colsep0 rowsep0" align="left">lymphoma</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCT-116</td><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="left">KU812</td><td class="colsep0 rowsep0" align="left">leukemia</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LoVo</td><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="char" char=".">0.066</td><td class="colsep0 rowsep0" align="left">HEL</td><td class="colsep0 rowsep0" align="left">erythroleukemia</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LoVo/Dx</td><td class="colsep0 rowsep0" align="left">colon resistant to doxorubicin</td><td class="colsep0 rowsep0" align="char" char=".">0.078</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the mean of 2−3 experiments with a coefficient of variation below 35%.</p></div></div></div><div class="NLM_p">To access the phenotype of cells treated with <b>49</b>, U2OS cells were treated either with <b>49</b> or transfected with siRNA specific for Plk1 and assessed for markers for the mitotic spindle (α-tubulin), DNA, and pSer10 histone H3, using confocal microscopy. Clearly, the presence of aberrant, predominantly monopolar spindles was observed in both siRNA transfected cells and in <b>49</b> treated cells, which is in line with the expected mechanism of action of inhibitng Plk-1, while normal bipolar spindles were present in control cells (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).</div><figure id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0015.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Aberrant monopolar spindles upon inhibition of Plk1. Immunofluorescence pictures of representative U2OS cells during mitosis. Control (A), siRNA targeting Plk1 (NM005030, sense strand 5′-CGAGCUGCUUAAUGACGAG) as assessed 72 h after transfection (B), and treatment with 0.3 μM of compound <b>49</b> for 72 h (C). Blue, DNA; red, pSer10 histone H3; green, α-tubulin. Images were taken with an objective 40× by using a confocal laser mounted on a Zeiss microscopy (Radiance 2000, Biorad).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, in vitro physicochemical ADME properties were evaluated showing that compound <b>49</b> had an excellent metabolic stability, both in rat (Cl<sub>int</sub> = 12.5 L/h/kg at 1 μM) and in human liver hepatocytes (Cl<sub>int</sub> = 0.6 L/h/kg) (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Inhibitor <b>49</b> also displayed high permeability in PAMPA as well as in Caco-2 cell models (<i>P</i><sub>app</sub> 10<sup>−6</sup> cm/s = 50 and 29.4, respectively), suggesting a possible oral bioavailability for the compound. In vivo pharmacokinetic properties were assessed in rodent species following intravenous (iv) and oral (po) dosing (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). In mice, after iv dosing, <b>49</b> showed medium/high clearance (3.55 L/h/kg) and a volume of distribution about three times the mouse total body water (2.43 L/kg), indicating a good tissue distribution. Plasma levels were detectable up to 6 h post dosing, with a half-life of 0.7 h and an AUC of 6.51 μM·h. After po dosing, the <i>t</i><sub>max</sub> of compound <b>49</b> was found to be reached at 0.4 h, with a terminal half-life compatible to that found after iv administration and with a modest but acceptable oral bioavailability (<i>F</i> = 13.7%).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vitro ADME Parameters of Compound <b>49</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">permeability</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">metabolic stability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">solubility 10% Tween 80 (mg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">Caco-2 (<i>P</i><sub>app</sub> 10<sup>−6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a> (<i>P</i><sub>app</sub> 10<sup>−6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>int</sub> (L/h/kg) rat hepatocyte (1 μM)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>int</sub> (L/h/kg) HLM<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a> (1 μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">29.4</td><td class="colsep0 rowsep0" align="char" char=".">50.0</td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Parallel artificial membrane permeability.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Human liver microsomes.</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Mean ± Standard Deviation Pharmacokinetic Parameters of Compound <b>49</b> Following iv Bolus Single Dose and Oral Single Dose in Harlan nu/nu Mice<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="10" align="center" char="±">in vivo ADME parameters</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center" char="±">PK data (iv), dose<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a>: 10 mg/kg</th><th class="colsep0 rowsep0" colspan="5" align="center" char="±">PK data (po), dose<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a>: 10 mg/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="±"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="char" char="±">AUC<sub>∞</sub> (μM·h)</td><td class="colsep0 rowsep0" align="char" char="±">CL (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char="±"><i>V</i>ss (L/kg)</td><td class="colsep0 rowsep0" align="char" char="±"><i>t</i><sub><sub>1/2</sub></sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="char" char="±"><i>t</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">AUC<sub>∞</sub> (μM·h)</td><td class="colsep0 rowsep0" align="char" char="±"><i>t</i><sub><sub>1/2</sub></sub> (h)</td><td class="colsep0 rowsep0" align="char" char="."><i>F</i><a class="ref internalNav" href="#t9fn3" aria-label="c">c</a> (%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="±">6.07 ± 1.27</td><td class="colsep0 rowsep0" align="char" char="±">6.51 ± 0.60</td><td class="colsep0 rowsep0" align="char" char="±">3.55 ± 0.43</td><td class="colsep0 rowsep0" align="char" char="±">2.43 ± 0.31</td><td class="colsep0 rowsep0" align="char" char="±">0.73 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.85 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">0.42 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">1.36 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">0.86 ± 0.17</td><td class="colsep0 rowsep0" align="char" char=".">13.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last"><i>n</i> = 3 animals per study.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Dosed as HCl in situ salt/glucosate.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">Bioavailability.</p></div></div></div><div class="NLM_p">In vivo efficacy of compound <b>49</b> was evaluated in male BALB/c nu/nu mice subcutaneously xenografted with HCT116 colon adenocarcinoma cells. The compound was administered by oral route at 90 mg/kg, day 1−2 on a weekly schedule × 4 cycles showing good antitumor activity (TG<i>I</i><sub>max</sub> 81%) and good tolerability (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).</div><figure id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0016.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>49</b> shows antitumor activity (TGI = 82%) in rodent BALB/c nu/nu mice carrying subcutaneous HCT116 human colon adenocarcinoma. Mice were treated with either vehicle or <b>49</b> by oral administration (schedule 90 mg/kg 1, 2 daily × 4 cycles). Data are represented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have reported the discovery of a new 4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline class of ATP competitive Plk1 inhibitors. Optimization of the HTS hit compound <b>1a</b> led to 8-{[2-methoxy-5-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide inhibitor <b>49</b>. The crystal structure of methylated Plk1<sub>36−345</sub> construct in complex with several inhibitors together with the SAR information acquired in the optimization of the class have been fruitful to identify key structural components necessary to achieve Plk1 activity and kinase selectivity. This resulted in compound <b>49</b>, which is active on Plk1 in the low nM range, selective vs Plk2, Plk3, and a panel of 39 unrelated Plk kinases, with high in vitro potency across a wide range of solid as well as hematological tumor cell lines. The compound has shown modest but acceptable oral bioavailability resulting in a plasma exposure sufficient to achieve good tumor growth inhibition in subcutaneous HCT-116 tumor xenograft and it was well tolerated after repeated oral administration.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">1 Chemistry</h3><div class="NLM_p">All solvents and reagents, unless otherwise stated, were high grade, commercially available, and used without further purification. All experiments dealing with moisture-sensitive compounds were conducted under dry nitrogen or argon. Organic solutions were evaporated using a Heidolph WB 2001 rotary evaporator at 15−20 mmHg. Thin-layer chromatography was performed on Merck silica gel 60 F<sub>254</sub> precoated plates. Column chromatography was conducted either under medium pressure on silica (Merck silica gel 40−63 μm) or on prepacked silica gel cartridges (Biotage). Components were visualized by UV light (λ: 254 nm) and by iodine vapor. NMR spectra were recorded in DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> on a Varian Inova 400 spectrometer operating at 400.50 MHz for <sup>1</sup>H and on a Varian Inova 500 spectrometer operating at 499.75 MHz for <sup>1</sup>H and at 125.67 MHz for <sup>13</sup>C. Residual solvent signal was used as reference (δ = 2.50 or 7.27 ppm for <sup>1</sup>H and δ = 39.5 ppm for <sup>13</sup>C). Chemical shifts (δ) are reported in parts per million (ppm) and coupling constants (<i>J</i>) in Hz. The following abbreviations are used for multiplicities: s = singlet, bs = broad signal, d = doublet, t = triplet, m = multiplet, dd = doublet of doublets. Standard two-dimensional sequences provided by Varian (gradient-enhanced HSQC and HMBC) were used to assign carbons.</div><div class="NLM_p">Electrospray (ESI) mass spectra were obtained on a Finnigan LCQ ion trap. Unless otherwise specified, all final compounds were homogeneous (purity of not less than 95%), as determined by high-performance liquid chromatography (HPLC). HPLC-UV-MS analyses, used to assess compound purity, were carried out combining the ion trap MS instrument with HPLC system SSP4000 (Thermo Separation Products) equipped with an autosampler LC Pal (CTC Analytics) and UV6000LP diode array detector (UV detection 215−400 nm). Instrument control, data acquisition and processing were performed with the Xcalibur 1.2 software (Finnigan). HPLC chromatography was run at room temperature, and 1 mL/min flow rate, using a Waters X Terra RP 18 column (4.6 mm × 50 mm; 3.5 μm). Mobile phase A was ammonium acetate 5 mM buffer (pH 5.5 with acetic acid):acetonitrile 90:10, and mobile phase B was ammonium acetate 5 mM buffer (pH 5.5 with acetic acid):acetonitrile 10:90; the gradient was from 0 to 100% B in 7 min then hold 100% B for 2 min before requilibration. ESI(+) high resolution mass spectra (HRMS) were obtained on a Waters Q-Tof Ultima directly connected with micro HPLC 1100 Agilent as previously described.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">Synthesis of compounds <b>1a</b>, <b>2</b>, <b>4a</b>, <b>5a</b>, <b>7a</b>, <b>9</b>−<b>13</b>, <b>15</b>−<b>18</b> was previously described,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> compounds <b>4a</b>−<b>c</b>, <b>8a</b>−<b>d</b>, <b>14a</b>−<b>d</b>, and <b>50</b>−<b>76</b> are commercially available.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Ethyl 7-Oxo-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>3</b>)</h4><div class="NLM_p last">To a solution of ethyl (3-ethoxy-2-oxocyclohex-3-en-1-yl)(oxo)acetate <b>2</b> (10.0 g, 41.62 mmol) in ethanol (100 mL), hydrazine hydrate (2.1 mL, 67.4 mmol) was added and the solution stirred at reflux for one day. The solvent was evaporated and the residue redissolved with DCM (20 mL). The organic layer was washed with water (20 mL), dried over anhydrous sodium sulfate, and evaporated to dryness. The crude residue was triturated with diethyl ether and filtered to give the title compound (6.0 g, 70%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.30 (t, <i>J</i> = 7.1 Hz, 3H), 2.03−2.09 (m, 2H), 2.52 (t, <i>J</i> = 6.1 Hz, 2H), 2.91 (t, <i>J</i> = 6.1 Hz, 2H), 4.29 (q, <i>J</i> = 7.1 Hz, 2H), 14.41 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 209 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Ethyl 7-Oxo-1-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>4b</b>)</h4><div class="NLM_p last">To a solution of <b>2</b> (10.0 g, 41,62 mmol) in glacial acetic acid (15 mL), trifluoroethylhydrazine (70% in water, 6.3 mL, 50.0 mmol) was added. The mixture was stirred at room temperature for 6 h. The solvent was evaporated and the crude redissolved in water (20 mL), made basic with 30% NH<sub>4</sub>OH, and extracted with DCM (2 × 50 mL). The combined organic layers were then dried over anhydrous sodium sulfate and evaporated to dryness. The crude residue was triturated with diethyl ether and filtered to give the title compound (6.64 g, 55%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.31 (t, <i>J</i> = 7.1 Hz, 3H), 2.05−2.09 (m, 2H), 2.59 (dd, <i>J</i> = 6.1, 7.3 Hz, 2H), 2.95 (t, <i>J</i> = 6.1 Hz, 2H), 4.31 (q, <i>J</i> = 7.1 Hz, 2H), 5.48 (q, <i>J</i> = 8.8 Hz, 2H). LCMS (ESI) <i>m</i>/<i>z</i> 291 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>12</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> + H<sup>+</sup> 291.0951, found 291.0941.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Ethyl 7-Oxo-1-phenyl-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>4c</b>)</h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>2</b> and using the suitable substituted hydrazine, the compound <b>4c</b> was prepared. Yield, 36%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.32 (t, <i>J</i> = 7.1 Hz, 3H), 2.08−2.15 (m, 2H), 2.56 (dd, <i>J</i> = 5.7, 7.5 Hz, 2H), 3.03 (t, <i>J</i> = 6.1 Hz, 2H), 4.34 (q, <i>J</i> = 7.1 Hz, 2H), 7.51 (s, 5H). LCMS (ESI) <i>m</i>/<i>z</i> 285 (M + H)<sup>+</sup>; HRMS (ESI) calcd for C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub> + H<sup>+</sup> 285.1234, found 285.1236.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Ethyl 7-Oxo-1-trityl-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>4d</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (2.1 g, 10.00 mmol) in DCM (100 mL), triethylamine (1.59 mL, 11.00 mmol) and triphenylmethyl chloride (3.2 g, 11.00 mmol) were added. The solution was stirred at room temperature for 6 h, then DCM (50 mL) was added and finally washed with water (30 mL). The combined organic layers were dried over anhydrous sodium sulfate and evaporated to dryness. The crude residue was triturated with diethyl ether and filtered to give the title compound (3.2 g, 72%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.25 (t, <i>J =</i> 7.0 Hz, 3H), 1.90−1.97 (m, 2H), 2.18 (dd, <i>J</i> = 5.5, 7.5 Hz, 2H), 3.00 (t, <i>J</i> = 6.1 Hz, 2H), 4.26 (q, <i>J =</i> 7.0 Hz, 2H), 6.90−7.35 (m, 15H). LCMS (ESI) <i>m</i>/<i>z</i> 468 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI) calcd for C<sub>29</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub> + NH<sub>4</sub><sup>+</sup> 468.2282, found 468.2289.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Ethyl 6-[(Dimethylamino)methylidene]-7-oxo-1-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>5b</b>)</h4><div class="NLM_p last">To a solution of <b>4b</b> (10.0 g, 34.45 mmol) in DMF (100 mL) <i>N</i>,<i>N</i>-dimethylformamide diisopropyl acetal (12.4 mL, 86.17 mmol) was added. The reaction mixture was stirred at 60 °C for 8 h. The solvent was then evaporated in vacuo and the product crystallized from EtOH to give the title compound (16.9 g, 71%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.30 (t, <i>J</i> = 7.1 Hz, 3H), 2.85 (t, <i>J</i> = 6.3 Hz, 2H), 2.93 (t, <i>J</i> = 6.3 Hz, 2H), 3.14 (s, 6H), 4.30 (q, <i>J</i> = 7.1 Hz, 2H), 5.60 (q, <i>J</i> = 9.0 Hz, 2H), 7.55 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 346 (M + H)<sup><b>+</b></sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Compounds <b>5c</b> and <b>5d</b></h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>4c</b> and <b>4d</b>, the compounds <b>5c</b> and <b>5d</b> were prepared.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Ethyl 6-[(Dimethylamino)methylidene]-7-oxo-1-phenyl-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>5c</b>)</h4><div class="NLM_p last">Yield, 60%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.32 (t, <i>J</i> = 7.1 Hz, 3H), 2.83 (t, <i>J</i> = 6.3 Hz, 2H), 2.95 (t, <i>J</i> = 6.3 Hz, 2H), 3.12 (s, 6H), 4.30 (q, <i>J</i> = 7.1 Hz, 2H), 7.40 (s, 1H), 7.51 (s, 5H). LCMS (ESI) <i>m</i>/<i>z</i> 340 (M + H)<sup><b>+</b></sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Ethyl 6-[(Dimethylamino)methylidene]-7-oxo-1-trityl-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylate (<b>5d</b>)</h4><div class="NLM_p last">Yield, 54%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.26 (t, <i>J =</i> 7.1 Hz, 3 H), 2.74−2.79 (m, 2 H), 2.85−2.90 (m, 2 H), 3.10 (s, 6H), 4.24 (q, <i>J =</i> 7.1 Hz, 2 H), 6.90−7.30 (m, 15 H), 7.43 (s, 1 H). LCMS (ESI) <i>m</i>/<i>z</i> 506 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>32</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 506.2444, found 506.2439.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Ethyl 8-(Phenylamino)-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>7b</b>)</h4><div class="NLM_p last">Phenyl guanidine carbonate (2.13 g, 13.31 mmol) was added to a suspension of <b>5b</b> (3.58 g, 10.81 mmol) in DMF (30 mL) and stirred at 110 °C for 6 h. After the mixture was cooled, the solvent was evaporated and the residue was dissolved in DCM and washed with water. The organic layer was then dried over sodium sulfate and concentrated. The residue was triturated with diethyl ether and filtered to give <b>7b</b> as a white solid (4.51 g, 67%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.35 (t, <i>J</i> = 7.1 Hz, 3H), 2.89 (t, <i>J</i> = 7.1 Hz, 2H), 3.04 (t, <i>J</i> = 7.1 Hz, 2H), 4.38 (q, <i>J</i> = 7.1 Hz, 2H), 5.55 (q, <i>J</i> = 8.8 Hz, 2H), 6.89−6.94 (m 1H), 7.24−7.29 (m, 2H), 7.79−7.83 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> 418 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>20</sub>H<sub>18</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 418.1486, found 418.1472.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Compounds <b>7c</b> and <b>7d</b></h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>5c</b> and <b>5d</b>, the compounds <b>7c</b> and <b>7d</b> were prepared.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Ethyl 1-Phenyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>7c</b>)</h4><div class="NLM_p last">Yield, 62%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.34 (t, <i>J</i> = 7.1 Hz, 3H), 2.93 (t, <i>J</i> = 7.3 Hz, 2H), 3.04 (t, <i>J</i> = 7.3 Hz, 2H), 4.35 (q, <i>J</i> = 7.1 Hz, 2H), 6.75 (t, <i>J</i> = 7.19 Hz, 1H), 6.72−6.77 (m, 1H), 6.87−6.92 (m, 2H), 6.98−7.02 (m, 2H), 7.54−7.62 (m, 5H), 8.47 (s, 1H), 9.36 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 412 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>24</sub>H<sub>21</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 412.1768, found 412.1763.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Ethyl 8-(Phenylamino)-1-trityl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>7d</b>)</h4><div class="NLM_p last">Yield, 22%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.28 (t, <i>J</i> = 7.1 Hz, 3H), 2.69 (t, <i>J</i> = 6.7 Hz, 2H), 3.01 (t, <i>J</i> = 6.7 Hz, 2H), 4.26 (q, <i>J</i> = 7.1 Hz, 2H), 6.83 (m, 1H), 6.96−7.06 (m, 8H), 7.14 (m, 2H), 7.19−7.28 (m, 9H), 7.41 (bs, 1H), 8.18 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 578 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>37</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 578.2551, found 578.2545.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Ethyl 8-(Phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>7e</b>)</h4><div class="NLM_p last">Compound <b>7d</b> (1.5 g, 2.66 mmol) in DCM (50 mL) was treated with trifluoroacetic acid (5 mL). The resulting mixture was stirred at room temperature for 1 h. DCM (40 mL) was added, and the organic phase was washed with saturated solution of sodium hydrogen carbonate, then with brine, dried over sodium sulfate, and concentrated. By crystallization from diisopropyl ether, the title compound was obtained (0.7 g, 80%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.33 (t, <i>J</i> = 7.1 Hz, 3H), 2.87 (t, <i>J</i> = 7.4 Hz, 2H), 2.99 (t, <i>J</i> = 7.4 Hz, 2H), 4.33 (q, <i>J</i> = 7.1 Hz, 2H), 6.90−6.95 (m, 1H), 7.25−7.30 (m, 2H), 7.85−7.90 (m, 2H), 8.40 (s, 1H), 9.53 (bs, 1H), 14.17 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 336 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup> 336.1455, found 336.1454.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 8-(Phenylamino)-1-(2,2,2-trifluoroethyl)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1b</b>)</h4><div class="NLM_p last">Compound <b>7b</b> (10.86 g, 26.04 mmol) was suspended in anhydrous EtOH (250 mL) and treated with 1.5 M KOH in 95% EtOH (60 mL, 90 mmol). The resulted suspension was refluxed for 2 h until an HPLC control revealed the disapparance of the starting material. The resulting precipitate was collected by filtration to give 10.68 g of potassium 1-methyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (96%), which was used as such, without any purification. A suspension of this intermediate (197 mg, 0.46 mmol) in anhydrous DMF (5 mL) was treated with <i>N</i>,<i>N</i>-diisopropylethylamine (0.12 mL, 0.69 mmol), EDC (131 mg, 0.69 mmol) and HOBt·NH<sub>3</sub> (105 mg, 0.69 mmol). The reaction was kept at room temperature overnight and then was diluted with water and the resulting precipitate was collected by filtration to afford <b>1b</b> (148 mg, 78%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.85 (t, <i>J</i> = 8.0 Hz, 2H), 3.02 (t, <i>J</i> = 8.0 Hz, 2H), 5.79 (q, <sup>3</sup><i>J</i><sub>HF</sub> = 8.9 Hz, 2H), 6.98−7.02 (m, 1H), 7.28−7.32 (m, 2H), 7.42 (bs, 1H), 7.46 (bs, 1H), 7.57−7.61 (m, 2H), 8.44 (s, 1H), 9.58 (bs, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.2, 159.0, 157.4, 151.5, 143.3, 140.0, 137.2, 2 × 128.8, 124.9, 123.6 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 280 Hz), 121.7, 2 × 119.4, 118.6, 50.6, 23.6, 18.6. LCMS (ESI) <i>m</i>/<i>z</i> 389 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Compounds <b>1c</b> and <b>1e</b></h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>7c</b> and <b>7e</b>, the compounds <b>1c</b> and <b>1e</b> were prepared.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-Phenyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1c</b>)</h4><div class="NLM_p last">Yield, 85%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.84−2.93 (m, 2H), 3.00−3.06 (m, 2H), 6.70−6.77 (m, 1H), 6.84−6.92 (m, 2H), 6.98−7.03 (m, 2H), 7.37 (bs, 1H), 7.50−7.63 (m, 5H), 7.63 (bs, 1H), 8.45 (s, 1H), 9.33 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.7, 158.8, 157.5, 151.9, 143.4, 140.6, 140.4, 137.4, 3 × 129.1, 2 × 128.3, 126.5, 2 × 125.2, 120.1, 118.9, 2 × 117.2, 28.9, 19.1. LCMS (ESI) <i>m</i>/<i>z</i> 383 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>22</sub>H<sub>18</sub>N<sub>6</sub>O + H<sup>+</sup> 383.1615, found 383.1626.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 8-(Phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1e</b>)</h4><div class="NLM_p last">Yield, 56%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.84 (t, <i>J</i> = 8.0 Hz, 2H), 3.00 (t, <i>J</i> = 8.0 Hz, 2H), 6.93 (m, 1H), 7.25−7.34 (m, 2H), 7.34 (bs, 1H), 7.47 (bs, 1H), 7.85−7.90 (m, 2H), 8.38 (s, 1H), 13.91 (bs, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.4, 159.7, 156.9, 152.9, 141.3, 140.8, 138.4, 2 × 128.3, 122.8, 120.8, 118.8, 2 × 118.2, 23.7, 18.9. HRMS (ESI) calcd for C<sub>16</sub>H<sub>14</sub>N<sub>6</sub>O + H<sup>+</sup> 307.1302, found 307.1306.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-Cyclohexyl-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1f</b>)</h4><div class="NLM_p last">A mixture of <b>1e</b> (46 mg, 0.15 mmol) in THF (4 mL) was treated with triphenylphosphine polimer-bound (0.2 g, 0.6 mmol), di-<i>tert</i>-butylazadicarboxylate (80 mg, 0.45 mmol), and cyclohexanol (60 μL, 0.6 mmol) for 1 h at room temperature. The resin was filtered off, and the solution was concentrated. Crystallization from diethyl ether gave the title compound (14 mg, 24%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.10−1.96 (m, 10H), 2.79 (t, <i>J</i> = 8.0 Hz, 2H), 2.97 (t, <i>J</i> = 8.0 Hz, 2H), 5.50−5.59 (m, 1H), 6.97−7.02 (m 1H), 7.23 (bs, 1H), 7.28−7.34 (m, 2H), 7.34 (bs, 1H), 7.61−7.65 (m, 2H), 8.40 (s, 1H), 9.42 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 164.1, 159.0, 157.0, 153.1, 140.8, 140.4, 135.3, 2 × 128.6, 124.3, 121.4, 2 × 119.2, 118.9, 57.8, 2 × 32.1, 3 × 24.3, 23.7, 18.3. LCMS (ESI) <i>m</i>/<i>z</i> 389 (M + H)<sup>+</sup>.HRMS (ESI) calcd for C<sub>22</sub>H<sub>24</sub>N<sub>6</sub>O + H<sup>+</sup> 389.2084, found 389.2084.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Compounds <b>1g</b>−<b>1i</b></h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>1e</b> and using the suitable alcohol, the compounds <b>1g</b>−<b>1i</b> were prepared.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 8-(Phenylamino)-1-(propan-2-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1g</b>)</h4><div class="NLM_p last">Yield, 48%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.48 (d, <i>J</i> = 6.6 Hz, 6H), 2.79 (t, <i>J</i> = 7.2 Hz, 2H), 2.97 (t, <i>J</i> = 7.2 Hz, 2H), 5.97 (m, 1H), 6.95−7.00 (m, 1H), 7.26 (bs, 1H), 7.31 (m, 2H), 7.36 (bs, 1H), 7.65−7.69 (m, 2H), 8.40 (s, 1H), 9.48 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 349 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>20</sub>N<sub>6</sub>O + H<sup>+</sup> 349.1771, found 349.178.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(1-Methylpiperidin-4-yl)-8-(phenylamino)-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1h</b>)</h4><div class="NLM_p last">Yield, 62%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.85−1.97 (m, 4H), 2.10−2.14 (m, 2H), 2.18 (s, 3H), 2.76−2.82 (m, 4H), 2.96 (t, <i>J</i> = 7.8 Hz, 2H), 5.43−5.54 (m, 1H), 7.00−7.03 (m, 1H), 7.25 (bs, 1H), 7.31−7.35 (m, 2H), 7.36 (bs, 1H), 7.59−7.61 (m, 2H), 8.40 (s, 1H), 9.42 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 404 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>22</sub>H<sub>25</sub>N<sub>7</sub>O + H<sup>+</sup> 404.2193, found 404.2211.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 8-(Phenylamino)-1-[2-(piperidin-1-yl)ethyl]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>1i</b>)</h4><div class="NLM_p last">Yield, 60%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.20−1.26 (m, 6H), 2.18−2.24 (m, 4H), 2.62 (t, <i>J</i> = 6.6 Hz, 2H), 2.79 (t, <i>J</i> = 7.6 Hz, 2H), 2.97 (t, <i>J</i> = 7.6 Hz, 2H), 4.89 (t, <i>J</i> = 6.6 Hz, 2H), 6.94−6.99 (m, 1H), 7.25 (bs, 1H), 7.28−7.33 (m, 2H), 7.41 (bs, 1H), 7.63−7.67 (m, 2H),8.40 (s, 1H), 9.44 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 164.1, 159.2, 153.1, 156.8, 141.5, 140.8, 136.9, 2 × 128.1, 124.5, 121.1, 2 × 119.3, 118.8, 58.6, 2 × 53.8, 48.8, 2 × 25.4, 23.9, 23.7, 18.9. LCMS (ESI) <i>m</i>/<i>z</i> 418 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>23</sub>H<sub>27</sub>N<sub>7</sub>O + H<sup>+</sup> 418.235, found 418.2363.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 8-[(2-Acetylphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>22</b>)</h4><div class="NLM_p last">Palladium acetate Pd(OAc)<sub>2</sub> (20 mg, 0.09 mmol), (±)-BINAP (55 mg, 0.09 mmol), and DMF (5 mL) were charged in a round-bottom flask flushed with argon. The flask was evacuated and backfilled with argon. The mixture was stirred under argon for 30 min and added to a mixture of <b>18</b> (319 mg, 0.9 mmol), 2-acetylaniline (0.162 mL, 1.35 mmol), and potassium carbonate (1.24 g, 8.97 mmol) in DMF (10 mL). The resulting mixture was stirred at 80 °C for 4 h under argon. After cooling to room temperature, the reaction mixture was filtered on a pad of celite. The solvent was concentrated, the crude solid was purified by flash chromatography on silica gel (eluant, DCM/EtOH 90/10) to afford 153 mg (47%) of the title compound; mp 287 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.69 (s, 3H), 2.86 (t, <i>J</i> = 8.0 Hz, 2H), 3.01 (t, <i>J</i> = 8.0 Hz,, 2H), 4.34 (s, 3H), 7.09 (ddd, <i>J</i> = 8.0, 7.2, 1.1 Hz, 1H), 7.27 (bs, 1H), 7.49 (bs, 1H), 7.64 (ddd, <i>J</i> = 8.5, 7.2, 1.1 Hz, 1H), 8.07 (dd, <i>J</i> = 8.0, 1.1 Hz, 1H) 8.50 (s, 1H), 8.73 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 11.59 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 203.1, 164.0, 158.2, 157.1, 153.2, 141.9, 141.0, 136.1, 134.7, 132.7, 124.8, 121.5, 120.8, 120.2, 118.7, 39.4, 28.7, 24.1, 18.7. LCMS (ESI) <i>m</i>/<i>z</i> 363 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 363.1564, found: 363.155.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Compounds <b>19</b>−<b>21</b>, <b>23</b>−<b>49</b></h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>18</b> and using the suitable substituted aniline, the compounds <b>19</b>−<b>21</b>, <b>23−49</b> were prepared.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-Methyl-8-{[2-(trifluoromethyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>19</b>)</h4><div class="NLM_p last">Yield, 10%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.79 (t, <i>J</i> = 7.2 Hz, 2H), 2.96 (t, <i>J</i> = 7.2 Hz, 2H), 4.03 (s, 3H), 7.22 (bs, 1H), 7.41 (t, <i>J</i> = 7.4 Hz, 1H), 7.43 (bs, 1H), 7.68 (t, <i>J</i> = 7.4 Hz, 1H), 7.74 (d, <i>J</i> = 7.4 Hz, 2H), 8.32 (s, 1H), 8.73 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.9, 160.5, 157.3, 152.9, 141.0, 137.9, 136.2, 132.9, 129.4, 126.5, 125.4, 124.4, 123.9 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 270 Hz, 120.0, 119.1, 38.2, 23.9, 18.8). LCMS (ESI) <i>m</i>/<i>z</i> 389 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>N<sub>6</sub>O + H<sup>+</sup> 389.1332, found 389.132.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-Methyl-8-{[3-(trifluoromethyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>20</b>)</h4><div class="NLM_p last">Yield, 25%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.84 (t, <i>J</i> = 7.2 Hz, 2H), 3.00 (t, <i>J</i> = 7.2 Hz, 2H), 4.32 (s, 3H), 7.26 (bs, 1H), 7.28 (d, <i>J</i> = 8.6 Hz, 1H), 7.46 (bs, 1H), 7.53 (t, <i>J</i> = 8.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.6 Hz, 1H), 8.19 (s, 1H), 8.47 (s, 1H), 9.87 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.9, 158.6, 156.7, 152.9, 141.6, 141.1, 136.4, 130.3, 129.3, 125.5 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 270 Hz), 124.9, 122.0, 119.9, 116.6, 114.2, 39.2, 24.1, 18.2. LCMS (ESI) <i>m</i>/<i>z</i> 389 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-Methyl-8-{[4-(trifluoromethyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>21</b>)</h4><div class="NLM_p last">Yield, 9.5%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.84 (t, <i>J</i> = 7.2 Hz, 2H), 3.00 (t, <i>J</i> = 7.2 Hz, 2H), 4.35 (s, 3H), 7.26 (bs, 1H), 7.48 (bs, 1H), 7.65 (m, 2H), 7.95 (m, 2H), 8.48 (s, 1H), 9.97 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 164.2, 158.9, 157.1, 153.3, 144.7, 141.3, 136.6, 2 × 125.7, 124.9, 124.5 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 270 Hz), 121.5, 120.5, 2 × 118.1, 39.8, 23.9, 18.6. LCMS (ESI) <i>m</i>/<i>z</i> 389 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>N<sub>6</sub>O + H<sup>+</sup> 389.1332, found 389.1317.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 8-[(3-Acetylphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>23</b>)</h4><div class="NLM_p last">Yield, 8%; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.57 (s, 3H), 2.83 (t, <i>J</i> = 7.2 Hz, 2H), 2.99 (t, <i>J</i> = 7.2 Hz, 2H), 4.33 (s, 3H), 7.26 (bs, 1H), 7.46 (t, <i>J</i> = 7.8 Hz, 1H), 7.47 (bs, 1H), 7.59 (ddd, <i>J</i> = 7.8, 1.6, 1.0 Hz, 1H), 7.94 (ddd, <i>J</i> = 7.8, 2.2, 1.0 Hz, 1H), 8.32 (t, J = 2.2, 1.6 Hz, 1H), 8.44 (s, 1H), 9.73 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 198.3, 163.4, 158.8, 156.8, 153.0, 141.0, 140.9, 137.6, 136.3, 129.0, 124.6, 123.6, 121.7, 119.5, 118.0, 39.5, 26.7, 24.0, 18.9. LCMS (ESI) <i>m</i>/<i>z</i> 363 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 363.1564, found 363.1548.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 8-[(4-Acetylphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>24</b>)</h4><div class="NLM_p last">Yield, 8%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.52 (s, 3H), 2.85 (t, <i>J</i> = 7.4 Hz, 2H), 3.00 (t, <i>J</i> = 7.4 Hz, 2H), 4.37 (s, 3H), 7.26 (bs, 1H), 7.48 (bs, 1H), 7.85−7.90 (m, 2H), 7.91−7.95 (m, 2H), 8.49 (s, 1H), 9.99 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 363 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 363.1564, found 363.1559.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 8-[(2-Methoxyphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>25</b>)</h4><div class="NLM_p last">Yield, 77%; mp 256 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.81 (t, <i>J</i> = 7.7 Hz, 2H), 2.98 (t, <i>J</i> = 7.7 Hz, 2H), 3.85 (s, 3H), 4.25 (s, 3H), 6.92−6.99 (m, 1H), 7.00−7.09 (m, 2H), 7.24 (br s, 1H), 7.45 (br s, 1H), 8.01−8.05 (m, 1H), 8.13 (s, 1H), 8.38 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.4, 159.6, 156.2, 153.4, 150.5, 141.4, 136.6, 129.2, 124.9, 122.3, 120.2, 119.6, 119.4, 110.0, 54.6, 38.5, 23.2, 18.0. LCMS (ESI) <i>m</i>/<i>z</i> 351 (M + H)<sup>+</sup>.; HRMS (ESI) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 351.1564, found 351.1559.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 8-[(3-Methoxyphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>26</b>)</h4><div class="NLM_p last">Yield, 25%; mp 298 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.81 (t, <i>J</i> = 7.4 Hz, 2H), 2.98 (t, <i>J</i> = 7.4 Hz, 2H), 3.74 (s, 3H), 4.34 (s, 3H), 6.54 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (dd, <i>J</i> = 8.3, 8.0 Hz, 1H), 7.25 (bs, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (bs, 1H), 7.45 (bs, 1H), 8.41 (s, 1H), 9.48 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 164.7, 160.7, 159.7, 157.0, 153.8, 142.7, 141.8, 137.2, 125.5, 119.9, 129.3, 106.3, 104,9, 104.9, 54.8, 39.3, 23.5, 18.8. LCMS (ESI) <i>m</i>/<i>z</i> 351 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 351.1564, found 351.1566.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 8-[(4-Methoxyphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>27</b>)</h4><div class="NLM_p last">Yield, 62%; mp 234 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.79 (t, <i>J</i> = 7.2 Hz, 2H), 2.97 (t, <i>J</i> = 7.2 Hz, 2H), 3.73 (s, 3H), 4.30 (s, 3H), 6.87−6.91 (m, 2H), 7.25 (bs, 1H), 7.45 (s, 1H), 7.55−7.60 (m, 2H), 8.34 (s, 1H), 9.29 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 164.0, 159.2, 156.6, 154.4, 152.7, 140.9, 136.4, 133.4, 124.3 2 × 120.7, 118.1, 2 × 113.2, 54.9, 39.3, 23.8, 18.7. LCMS (ESI) <i>m</i>/<i>z</i> 351 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 351.1564, found 351.1557.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-Methyl-8-[(2-nitrophenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>28</b>)</h4><div class="NLM_p last">Yield, 74%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.84 (t, <i>J</i> = 7.7 Hz, 2H), 3.00 (t, <i>J</i> = 7.70 Hz, 2H), 4.21 (s, 3 H), 7.25 (m, 1H), 7.27 (bs, 1H), 7.47 (bs, 1H), 7.73 (m, 1 H), 8.08 (m, 1H), 8.16 (m, 2H), 8.44 (s, 1H), 10.02 (s, 1 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.9, 158.0, 156.9, 152.9, 140.9, 139.7, 135.9, 134.9, 134.3, 124.9, 124.6, 123.6, 122.3, 120.8, 39.0, 23.4, 18.5. LCMS (ESI) <i>m</i>/<i>z</i> 366 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>17</sub>H<sub>15</sub>N<sub>7</sub>O<sub>3</sub> + H<sup>+</sup> 366.1309, found 366.1295.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-Methyl-8-[(3-nitrophenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>29</b>)</h4><div class="NLM_p last">Yield, 64%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.85 (t, <i>J</i> = 7.6 Hz, 2H), 3.01 (t, <i>J</i> = 7.6 Hz, 2H), 4.36 (s, 3H), 7.27 (bs, 1H), 7.48 (bs, 1H), 7.59 (t, <i>J</i> = 8.2 Hz, 1H), 7.80 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 8.02 (dd, <i>J</i> = 8.2, 1.0 Hz, 1H), 8.51 (s, 1H), 8.82 (dd, <i>J</i> = 1.9, 1.0 Hz, 1H), 10.08 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.8, 158.6, 156.8, 153.2, 148.4, 142.0, 140.8, 136.2, 129.3, 124.7, 123.8, 120.3, 115.0, 111.6, 39.2, 23.5, 18.3. LCMS (ESI) <i>m</i>/<i>z</i> 366 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>17</sub>H<sub>15</sub>N<sub>7</sub>O<sub>3</sub> + H<sup>+</sup> 366.1309, found 366.1294.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-Methyl-8-[(4-nitrophenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>30</b>)</h4><div class="NLM_p last">Yield, 63%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.87 (t, <i>J</i> = 7.3 Hz, 2H), 3.01 (t, <i>J</i> = 7.3 Hz, 2H), 4.37 (s, 3H), 7.30 (bs, 1H), 7.54 (bs, 1H), 7.97−8.00 (m, 2H), 7.22−7.25 (m, 2H), 8.54 (s, 1H), 10.39 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 366 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>17</sub>H<sub>15</sub>N<sub>7</sub>O<sub>3</sub> + H<sup>+</sup> 366.1309, found 366.1303.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-Methyl-8-[(2-methylphenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>31</b>)</h4><div class="NLM_p last">Yield, 7%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.24 (s, 3H), 2.78 (t, <i>J</i> = 7.3 Hz, 2H), 2.96 (t, <i>J</i> = 7.3 Hz, 2H), 4.11 (s, 3H), 7.05 (m, 1H), 7.17 (m, 1H), 7.21 (bs, 1H), 7.22 (bs, 1H), 7.22 (m, 1H), 7.42 (bs, 1H), 7.50 (m, 1H), 8.31 (s, 1H), 8.73 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 335 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>O + H<sup>+</sup> 335.1615, found 335.1614.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-Methyl-8-{[2-(methylsulfanyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>32</b>)</h4><div class="NLM_p last">Yield, 52%; mp 215 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.39 (s, 3H), 2.79 (t, <i>J</i> = 7.3 Hz, 2H), 2.96 (t, <i>J</i> = 7.3 Hz, 2H), 4.12 (s, 3H), 7.15−7.25 (m, 2H), 7.22 (bs, 1H), 7.36−7.40 (m, 1H), 7.43 (bs, 1H), 7.60−7.63 (m, 1H), 8.32 (s, 1H), 8.63 (bs, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.7, 159.8, 157.1, 152.9, 140.9, 137.5, 136.1, 133.3, 127.3, 125.3, 125.2, 125.2, 124.1, 118.4, 39.3, 23.8, 19.3, 15.1. LCMS (ESI) <i>m</i>/<i>z</i> 367 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>6</sub>OS + H<sup>+</sup> 367.1336, found 367.1346.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-Methyl-8-{[2-(methylamino)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>33</b>)</h4><div class="NLM_p last">Yield, 30%; mp 256 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.71 (d, <i>J</i> = 5 Hz, 3H), 2.76 (t, <i>J</i> = 7.8 Hz, 2H), 2.95 (t, <i>J</i> = 7.8 Hz, 2H), 4.09 (s, 3H), 5.05 (q, <i>J</i> = 5 Hz, 1H), 6.56−6.61 (m, 2H), 7.01−7.06 (m, 1H), 7.21 (bs, 1H), 7.24−7.27 (m, 1H), 7.42 (bs, 1H), 8.28 (s, 1H), 8.40 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.1, 160.6, 156.7, 153.0, 144.8, 141.2, 136.6, 125.5, 125.5, 125.4, 124.2, 117.9, 114.9, 109.4, 38.7, 29.5, 23.7, 18.9. LCMS (ESI) <i>m</i>/<i>z</i> 350 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>19</sub>N<sub>7</sub>O + H<sup>+</sup> 350.1724, found: 350.1714.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 8-[(2-Fluorophenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>34</b>)</h4><div class="NLM_p last">Yield, 13%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.80 (t, <i>J</i> = 7.2 Hz, 2H), 2.97 (t, <i>J</i> = 7.2 Hz, 2H), 4.16 (s, 3H), 7.10−7.27(m, 3H), 7.23 (bs, 1H), 7.44 (bs, 1H), 7.70−7.76 (m, 1H), 8.36 (s, 1H), 9.08 (bs, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.3, 159.6, 157.0, 155.8 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 160 Hz), 153.1, 141.2, 136.4, 128.0, 125.3, 124.6, 124.4, 123.7, 119.0, 115.1, 38.9, 23.8, 18.6. LCMS (ESI) <i>m</i>/<i>z</i> 339 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>6</sub>O + H<sup>+</sup> 339.1364, found 339.1348.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-Methyl-8-{[2-(propan-2-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>35</b>)</h4><div class="NLM_p last">Yield, 17%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.13 (d, <i>J</i> = 7.0 Hz, 6H), 2.76 (t, <i>J</i> = 7.8 Hz, 2H), 2.95 (t, <i>J</i> = 7.8 Hz, 2H), 3.25 (m, 1H), 4.05 (s, 3H), 7.15−7.22 (m, 2H), 7.20 (bs, 1H), 7.30−7.36 (m, 2H), 7.41 (bs, 1H), 8.26 (s, 1H), 8.74 (bs, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.8, 161.1, 157.1, 152.9, 144.3, 140.9, 136.9, 136.3, 127.3, 125.5, 125.5, 125.2, 124.2, 117.7, 38.7, 26.8, 23.8, 2 × 22.7, 18.7. LCMS (ESI) <i>m</i>/<i>z</i> 363 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>20</sub>H<sub>22</sub>N<sub>6</sub>O + H<sup>+</sup> 363.1928, found 363.1913.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Methyl 2-[(3-Carbamoyl-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazolin-8-yl)amino]benzoate (<b>36</b>)</h4><div class="NLM_p last">Yield, 18%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.86 (t, <i>J</i> = 7.9 Hz, 2H), 3.01 (t, <i>J</i> = 7.9 Hz, 2H), 3.87 (s, 3H), 4.33 (s, 3H), 7.07 (dd, <i>J</i> = 8.7, 7.9 Hz, 1H), 7.27 (bs, 1H), 7.48 (bs, 1H), 7.64 (dd, <i>J</i> = 8.2, 7.9 Hz, 1H), 7.99 (d, <i>J</i> = 8.2 Hz, 1H), 8.50 (s, 1H), 8.67 (d, <i>J</i> = 8.7 Hz, 1H), 10.73 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 379 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub> + H<sup>+</sup> 379.1513, found 379.1517.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 8-[(2-Carbamoylphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>37</b>)</h4><div class="NLM_p last">Yield, 25%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.84 (t, <i>J</i> = 7.3 Hz, 2H), 3.00 (t, <i>J</i> = 7.3 Hz, 2H), 4.33 (s, 3H), 7.01 (m, 1H), 7.26 (bs, 1H), 7.47 (bs, 1H), 7.50 (m, 1H), 7.62 (bs, 1H), 7.78 (dd, J = 7.8, 1.5 Hz, 1H), 8.19 (bs, 1H), 8.45 (s, 1H), 8.61 (dd, J = 8.5, 0.7 Hz, 1H), 11.45 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 171.5, 163.8, 158.5, 156.8, 152.6, 141.3, 140.9, 136.1, 131.6, 128.7, 124.5, 119.9, 119.8, 119.0, 118.9, 39.4, 23.5, 17.4. LCMS (ESI) <i>m</i>/<i>z</i> 364 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>18</sub>H<sub>17</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 364.1516, found 364.1516.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 1-Methyl-8-[(2-sulfamoylphenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>38</b>)</h4><div class="NLM_p last">Yield, 22%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.86 (t, <i>J</i> = 7.3 Hz, 2H), 3.01 (t, <i>J</i> = 7.3 Hz, 2H), 4.29 (s, 3H), 7.14 (ddd, <i>J</i> = 8.0, 7.4, 1.0 Hz, 1H), 7.26 (bs, 1H), 7.48 (bs, 1H), 7.56 (ddd, <i>J</i> = 8.4, 7.4, 1.6 Hz, 1H), 7.84 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 8.46 (dd, <i>J</i> = 8.4, 1.0 Hz, 1H), 8.48 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 400 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>O<sub>3</sub>S + H<sup>+</sup> 400.1186, found 400.1188.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 8-(Biphenyl-2-ylamino)-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>39</b>)</h4><div class="NLM_p last">Yield, 30%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.73 (t, <i>J</i> = 7.2 Hz, 2H), 2.93 (t, <i>J</i> = 7.2 Hz, 2H), 4.10 (s, 3H), 7.22 (bs, 1H), 7.23−7.43 (m, 9H), 7.71 (dd, <i>J</i> = 8.0, 1.1 Hz, 1H), 8.23 (s, 1H), 8.38 (bs, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.9, 160.1, 157.2, 152.7, 141.1, 139.7, 137.0, 136.6, 136.4, 130.2, 2 × 128.8, 2 × 128.2, 128.2, 126.8, 126.1, 124.8, 124.3, 118.2, 38.9, 23.9, 18.5. LCMS (ESI) <i>m</i>/<i>z</i> 397 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>23</sub>H<sub>20</sub>N<sub>6</sub>O + H<sup>+</sup> 397.1771, found 397.1778.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-Methyl-8-[(2-phenoxyphenyl)amino]-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>40</b>)</h4><div class="NLM_p last">Yield, 62%.; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.79 (t, <i>J</i> = 7.3 Hz, 2H), 2.96 (t, <i>J</i> = 7.3 Hz, 2H), 4.23 (s, 3H), 6.93−6.99 (m, 3H), 7.06−7.11 (m, 2H), 7.18 (ddd, <i>J</i> = 8.0, 8.0, 1.6 Hz, 1H), 7.24 (bs, 1H), 7.31−7.36 (m, 2H), 7.44 (bs, 1H), 8.01 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H), 8.33 (s, 1H), 8.50 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.8, 158.7, 157.4, 157.1, 152.8, 147.8, 140.8, 135.9, 131.3, 2 × 130.3, 124.4, 124.0, 124.0, 123.9, 123.9, 119.5, 118.9, 2 × 118.1, 39.7, 24.3, 19.3. LCMS (ESI) <i>m</i>/<i>z</i> 413 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>23</sub>H<sub>20</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 413.172, found 413.1711.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 8-[(2-Benzylphenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>41</b>)</h4><div class="NLM_p last">Yield, 33%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.76 (t, <i>J</i> = 7.3 Hz, 2H), 2.95 (t, <i>J</i> = 7.3 Hz, 2H), 4.02 (s, 2H), 4.06 (s, 3H), 7.07−7.25 (m, 9H), 7.42 (bs, 1H), 7.53 (dd, <i>J</i> = 7.9, 0.8 Hz, 1H), 8.28 (s, 1H), 8.69 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 411 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>24</sub>H<sub>22</sub>N<sub>6</sub>O + H<sup>+</sup> 411.1928, found 411.1931.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-Methyl-8-{[2-(phenylamino)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>42</b>)</h4><div class="NLM_p last">Yield, 22%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.79 (t, <i>J</i> = 7.3 Hz, 2H), 2.97 (t, <i>J</i> = 7.3 Hz, 2H), 4.21 (s, 3H), 6.73−6.78 (m, 1H), 6.85−6.90 (m, 2H), 6.99−7.07 (m, 2H), 7.13−7.19 (m, 2H), 7.23 (bs, 1H), 7.25−7.28 (m, 1H), 7.44 (bs, 1H), 7.82−7.87 (m, 1H), 8.35 (s, 1H), 8.44 (bs, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.6, 159.4, 156.8, 152.8, 144.5, 140.8, 136.2, 135.0, 131.8, 2 × 128.8, 124.3, 124.1, 123.9, 122.0, 120.6, 118.9, 118.5, 2 × 115.9, 39.0, 23.8, 18.7. LCMS (ESI) <i>m</i>/<i>z</i> 412 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>23</sub>H<sub>21</sub>N<sub>7</sub>O + H<sup>+</sup> 412.188, found: 412.1867.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-Methyl-8-{[2-(phenylcarbonyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>43</b>)</h4><div class="NLM_p last">Yield, 55%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.79 (t, <i>J</i> = 7.3 Hz, 2H), 2.98 (t, <i>J</i> = 7.3 Hz, 2H), 4.26 (s, 3H), 7.14 (ddd, J = 8.4, 7.8, 1.1 Hz, 1H), 7.26 (bs, 1H), 7.45−7.66 (m, 8H), 8.23 (dd, J = 8.4, 0.7 Hz, 1H), 8.27 (s, 1H), 10.27 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 425 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>24</sub>H<sub>20</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 425.172, found 425.1715.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-Methyl-8-{[2-(phenylsulfanyl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>44</b>)</h4><div class="NLM_p last">Yield, 44%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.80 (t, <i>J</i> = 7.3 Hz, 2H), 2.97 (t, <i>J</i> = 7.3 Hz, 2H), 4.18 (s, 3H), 7.13 (td, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.18−7.23 (m, 3H), 7.24 (bs, 1H), 7.26−7.32 (m, 2H), 7.41−7.45 (m, 2H), 7.46 (bs, 1H), 8.00 (dd, <i>J</i> = 8.7, 1.5 Hz, 1H), 8.35 (s, 1H), 8.64 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 163.8, 159.1, 156.9, 153.1, 141.0, 140.6, 136.1, 135.7, 134.1, 2 × 129.4, 129.1, 2 × 128.7, 126.7, 125.7, 124.5, 124.4, 123.2, 119.5, 39.1, 23.9, 18.6. LCMS (ESI) <i>m</i>/<i>z</i> 429 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>23</sub>H<sub>20</sub>N<sub>6</sub>OS + H<sup>+</sup> 429.1492, found 429.1505.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 8-{[2-Acetyl-3-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>45</b>)</h4><div class="NLM_p last">Yield, 36%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.22 (s, 3H), 2.40−2.48 (m, 4H), 2.56 (s, 3H), 2.80 (t, <i>J</i> = 7.3 Hz, 2H), 2.89−2.94 (m, 4H), 2.97 (t, <i>J</i> = 7.3 Hz, 2H), 4.22 (s, 3H), 6.94 (d, <i>J</i> = 8.8 Hz, 1H), 7.24 (bs, 1H), 7.39 (dd, <i>J</i> = 8.8, 7.8 Hz), 7.45 (bs, 1H), 7.70 (d, <i>J</i> = 7.8 Hz, 1H), 8.35 (s, 1H), 9.03 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 206.2, 164.7, 158.9, 156.7, 153.3, 152.1, 141.1, 137.2, 136.2, 130.7, 127.7, 124.6, 119.5, 117.8, 114.1, 2 × 54.5, 2 × 52.5, 45.4, 39.2, 30.9, 24.1, 18.8. LCMS (ESI) <i>m</i>/<i>z</i> 461 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>24</sub>H<sub>28</sub>N<sub>8</sub>O<sub>2</sub> + H<sup>+</sup> 461.2408, found 461.2417.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 8-{[2-Acetyl-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>46</b>)</h4><div class="NLM_p last">Yield, 50%; mp 242 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.26 (s, 3H), 2.47−2.55 (signal obscured by DMSO, 4H), 2.65 (s, 3H), 2.82 (t, <i>J</i> = 7.7 Hz, 2H), 2.99 (t, <i>J</i> = 7.7 Hz, 2H), 3.12−3.19 (m, 4H), 4.31 (s, 3H), 7.25 (br s, 1H), 7.32 (dd, <i>J</i> = 9.1, 2.7 Hz, 1H), 7.43 (d, <i>J</i> = 2.7 Hz, 1H), 7.47 (bs, 1H), 8.42 (s, 1H), 8.48 (d, <i>J</i> = 9.1 Hz, 1H), 11.03 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 203.2, 163.9, 158.2, 157.0, 153.2, 145.3, 140.7, 136.3, 133.8, 124.6, 123.4, 122.5, 120.6, 119.9, 117.8, 2 × 54.5, 2 × 48.4, 45.7, 39.3, 28.6, 24.0, 18.6. LCMS (ESI) <i>m</i>/<i>z</i> 461 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>24</sub>H<sub>28</sub>N<sub>8</sub>O<sub>2</sub> + H<sup>+</sup> 461.2408, found 461.2411.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 8-{[2-Acetyl-5-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>47</b>)</h4><div class="NLM_p last">Yield, 45%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.23 (s, 3H), 2.42−2.47 (m, 4H), 2.54 (s, 3H), 2.85 (t, <i>J</i> = 7.3 Hz, 2H), 3.00 (t, <i>J</i> = 7.7 Hz, 2H), 3.35−3.40 (m, 4H), 4.33 (s, 3H), 6.60 (dd, <i>J</i> = 9.1, 2.7 Hz, 1H), 7.27 (bs, 1H), 7.48 (bs, 1H), 7.85 (d, <i>J</i> = 9.1 Hz, 1H), 8.30 (d, <i>J</i> = 2.7 Hz, 1H), 8.52 (s, 1H), 12.12 (s, 1H). <sup>13</sup>C NMR (DMSO-<sub>d</sub><sub>6</sub>) δ ppm 200.0, 164.8, 158.4, 156.1, 155.1, 153.6, 144.4, 141.1, 136.2, 133.9, 125.3, 120.7, 111.9, 105.4, 100.6, 2 × 54.2, 2 × 46.0, 45.3, 38.9, 27.4, 24.0, 18.2. LCMS (ESI) <i>m</i>/<i>z</i> 461 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>24</sub>H<sub>28</sub>N<sub>8</sub>O<sub>2</sub> + H<sup>+</sup> 461.2408, found 461.2394.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 8-{[2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>48</b>)</h4><div class="NLM_p last">Yield, 11%; mp 127 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.30 (br s, 3H), 2.52−2.62 (m, 4H), 2.77 (t, <i>J</i> = 7.7 Hz, 2H), 2.96 t, <i>J</i> = 7.7 Hz, 2H), 3.10−3.20 (m, 4H), 3.80 (s, 3H), 4.22 (s, 3H), 6.50 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.63 (d, <i>J</i> = 2.5 Hz, 1H), 7.23 (br s, 1H), 7.43 (s, 1H), 7.65 (d, <i>J</i> = 8.8 Hz, 1H), 8.00 (s, 1H), 8.28 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 164.9, 160.0, 157.1, 153.3, 152.4, 149.0, 141.4, 136.8, 124.9, 123.7, 121.0, 118.4, 106.3, 100.0, 55.7, 2 × 54.5, 2 × 48.9, 45.8, 39.2, 24.3, 18.9. LCMS (ESI) <i>m</i>/<i>z</i> 449 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>N<sub>8</sub>O<sub>2</sub> + H<sup>+</sup> 449.2408, found 449.2398.</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 8-{[2-Methoxy-5-(4-methylpiperazin-1-yl)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>49</b>)</h4><div class="NLM_p last">Yield, 25%; mp 133 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.22 (s, 3H), 2.43−2.49 (m, 4H), 2.80 (t, <i>J</i> = 7.7 Hz, 2H), 2.98 (t, <i>J</i> = 7.7 Hz, 2H), 2.99−3.03 (m, 4H), 3.78 (s, 3H), 4.26 (s, 3H), 6.58 (dd, <i>J</i> = 8.9, 2.9 Hz, 1H), 6.91 (d, <i>J</i> = 8.9 Hz, 1H), 7.25 (bs., 1H), 7.45 (bs, 1H), 7.72 (d, <i>J</i> = 2.9 Hz, 1H), 8.06 (s, 1H), 8.39 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 163.6, 158.9, 157.2, 152.9, 145.7, 143.8, 140.9, 136.1, 129.0, 124.4, 118.9, 111.3, 110.7, 110.1, 56.2, 2 × 54.7, 2 × 49.9, 45.9, 39.2, 23.8, 18.8. LCMS (ESI) <i>m</i>/<i>z</i> 449 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>23</sub>H<sub>28</sub>N<sub>8</sub>O<sub>2</sub> + H<sup>+</sup> 449.2408, found 449.24.</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Ethyl 8-({2-[(<i>tert</i>-Butoxycarbonyl)amino]phenyl}amino)-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>77</b>)</h4><div class="NLM_p last">Palladium acetate [Pd(OAc)<sub>2</sub>] (101 mg, 0.45 mmol), (±)-BINAP (280 mg, 0.45 mmol), and DMF (65 mL) were charged to a round-bottom flask flushed with argon. The flask was evacuated and backfilled with argon. The mixture was stirred under argon for 30 min and added to a mixture of <i>N</i>-Boc-<i>o</i>-phenylendiamine (2.6 g, 12.52 mmol), compound <b>16</b> (1.6 g, 4.16 mmol), and potassium carbonate (5.74 g, 41.53 mmol) in DMF (50 mL). The resulting mixture was stirred at 70 °C for 6 h under argon. After cooling to room temperature, the reaction mixture was filtered on a pad of celite. The solvent was concentrated, the crude solid was purified by flash chromatography on silica gel (eluant, hexane/ethyl acetate 60/40) to afford the title compound (1.18 g, 61%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.30 (t, <i>J</i> = 7.1 Hz, 3H), 1.44 (s, 9H), 2.83 (t, <i>J</i> = 7.3 Hz, 2H), 2.96 (t, <i>J</i> = 7.7 Hz, 2H), 4.18 (s, 3H), 4.28 (q, <i>J =</i> 7.7 Hz, 2H), 7.06−7.15 (m, 2 H), 7.47−7.52 (m, 1H), 7.68−7.71 (m, 1H), 8.36 (s, 1H), 8.64 (s, 1H), 8.68 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 465 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>24</sub>H<sub>28</sub>N<sub>6</sub>O<sub>4</sub> + H<sup>+</sup> 465.2245, found 465.2238.</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Ethyl 8-[(2-aminophenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>78</b>)</h4><div class="NLM_p last">To a solution of <b>77</b> (0.85 g, 1.83 mmol) in DCM (50 mL) HCl 4 N in dioxane (30 mL) was added. The solution was stirred at room temperature for 2 h and then the solvent removed in vacuo. The residue was crystallized from diethyl ether to give compound <b>78</b> (0.70 g, 96%) of the title compound. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm (as free base) 1.30 (t, <i>J =</i> 7.1 Hz, 3H), 2.80 (t, <i>J</i> = 7.3 Hz, 2H), 2.95 (t, <i>J</i> = 7.7 Hz, 2H), 4.17 (s, 3 H), 4.28 (q, <i>J =</i> 7.1 Hz, 2 H), 4.83 (bs, 2 H), 6.56 (td, <i>J =</i> 7.9, 1.5 Hz, 1H), 6.74 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 6.88 (td, <i>J =</i> 7.9, 1.5 Hz, 1H), 7.30 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 8.31 (s, 1H), 8.51 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 365 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>20</sub>N<sub>6</sub>O<sub>2</sub> + H<sup>+</sup> 365.172, found 365.1713.</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Ethyl 8-{[2-(Acetylamino)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxylate (<b>79</b>)</h4><div class="NLM_p last">To a solution of <b>78</b> (0.3 g, 0.75 mmol) and DIPEA (0.51 mL, 2.93 mmol) in DCM (30 mL) under nitrogen acetyl chloride (0.11 mL, 1.49 mmol) dissolved in DCM (2 mL) was added. After 1 h the reaction mixture was concentrated and the residue was diluted with DCM, washed with NaHCO<sub>3</sub> (2 × 30 mL) and water (1 × 20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude residue was diluted with diethyl ether and decanted, to give 0.22 g (72%) of the final compound. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.30 (t, <i>J</i> = 7.1 Hz, 3H), 2.07 (s, 3H), 2.83 (t, <i>J</i> = 7.4 Hz, 2H), 2.96 (t, <i>J</i> = 7.4 Hz, 2H), 4.18 (s, 3H), 4.28 (q, <i>J</i> = 7.1 Hz, 1H), 7.05−7.11 (m, 1H), 7.14−7.20 (m, 1H), 7.48 (d, <i>J</i> = 7.7 Hz, 1H), 7.77 (d, <i>J</i> = 7.7 Hz, 1H), 8.37 (s, 1 H), 8.58 (bs, 1H), 9.62 (bs, 1 H). HRMS (ESI) calcd for C<sub>21</sub>H<sub>22</sub>N<sub>6</sub>O<sub>3</sub> + H<sup>+</sup> 336.1567, found: 336.1582.</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 8-[(2-Aminophenyl)amino]-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>80</b>)</h4><div class="NLM_p last">To a suspension of <b>78</b> (65 mg, 0.18 mmol) in EtOH (10 mL) 30% NH<sub>4</sub>OH (20 mL) was added. The mixture was maintained at 70 °C under stirring for 12 h in a sealed bottle. The solvent was then evaporated to dryness and the crude was purified by reverse phase chromatography to give <b>80</b> (10 mg, 17%) of the final compound. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.7 (t, <i>J</i> = 7.3 Hz, 2H), 2.96 (t, <i>J</i> = 7.7 Hz, 2H), 4.15 (s, 3H), 4.84 (bs, 2H), 6.57 (td, <i>J</i> = 7.9, 1.5 Hz, 1H), 6.74 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 6.88 (td, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.21 (bs, 1 H), 7.32 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.42 (bs, 1H), 8.29 (s, 1H), 8.47 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 164.2, 160.3, 155.9, 153.3, 142.7, 140.9, 136.5, 125.3, 125.2, 125.1, 124.4, 124.2, 117.9, 115.7, 38.3, 23.8, 18.7. LCMS (ESI) <i>m</i>/<i>z</i> 336 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>17</sub>H<sub>17</sub>N<sub>7</sub>O + H<sup>+</sup> 336.1567, found 336.1582.</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 8-{[2-(Acetylamino)phenyl]amino}-1-methyl-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (<b>81</b>)</h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>79</b>, the compound <b>81</b> was prepared. Yield, 64%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm: 2.07 (s, 3H), 2.83 (t, <i>J</i> = 7.4 Hz, 2H), 2.97 (t, <i>J</i> = 7.4 Hz, 2H), 4.16 (s, 3H), 7.06−7.12 (m, 1H), 7.14−7.20 (m, 1H), 7.23 (bs, 1H), 7.44 (bs, 1H), 7.47 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.80 (dd, <i>J</i> = 7.9, 1.2 Hz, 1H), 8.35 (s, 1H), 8.56 (bs, 1 H), 9.62 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 378 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>19</sub>H<sub>19</sub>N<sub>7</sub>O<sub>2</sub> + H<sup>+</sup> 378.1673, found: 378.1679.</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i>-(4-Bromo-2-methoxyphenyl)acetamide (<b>83a</b>)</h4><div class="NLM_p last">A mixture of 4-bromo-2-methoxy-phenylamine <b>82a</b> (2.00 g, 9.90 mmol) in acetic anhydride (2 mL, 21.15 mmol) was stirred at room temperature overnight. The solvent was evaporated to dryness, and the solid was tritured with diethyl ether and filtered to give the title compound (1.26 g, 51%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.07 (s, 3H), 3.84 (s, 3H), 7.07 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.20 (d, <i>J</i> = 2.2 Hz, 1H), 7.89 (d, <i>J</i> = 8.5 Hz, 1H), 9.17 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 245 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-(2-Acetyl-4-bromophenyl)acetamide (<b>83b</b>)</h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>82b</b>, the compound <b>83b</b> was prepared. Yield, 42%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.10 (s, 3H), 2.60 (s, 3H), 7.75 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 8.04 (d, <i>J</i> = 2.4 Hz, 1H), 8.11 (d, <i>J</i> = 8.9 Hz, 1H), 10.94 (s, 1 H). LCMS (ESI) <i>m</i>/<i>z</i> 257 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-[2-Methoxy-4-(4-methylpiperazin-1-yl)phenyl]acetamide (<b>84a</b>)</h4><div class="NLM_p last">Pd<sub>2</sub>(dba)<sub>3</sub> (47 mg, 0.05 mmol), 2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl (39 mg, 0.02 mmol), and <b>83a</b> (1.26 g, 5.16 mmol) in THF (5 mL) were charged in a round-bottom flask flushed with argon. The flask was evacuated and backfilled with argon. LiN(TMS)<sub>2</sub> solution (1 M in THF, 11.5 mL) and 4-methylpiperazine (0.67 mL, 6.2 mmol) were added, and the reaction refluxed for 3 h. The reaction mixture was then allowed to cool to room temperature and concentrated. The crude solid was purified by flash chromatography on silica gel (eluant, DCM/MeOH 90/10) to afford compound <b>84a</b> (1.26 g, 91%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.01 (s, 3H), 2.26 (bs, 3H), 2.46−2.54 (signal oscured by DMSO, 4H), 3.07−3.15 (m, 4H), 3.80 (s, 3H), 6.42 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 6.58 (d, <i>J =</i> 2.5 Hz, 1H), 7.58 (d, <i>J =</i> 8.66, 1H), 8.88 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 264 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-[2-Acetyl-4-(4-methylpiperazin-1-yl)phenyl]acetamide (<b>84b</b>)</h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>83b</b>, the compound <b>84b</b> was prepared. Yield, 53%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.10 (s, 3H), 2.27 (s, 3H), 2.60 (s, 3H), 2.43−2.57 (m, 4H), 3.07−3.17 (m, 4H), 7.11 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 7.43 (d, <i>J</i> = 2.6 Hz, 1H), 7.82 (d, <i>J</i> = 8.7 Hz, 1H), 10.94 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 276 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1-(4-Methoxy-3-nitrophenyl)-4-methylpiperazine (<b>84c</b>)</h4><div class="NLM_p last">Pd(OAc)<sub>2</sub> (85 mg, 0.38 mmol), 2-dicyclohexylphosphino-2′-(<i>N,N</i>-dimethylamino)-biphenyl (225 mg, 0.57 mmol), K<sub>3</sub>PO<sub>4</sub> (2.26 g, 10.68 mmol), and 4-bromo-1-methoxy-2-nitro-benzene <b>83c</b> (1.77 g, 7.63 mmol) in THF (50 mL) were charged in a round-bottom flask flushed with argon. The flask was evacuated and backfilled with argon. 4-Methylpiperazine (1.0 mL, 9.15 mmol) was added, and the reaction mixture was refluxed for 72 h. The reaction mixture was then allowed to cool to room temperature and concentrated. The crude solid was purified by flash chromatography on silica gel (eluant, DCM/EtOH 90/10) to afford the title compound (1.0 g, 55%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.22 (s, 3H), 2.42−2.48 (m, 4H), 3.07−3−13 (m, 4H), 3.83 (s, 3H), 7.22 (part of ABX sytem, <i>J</i> = 9.3 Hz, 1H), 7.26 (part of ABX sytem, <i>J</i> = 9.3, 2.9 Hz, 1H), 7.35 (d, <i>J</i> = 2.9 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 252 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>12</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 252.1343, found 252.1342.</div></div><div id="sec5_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 1-[2-(4-Methylpiperazin-1-yl)-6-nitrophenyl]ethanone (<b>84d</b>)</h4><div class="NLM_p last">In a sealed tube, 1-(2-chloro-6-nitro-phenyl)-ethanone <b>83d</b> (300 mg, 1.5 mmol) and 4-methylpiperazine (12.0 mL) were heated for 40 h at 120 °C. The solvent was removed under reduced pressure, and the residue was dissolved in DCM. The solution was washed twice with water, and the organic phase was dried over anhydrous sodium sulfate. The crude was purified by flash chromatography (eluant, acetone/MeOH 75:25), affording <b>84</b> (272 mg, 68%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.21 (s, 3H), 2.35−2.44 (m, 4H), 2.86−2.91 (m, 4H), 7.66 (t, <i>J</i> = 8.7 Hz, 1H), 7.76 (dd, <i>J</i> = 8.7, 0.8 Hz, 1H), 7.91 (dd, <i>J</i> = 8.7, 0.8 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 264 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub> + H<sup>+</sup> 264.1343, found 264.133.</div></div><div id="sec5_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 2-Methoxy-4-(4-methylpiperazin-1-yl)aniline (<b>85a</b>)</h4><div class="NLM_p last">A solution of <b>84a</b> (2.3 g, 8.73 mmol) in EtOH (52 mL) was treated with HCl 37% (26 mL). After 1 h under reflux, the mixture was concentrated and tritured with hexane to give in quantitative yield, 2.5 g of the title compound as dihydrochloride salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.82 (bs, 3H), 3.08−3.16 (m, 4 H), 3.46−3.53 (m, 2H), 3.85−3.92 (m, 2H), 3.90 (s, 3H), 6.60 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 6.78 (d, <i>J</i> = 2.6 Hz, 1H), 7.25 (d, <i>J</i> = 8.8 Hz, 1H), 9.74 (bs, 3H) 10.79 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 222 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>12</sub>H<sub>19</sub>N<sub>3</sub>O + H<sup>+</sup> 222.1601, found 222.1596.</div></div><div id="sec5_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 1-[2-Amino-4-(4-methylpiperazin-1-yl)phenyl]ethanone (<b>85b</b>)</h4><div class="NLM_p last">By employment of the above-described procedure, starting from <b>84b</b>, the compound <b>85b</b> was prepared. Yield, 45%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.53 (s, 3H), 2.82 (bs, 3H), 2.92−3.03 (m, 4H), 3.08−3.25 (m, 4H), 3.58−3.66 (m, 4H), 6.85 (d, <i>J</i> = 8.5 Hz, 1H), 7.15 (dd, <i>J</i> = 8.5, 2.5 Hz, 1H), 7.27 (d, <i>J</i> = 2.5 Hz, 1H), 10.40 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 234 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>13</sub>H<sub>19</sub>N<sub>3</sub>O + H<sup>+</sup> 234.1601, found 234.1602.</div></div><div id="sec5_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-Methoxy-5-(4-methylpiperazin-1-yl)aniline (<b>85c</b>)</h4><div class="NLM_p last">A solution of <b>84c</b> (1.0 g, 3.97 mmol) in MeOH (100 mL) in the presence of Pd/C 10% (150 mg) was hydrogenated at 35 psi for 2 h. The mixture was filtered over a pad of celite, and the solution was concentrated to afford the title compound (0.8 g, 90%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.20 (s, 3H), 2.39−2.43 (m, 4H), 2.91−2.96 (m, 4H), 3.67 (s, 3H), 4.54 (bs, 2H), 6.08 (dd, <i>J</i> = 8.7, 2.9 Hz, 1H), 6.29 (d, <i>J</i> = 2.9 Hz, 1H), 6.63 (d, <i>J</i> = 8.7 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 222 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>12</sub>H<sub>19</sub>N<sub>3</sub>O + H<sup>+</sup> 222.1601, found 222.1609.</div></div><div id="sec5_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 1-[2-Amino-6-(4-methylpiperazin-1-yl)phenyl]ethanone (<b>85d</b>)</h4><div class="NLM_p last">To a solution of <b>84d</b> (0.270 g, 1.02 mmol) in a mixture (1:1:1.5:2.5) of cyclohexene:THF:H<sub>2</sub>O:EtOH (12 mL), Pd/C 10% (328 mg), and two drops of HCl 37% were added. The mixture was heated at 70 °C for 3 h. The Pd was filtered over a pad of celite, and the solvents were removed from the filtrate under reduced pressure. The crude was purified by flash chromatography (eluant, DCM/MeOH/7 N NH<sub>3</sub> in MeOH 9/1/1), to give compound <b>85d</b> as orange oil (225 mg, 95%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.51 (s, 3H), 2.84 (bs, 3H), 2.94−3.05 (m, 2H), 3.13−3.23 (m, 4H), 3.41−3.49 (m, 2H), 6.32 (dd, <i>J</i> = 7.9, 0.8 Hz, 1H), 6.49 (dd, <i>J =</i> 8.3, 0.8 Hz, 1H), 7.09 (dd, dd, <i>J =</i> 8.3, 7.9 Hz, 1H), 9.95 (bs, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 234 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>13</sub>H<sub>19</sub>N<sub>3</sub>O + H<sup>+</sup> 234.1601, found 234.1605.</div></div><div id="sec5_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 1-[2-Hydroxy-4-(4-methylpiperazin-1-yl)phenyl]ethanone (<b>87</b>)</h4><div class="NLM_p last">1-(4-Fluoro-2-hydroxy-phenyl)-ethanone <b>86</b> (4.5 g, 29.22 mmol) was treated with 4-methylpiperazine (5 mL) at 130 °C for 3 h. The solvent was evaporated under vacuum to yield give 6.7 g of the desired compound in a quantitative yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.20 (s, 3H), 2.37−2.41 (m, 4H), 2.47 (s, 3H), 3.33−3.38 (m, 4H), 6.26 (d, <i>J</i> = 2.6 Hz, 1H), 6.52 (dd, <i>J</i> = 9.1, 2.6 Hz, 1H), 7.66 (d, <i>J</i> = 9.1 Hz, 1H), 12.73 (s, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 235 (M + H)<sup>+</sup>. HRMS (ESI) calcd for C<sub>13</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub> + H<sup>+</sup> 235.1441, found 235.1431.</div></div><div id="sec5_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 1-[2-Amino-4-(4-methyl-piperazin-1-yl)-phenyl]-ethanone (<b>85e</b>)</h4><div class="NLM_p last">To a solution of <b>87</b> (5.2 g, 22.20 mmol) in DMA (50 mL), NaOH (2.7 g, 67.50 mmol) was added. The mixture was stirred at room temperature for 1 h, then 2-bromo-2-methylpropanamide (11.1 g, 66.7 mmol) was added and the mixture was stirred at room temperature overnight. NaOH (8.01 g, 200 mmol) was added, and the resulting mixture was stirred at 100 °C for 2 h, then water (50 mL) was added, and the mixture was stirred at 100 °C for 1 h. After cooling to room temperature, the mixture was concentrated, diluted with DCM, and washed with water. The organic phase was dried over sodium sulfate, the solvent allowed under reduced pressure, and the crude solid was purified by flash chromatography on silica gel (eluant: DCM/EtOH, 95/5) to afford <b>85e</b> (1.51 g, 30%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 2.21 (s, 3H), 2.36 (s, 3H), 2.37−2.43 (m, 4H), 3.19−3.25 (m, 4H), 6.08 (d, <i>J</i> = 2.8 Hz, 1H), 6.21 (dd, <i>J</i> = 9.1, 2.8 Hz, 1H), 7.06 (bs, 2H), 7.52 (d, <i>J</i> = 9.1 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i> 234 (M + H)<sup>+</sup>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93">2 Registry Numbers (RN)</h3><div class="NLM_p last">Methylhydrazine (RN, 60−34−4), hydrazine monohydrate (RN, 7803−57−8), phenylhydrazine (RN, 100−63−0), 2,2,2-trifluoroethylhydrazine soln 70% in water (RN, 5042−30−8), <i>N</i>,<i>N</i>-dimethylformamide diisopropyl acetal (RN, 18503−89−4), phenylguanidine carbonate salt (RN, 14018−90−7), cyclohexanol (RN, 108−93−0), 4-hydroxy-1-methylpiperidine (RN, 106−52−5), 1-(2-hydroxyethyl)-piperidine (RN, 3040−44−6), triphenylphosphine polymer bound (RN, 39319−11−4), methylamine (RN, 74−89−5), cyclopentylamine (RN, 1003−03−8), phenylamine (RN, 62−53−3), guanidine carbonate salt (RN, 593−85−1), 2-aminobenzotrifluoride (RN, 88−17−5), 3-aminobenzotrifluoride (RN, 89−16−8), 4-aminobenzotrifluoride (RN, 455−14−1), 2-aminoacetophenone (RN, 551−93−9), 3-aminoacetophenone (RN, 99−03−6), 4-aminoacetophenone (RN, 99−92−3), <i>o</i>-anisidine (RN, 90−04−0), <i>m</i>-anisidine (RN, 536−90−3), <i>p</i>-anisidine (RN, 104−94−9), <i>o</i>-nitroaniline (RN, 88−74−4), <i>m</i>-nitroaniline (RN, 99−09−2), <i>p</i>-nitroaniline (RN, 100−01−6), <i>o</i>-toluidine (RN, 95−53−4), 2-(methylthio)aniline (RN, 2987−53−3), <i>N</i>-methyl-1,2-phenylenediamine (RN, 4760−44−3), 2-fluoroaniline (RN, 348−54−9), 2-isopropylaniline (RN, 643−28−7), methylantranilate (RN, 134−20−3), 2-aminobenzamide (RN, 88−68−6), 2-aminobenzenesulfonamide (RN, 3306−62−5), 2-aminobiphenyl (RN, 90−41−5), 2-aminodiphenyl ether (RN, 2688−84−8), 2-benzylaniline (RN, 28059−64−5), <i>N</i>-phenyl-2-phenylenediamine (RN, 534−85−0), 2-aminodiphenylsulfide (RN, 1134−94−7), 2-aminobenzophenone (RN, 2835−77−0), 4-bromo-2-methoxyaniline (RN, 59557−91−4), 5-bromo-2-methoxyaniline (RN, 6358−77−6), 4′-fluoro-2′-hydroxyacetophenone (RN, 1481−27−2), 1-(2-amino-5-bromophenyl)ethanone (RN, 29124−56−9), 1-(2-amino-6-chlorophenyl)ethanone (RN, 20895−91−4).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94">3 Protein Production and Characterization</h3><div class="NLM_p last">Plk1<sub>36−345</sub> has been expressed in H5 insect cells as GST tag protein. The tag has been removed by enzymatic digestion with PreScission Protease (GE), and the protein has been purified by ion exchange column. Plk1 has then been submitted to limited lysine methylation using a reductive methylation kit (Jena Biosciences). After methylation, the protein has been gel filtered to remove excess of reagents. Level of methylation has been assessed by LC/MS analysis on a 1100 Agilent instrument using a Vydac C-4 column (2.1 mm × 250 mm, 5 μm, poresize 300 Å) Positive ion ESI mass spectra were obtained using 1946 single quadrupole mass spectrometer (Agilent) with an orthogonal ESI.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95">4 Crystallography Methods</h3><div class="NLM_p last">In the final optimized crystallization conditions, methylated-Plk1<sub>36−345</sub> at a concentration of 20 mg/mL was incubated with 10 mM AMP-PNP and 10 mM MgCl<sub>2</sub> prior to crystallization via the vapor diffusion method. Crystallization was done by mixing 0.5 μL of protein mixture with 0.5 μL of a reservoir solution consisting of 1.2 M Na/K tartrate and 0.1 M MES buffer at pH 6.0. After one week at 4 °C, Zn acetate was added to the drops at a final concentration of about 25 mM, and the drops were immediately seeded using crystals of the methylated-Plk1<sub>36−345</sub>:AMP-PNP complex. Crystals grew in a few days. One crystal was soaked for three hours in a solution containing 1.2 M Na/K tartrate, 0.1 M MES pH 6.0, 20% glycerol, and 1 mM compound <b>49</b> and flash-cooled in liquid nitrogen. Diffraction data were collected at beamline ID14-EH3 at the European Synchrotron Radiation Facility (Grenoble, France). Data were processed with MOSFLM<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and programs of the CCP4 suite.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The structure has been solved by molecular replacement using MOLREP<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and an in-house available structure of PLK1<sub>36−345</sub> in complex with AMP-PNP as a search model. Crystals belong to space group <i>P</i>3<sub>2</sub>21 and contain one molecule in the asymmetric unit. The structure was refined with Refmac5,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> water molecules were added with Arp,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and model building was done with Coot.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The final model has <i>R</i><sub>factor</sub> = 0.210 and <i>R</i><sub>free</sub> = 0.298. All structural figures were generated with PyMol (<a href="http://pymol.sourceforge.net/" class="extLink">http://pymol.sourceforge.net/</a>).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96">5 Kinase Assays</h3><div class="NLM_p">The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a transphosphorylation assay. Specific peptide or protein substrates were transphosphorylated by their specific serine-threonine or tyrosine kinase, in the presence of ATP traced with <sup>33</sup>P-γ-ATP, at optimized buffer and cofactors conditions. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP was captured by adding an excess of the ion exchange dowex resin; the resin then settles down to the bottom of the reaction plate by gravity. Supernatant, containing the phosphorylated substrate, was subsequently withdrawn and transferred into a counting plate, followed by evaluation by β-counting. Inhibitory potency evaluation for all the tested kinases was performed at 25 °C using a 60 min end-point assay where the concentrations of ATP and substrates were kept equal to 2 × α<i>K</i><sub>m</sub> and saturated (>5 × α<i>K</i><sub>m</sub>), respectively.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Plk1 Assay</h4><div class="NLM_p last">Inhibition of Plk1 kinase activity was assessed using a Dowex resin capture technique. In this assay, 85 μM αCasein (Sigma) was phosphorylated by 3 nM Plk1 (2−345) in the presence of ATP (40 μM) traced with <sup>33</sup>P-γ-ATP in kinase buffer (50 mM Hepes pH = 7.9, 10 mM beta glycerylphosphate, 1 mM DTT, 3 μM NaVO<sub>3</sub>, 10 mM MgCl<sub>2</sub>, 0.2 mg/mL BSA) for 60 min. By addition of an acidic suspension of Dowex resin (SIGMA, custom-prepared resin Dowex 1 × 8200−400 mesh equilibrated in 150 mM sodium formate, pH = 3.0) the unreacted ATP was captured and separated from the supernatant which contained the phosphorylated substrate: this was then transferred into a new plate for radioactivity counting. The assay is run in a robotized format on 384-well plates.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Plk2 Assay</h4><div class="NLM_p last">Inhibition of Plk2 kinase activity was assessed using a Dowex resin capture technique. In this assay, 175 μM αCasein (Sigma) was phosphorylated by 5 nM Plk2 (2−375) in the presence of ATP (200 μM) traced with <sup>33</sup>P-γ-ATP in kinase buffer (50 mM Hepes pH = 7.9, 10 mM beta glycerylphosphate, 1 mM DTT, 3 μM NaVO<sub>3</sub>, 5 mM MgCl<sub>2</sub>, 0.2 mg/mL BSA) for 60 min. By addition of an acidic suspension of Dowex resins (SIGMA, custom-prepared resin Dowex 1 × 8200−400 mesh equilibrated in 150 mM sodium formate, pH = 3.0) the unreacted ATP is captured and separated from the supernatant which contained the phosphorylated substrate: this was then transferred into a new plate for radioactivity counting. The assay is run in a robotized format on 384-well plates.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Plk3 Assays</h4><div class="NLM_p last">Inhibition of Plk3 kinase activity was assessed using a Dowex resin capture technique. In this assay, 110 μM αCasein (Sigma) was phosphorylated by 0.5 nM Plk3 (2−355) in the presence of ATP (50 μM) traced with <sup>33</sup>P-γ-ATP in kinase buffer (50 mM Hepes pH = 7.9, 10 mM beta glycerylphosphate, 1 mM DTT, 3 μM NaVO<sub>3</sub>, 5 mM MgCl<sub>2</sub>, 0.2 mg/mL BSA) for 60 min at room temperature. By addition of an acidic suspension of Dowex resin (SIGMA, custom-prepared resin Dowex 1 × 8 200−400 mesh equilibrated in 150 mM sodium formate, pH = 3.0), the unreacted ATP was captured and separated from the supernatant which contained the phosphorylated substrate: this was then transferred onto a new plate for radioactivity counting. The assay is run in a robotized format on 384-well plates.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100">6 Cell Cycle Analysis</h3><div class="NLM_p last">Floating cells in the medium (usually mitotic or in apoptosis) or released during PBS washes were collected, added to adherent cells, detached from the plastic by mild treatment with trypsin, and fixed in 70% ethanol/PBS. Cells were washed with PBS to remove fixative and stained with 25 μg/mL propidium iodide, 5 μg/mL RNase, and 0.125 μg/mL Nonidet P40. Cells were kept at room temperature for 60 min in the dark and were analyzed using a flow cytometry BD FACSCalibur system (BD Biosciences). DNA content analysis was performed on ≥10000 gated cells and DNA histograms were analyzed using ModFit LT (Verity Software House, Topsham, ME).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101">7 Western Blot Analysis</h3><div class="NLM_p last">Cells were lysed in 125 mmol/L Tris-HCl (pH = 6.8) and 2% SDS and heated for 10 min at 95 °C. Total proteins (20 μg), as determined by BCA protein assay (Pierce, Rockford, IL), were separated by 4−12% SDS-PAGE. Immunoblot analysis was done using the following antibodies: anti-TCTP (BD Transduction Laboratories, Franklin Lakes, NJ), antiphosphorylated TCTP Ser46 (custom-made by Zymed, San Francisco, CA), antiphosphorylated histone H3 Ser10 (Upstate Biotechnology, Lake Placid, NY), anti-histone H3 (Abcam, Cambridge, United Kingdom), antiphosphorylated NPM Thr199 (Cell Signaling, Danvers, MA), anti-caspase-3 (Cell Signaling Technology, Inc.) and anti-GAPDH (FL-335) (Santa Cruz Biotechnology, Inc.). Immunoblot was carried out according to standard methods. Amersham ECL (GE Healthcare) was used for detection.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102">8 Immunohistochemisty and siRNA</h3><div class="NLM_p last">Immunohistochemisty and siRNA experiments were performed as previously described.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103">9 Cell Culture</h3><div class="NLM_p last">A2780 human ovarian cancer cells and their resistant variants, A431 epidermoid carcinoma, OPM-2 and NCI-H929 myeloma, KARPAS-299 and Jurkat lymphoma cells, KU812 leukemia, and HEL erythroleukemia lines were cultured in RPMI1640 supplemented with 10% fetal bovine serum, HCT116 colon adenocarcinoma in McCoy’s, LoVo colon adenocarcinoma, and its doxorubicin resistant derivative line in HAM’s F12, Mia-PaCa-2, and Panc-1 pancreatic adenocarcinoma in DMEM supplemented with 10% fetal bovine serum, MCF7 in EMEM plus 10% fetal bovine serum, and 1% NEAA, NHDF in fibroblast basal medium kit supplemented with the appropriate growth factors (PromoCell), 1 ng/mL bFGF, and 10% fetal bovine serum. A2780, A2780/ADR, A2780/cis, A431, HCT116, LoVo, MCF7, Mia-PaCa-2 lines were obtained from the ECACC, KARPAS-299, and OPM-2 from the DSMZ collection, A2780 1A9, and A2780 1A9/PTX22 were kind gifts from Professor R. Giavazzi (Mario Negri Institute, Milan), NHDF were purchased from PromoCell, the resistant variant LoVo/DX was generated growing its parent cell line in the presence of 100 ng/mL doxorubicin, all other lines were obtained from ATCC collection.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104">10 Inhibition of Cell Proliferation</h3><div class="NLM_p last">Cells were seeded into 384-well white plates at a density of 3000 cells/well for adherent and 5000 cells/well for nonadherent lines in complete growth medium and treated with compounds dissolved in 0.1% DMSO 24 h after the seeding. The cells were incubated at 37 °C and 5% CO<sub>2</sub> and after 72 h of treatment the plates were processed using CellTiter-Glo assay (Promega) following the manufacturer’s instruction. CellTiter-Glo is a homogeneous method based on the quantification of the ATP present as an indicator of metabolically active cells. ATP was measured using a system based on luciferase and <span class="smallcaps smallerCapital">d</span>-luciferin resulting in light generation. The luminescent signal is proportional to the number of cells present in culture. Briefly 25 μL/well reagent solution was added and mixed to each well, and after 5 min, the microplates were read in a luminometer. The concentration required to inhibit cell growth by 50% (IC<sub>50</sub>) was calculated from point-to-point curves using Assay Explorer (MDL) software.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105">11 High-Throughput Solubility</h3><div class="NLM_p last">Nominal 250 μM compounds suspensions/solutions in aqueous ammonium acetate buffer at pH = 7 were prepared on a Multiscreen-GV, 0.2 μm filter plate (Millipore, Billerica, MA). These solutions were stored for 24 h at room temperature to presaturate the membrane filter and to reach a “pseudothermodynamic solubility”. Then a premixed solution of acetonitrile/water (40/60 v/v) was stirred, filtered, and diluted (25-fold). The so obtained nominal 10 μM solutions were then analyzed simultaneously by LC-MS/MS with standard solutions for quantification.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106">12 Metabolic Stability in Human Liver Microsomes (HLM)</h3><div class="NLM_p">HLM (BD Gentest, Woburn, MA) at a concentration of 0.8 mg/mL, were preincubated with 1 mM test compound for 5 min at 37 °C in 0.1 M phosphate buffer, pH = 7.4, and then the reactions were initiated by adding warmed NADPH (1 mM). After 0, 5, 10, and 30 min incubations, the reactions were stopped with a double volume of ice-cold acetonitrile. The samples were centrifuged for 20 min at 1500 rpm, and the amount of compound remaining was determined with LC-MS/MS. The in vitro Cl<sub>int</sub> was calculated and then scaling factors have been used to estimate the in vivo Cl<sub>int</sub> according to the following equation:</div><span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/jm-2009-01713n_m001.gif" alt="" /></img><span class="labelSpan">(12)</span></span><div class="NLM_p last">where mg HLM/g of liver = 45 mg and g liver/kg body weight (human) = 20 g.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107">13 Intrinsic Clearance Determination in Rat Hepatocytes (RH)</h3><div class="NLM_p">Cl<sub>int</sub> determinations in rat hepatocytes (prepared in-house) suspensions were performed in Leibovitz’s medium, with 1.0 × 10<sup>6</sup> viable cells/mL and 1 mM test compound, at 37 °C. The reactions were stopped at 0, 10, 30, 60, and 90 min with a double volume of ice-cold acetonitrile. The samples were centrifuged at 700<i>g</i> for 20 min and then the amount of compound remaining was determined with LC-MS/MS. The in vitro Cl<sub>int</sub> was calculated, and then scaling factors were used to estimate the in vivo Cl<sub>int</sub> according to the following equation:</div><span class="NLM_disp-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/jm-2009-01713n_m002.gif" alt="" /></img><span class="labelSpan">(13)</span></span><div class="NLM_p last">where number of RH/g of liver = 1 × 10 <sup>8</sup> and g liver/kg body weight (rat) = 44 g.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108">14 Cell Permeability</h3><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Parallel Artificial Membrane Permeability Assay (PAMPA)</h4><div class="NLM_p last">A 96-well filtration plate, MAIP N45 (Millipore, Billerica, MA), was used as support for 4 μL of the membrane forming solution and as acceptor plate, filled with 200 μL of blank buffer solution, HBSS pH = 7.4 with HEPES (Gibco BRL). The membrane forming solution consisted of 15% soy lecithin in <i>n</i>-dodecane. Then 200 μL of donor solution, containing the compound at 10 μM, in HBSS pH 7.4 with HEPES, were placed in a 96-well donor plate (p-ION, Woburn, MA) and then the acceptor plate was placed on top of the donor plate. The obtained “sandwich” was incubated at 37 °C for 4 h. After incubation, acceptor, donor, and initial donor solution (reference) were analyzed by LC-MS/MS. Compound apparent Permeability (<i>P</i><sub>app</sub>) is calculated using the following formula:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/jm-2009-01713n_m003.gif" alt="" /></img></span>where <i>A</i> is the filter area, <i>V</i><sub>d</sub> is the donor volume, <i>V</i><sub>r</sub> is the receiver volume, <i>t</i> is the incubation time (s), <i>C</i><sub>r</sub>(<i>t</i>) is the concentration in the receiver at time <i>t</i>, <i>C</i><sub>d</sub>(<i>t</i>) is the concentration in the donor at time <i>t</i>, and <i>C</i><sub>eq</sub> is the equilibrium concentration [<i>C</i><sub>d</sub>(<i>t</i>) (<i>V</i><sub>d</sub> + <i>C</i><sub>r</sub>(<i>t</i>))<i>V</i><sub>r</sub>]/(<i>V</i><sub>d</sub> + <i>V</i><sub>r</sub>).</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Human Colon Adenocarcinoma Cells (Caco-2)</h4><div class="NLM_p last">Caco-2 cells (American Type Culture Collection, Rockville, MD) monolayers on 24-transwell plates were preincubated at 37 °C and pH = 7.4 with HBSS containing 25 mM Hepes (Gibco BRL). Permeability studies were performed in two transport directions, apical to basolateral (absorption) and basolateral to apical (secretion), adding fresh donor solution containing 10 μM of test compound in HBSS on the donor side while placing compound-free HBSS on the receiver side. The 24-transwell plates were placed on a heated plate shaker. After 120 min, the solutions from the receivers and donors chambers were collected and aliquots were analyzed by LC-MS/MS. The Permeability coefficients (<i>P</i><sub>app</sub>) were calculated using the following the equation:<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/jm-2009-01713n_m004.gif" alt="" /></img></span>where: <i>C</i><sub>o</sub> is the initial concentration, d<i>C</i>/d<i>t</i> is the flux across the monolayer, <i>V</i><sub>r</sub> is the volume of the receiver compartment, and <i>A</i> is the membrane surface area.</div></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111">15 In Vivo pharmacokinetics Nude Mouse</h3><div class="NLM_p">The pharmacokinetic profile of the compounds was investigated in overnight fasted male nude mice following a single dose given intravenously (iv) or orally (po). The compound was formulated as in situ hydrochloride salt in glucosate solution as vehicle. A total of six mice were treated (three for each leg). Blood samples of each mouse were collected from the saphenous vein at predose, 0.083, 0.5, 1, 6, and 24 h postdosing following iv dosing, and at predose, 0.25, 0.5, 1, 6, and 24 h following oral dosing. Samples were centrifuged at 10000 rpm for 3 min at 4 °C, and the plasma was stored at −80 °C until analysis. Samples were analyzed by LC/MS/MS technique.</div><div id="sec5_15_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Pharmacokinetic Noncompartmental Data Analysis</h4><div class="NLM_p last">The pharmacokinetic parameters were derived by noncompartmental methods using the WinNonlin software program. The highest concentration <i>C</i><sub>max</sub> and the time to peak <i>t</i><sub>max</sub> were read as the coordinates of the highest observed concentration. The terminal half-life (<i>t</i><sub>1/2,<i>z</i></sub>) was calculated by the formula <i>t</i><sub>1/2,<i>z</i></sub> = ln(2)/λ<i>z</i>, where λ<i>z</i> is the slope of the terminal linear phase of natural-log concentrations vs time curve. The choice of the points on the terminal phase was based on visual inspection of the data. The area under the plasma level vs time curve, AUC<sub>∞</sub>, was calculated by the linear trapezoidal rule up to the last detectable concentration <i>C</i>(<i>t</i><sub><i>z</i></sub>) and beyond that time by extrapolation from <i>C</i>(<i>t</i><sub><i>z</i></sub>) assuming monoexponential decay, using the following formula: AUC = AUC(0 − <i>t</i><sub><i>z</i></sub>) + <i>C</i>(<i>t</i><sub><i>z</i></sub>)/λ<sub><i>z</i></sub>. The following formulas were applied for the estimate of plasma clearance (CL) and volume of distribution at steady state (<i>V</i><sub>ss</sub>). CL = dose/AUC<sub>∞</sub>; MRT = AUMC/AUC<sub>∞</sub>; <i>V</i><sub>ss</sub> = CL·MRT; AUMC = AUMC(0 − <i>t</i><sub><i>z</i></sub>) + <i>C</i>(<i>t</i><sub><i>z</i></sub>) <i>t</i><sub><i>z</i></sub>/λ<sub><i>z</i></sub> + <i>C</i>(<i>t</i><sub><i>z</i></sub>)/λ<sub><i>z</i></sub><sup>2</sup>, with AUMC(0 − <i>t</i><sub><i>z</i></sub>) calculated using the linear trapezoidal rule on <i>C</i>·<i>t</i> vs <i>t</i> plots. The oral bioavailability (expressed as percent) was estimated by the ratio of dose-normalized AUC<sub>∞</sub> values after oral and iv dose.</div></div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113">16 LC-MS/MS Analyses</h3><div class="NLM_p last">Analyses were performed with an LC-MS/MS system which consisted of an 1100 binary pump (Agilent Technologies, Santa Clara, CA), an HTS-PAL autosampler (CTC Analytics AG, Zwingen, Switzerland), and an API 2000 mass spectrometer (AB/MDS-SCIEX, Concord, ON, Canada). Chromatography was performed on a SB-C8 guard-column, 5 μM, 12.5−4.6 mm (Agilent Technologies, Santa Clara, CA), eluted at a flow rate of 0.6 mL/min. Mobile phase A was 95% ammonium formate 10 mM, pH 4.0 and 5% acetonitrile, while mobile phase B was 5% ammonium formate 10 mM, pH 4.0 + 95% acetonitrile. Compound elution was obtained at a flow rate of 0.6 mL/min with a step gradient from 0 to 100% B at time zero. Detection was done by using a Turbo IonSpray source in the multiple-reaction monitoring MS/MS mode.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114">17 Evaluation of Antitumor Efficacy</h3><div class="NLM_p">BALB/c nu/nu male mice from Harlan Italy, 6 weeks old weighing 21−30 g, were maintained in cages with paper filter covers, food, sterilized bedding, and acidified water. HCT116 cells (from American Type Culture Collection) were inoculated subcutaneously. The treatments started when the tumors were measurable; mean tumor weight for all the groups was 0.170 g and compound <b>49</b> was suspendend in methocel. Treatments were administered orally once a day at day 13, 14, 17, 18, 22, 23, 27, and 28. In the control group, animals were treated with the vehicle with the same scheduling. The tumor growth was evaluated every three days. Tumour dimension was regularly measured by calipers during the experiments, and the tumor mass was calculated as described.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p last">The tumor growth inhibition (TGI, %) was calculated according to the equation: % TGI = 100 − (mean tumor weight of treated group/mean tumor weight of control group) × 100. Toxicity was evaluated on the basis of the body weight reduction. Mice were sacrificed when the tumors reached a volume that hampered them.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117"><a href="/doi/suppl/10.1021/jm901713n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic studies of compound <b>49</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901713n/suppl_file/jm901713n_si_001.pdf">jm901713n_si_001.pdf (49.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901713n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Italo Beria</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#610815000d0e4f0304130800210f04131708000f0e0c124f020e0c"><span class="__cf_email__" data-cfemail="4d24392c2122632f283f242c0d23283f3b242c2322203e632e2220">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dario Ballinari</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay Aaron Bertrand</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Borghi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Tiberio Bossi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Gabriella Brasca</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Cappella</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele Caruso</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Ceccarelli</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonella Ciavolella</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cinzia Cristiani</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valter Croci</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna De Ponti</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriele Fachin</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald Dale Ferguson</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline Lansen</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jurgen Karl Moll</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enrico Pesenti</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helena Posteri</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Perego</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maurizio Rocchetti</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paola Storici</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Volpi</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Valsasina</span> - <span class="hlFld-Affiliation affiliation">Nerviano Medical Sciences Srl, Oncology, Viale Pasteur 10, 20014 Nerviano, (Mi), Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i115">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to the group of assay development of Nerviano Medical Sciences and to Fulvia Roletto for the biochemical assay on Plk2 and Plk3. We thank Walter Moretti and Dania Tesei for their skilled synthetic chemistry support, Daniele Pezzetta, Cristina Ciocca for ADME characterization and solubilily data, Marina Fasolini for her support in the crystallographic screening, Stefania Re Depaolini, Simona Rizzi for constructs production, Francesco Sola and Maria Laura Giorgini for immunofluorescence images and for apoptosis evaluation, Francesco Colotta, Daniele Donati, Eduard Felder, Arturo Galvani, Antonella Isacchi, Nicola Mongelli, Mario Varasi for discussion and support.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This paper was published on April 16, 2010 with a production error in the Results and Discussion section. The revised version was published on April 21, 2010.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Donaldson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">The mitotic roles of Polo-like kinase</span> <span class="citation_source-journal">J. Cell. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2357</span><span class="NLM_x">–</span> <span class="NLM_lpage">2358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=11559744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFamt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2001&pages=2357-2358&author=M.+M.+Donaldsonauthor=A.+A.+Tavaresauthor=I.+M.+Haganauthor=E.+A.+Niggauthor=D.+M.+Glover&title=The+mitotic+roles+of+Polo-like+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The mitotic roles of Polo-like kinase</span></div><div class="casAuthors">Donaldson, Mary M.; Tavares, Alvaro A. M.; Hagan, Iain M.; Nigg, Erich A.; Glover, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2357-2358</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review and discussion, with 2 refs.  Topics discussed include mitotic entry, centrosome sepn. and maturation, the metaphase-anaphase transition and mitotic exit, and the septum-inducing network and cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_GZ2EhNqzV7Vg90H21EOLACvtfcHk0lgO7aSdwCHInQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFamt7s%253D&md5=7a7e70d672283fe57c1cac21aef5f151</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DM.%2BM.%26aulast%3DTavares%26aufirst%3DA.%2BA.%26aulast%3DHagan%26aufirst%3DI.%2BM.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DThe%2520mitotic%2520roles%2520of%2520Polo-like%2520kinase%26jtitle%3DJ.%2520Cell.%2520Sci.%26date%3D2001%26volume%3D114%26spage%3D2357%26epage%3D2358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Glover, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, I. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, A. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases: a team that plays throughout mitosis</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1101%2Fgad.12.24.3777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=9869630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=3777-3787&author=D.+M.+Gloverauthor=I.+M+Haganauthor=A.+A.+Tavares&title=Polo-like+kinases%3A+a+team+that+plays+throughout+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: a team that plays throughout mitosis</span></div><div class="casAuthors">Glover, David M.; Hagan, Iain M.; Tavares, Alvaro A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3777-3787</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with 73 refs. on role of polo-like serine-threonine kinases in regulating centromere behavior and mitosis in organisms from yeast to human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLL0Rl9j0JbVg90H21EOLACvtfcHk0lgO7aSdwCHInQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFCqsQ%253D%253D&md5=6d56713565a4c60897729a2e9e90622a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.24.3777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.24.3777%26sid%3Dliteratum%253Aachs%26aulast%3DGlover%26aufirst%3DD.%2BM.%26aulast%3DHagan%26aufirst%3DI.%2BM%26aulast%3DTavares%26aufirst%3DA.%2BA.%26atitle%3DPolo-like%2520kinases%253A%2520a%2520team%2520that%2520plays%2520throughout%2520mitosis%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D3777%26epage%3D3787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases: positive regulators of cell division from start to finish</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1016%2FS0955-0674%2898%2980121-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=9914175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK1MXitVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1998&pages=776-783&author=E.+A.+Nigg&title=Polo-like+kinases%3A+positive+regulators+of+cell+division+from+start+to+finish"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: positive regulators of cell division from start to finish</span></div><div class="casAuthors">Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">776-783</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">A review with 66 refs.  Present in organisms ranging from yeast to man, homologs of the Drosophila Polo kinase control multiple stages of cell division.  At the onset of mitosis, Polo-like kinases (Plks) function in centrosome maturation and bipolar spindle formation, and they contribute to the activation of cyclindependent kinase (Cdk) 1-cyclin B.  Subsequently, they are required for the inactivation of Cdk1 and exit from mitosis.  In the absence of Plk function, mitotic cyclins fail to be destroyed, indicating that Plks are important regulators of the anaphase-promoting complex/cyclosome (APC/C), a key component of the ubiquitin-dependent proteolytic degrdn. pathway.  Finally, recent evidence implicates Plks in the temporal and spatial coordination of cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq31f1X5czvprVg90H21EOLACvtfcHk0lgO7aSdwCHInQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVOltQ%253D%253D&md5=7dd85a1b4b9c90bfff971530db76533b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2898%2980121-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252898%252980121-X%26sid%3Dliteratum%253Aachs%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%253A%2520positive%2520regulators%2520of%2520cell%2520division%2520from%2520start%2520to%2520finish%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1998%26volume%3D10%26spage%3D776%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kumagai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunphy, W. G.</span><span> </span><span class="NLM_article-title">Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from <i>Xenopus</i> egg extracts</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=1377-1380&author=A.+Kumagaiauthor=W.+G.+Dunphy&title=Purification+and+molecular+cloning+of+Plx1%2C+a+Cdc25-regulatory+kinase+from+Xenopus+egg+extracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumagai%26aufirst%3DA.%26aulast%3DDunphy%26aufirst%3DW.%2BG.%26atitle%3DPurification%2520and%2520molecular%2520cloning%2520of%2520Plx1%252C%2520a%2520Cdc25-regulatory%2520kinase%2520from%2520Xenopus%2520egg%2520extracts%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D1377%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sillje, H. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell cycle division</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H+Silljeauthor=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+cycle+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0lgO7aSdwCHInQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillje%26aufirst%3DH.%2BH%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520cycle%2520division%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">van Vugt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Weerdt, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vader, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calafat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klompmaker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolthuis, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span> </span><span class="NLM_article-title">Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">36841</span><span class="NLM_x">–</span> <span class="NLM_lpage">36854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=36841-36854&author=M.+A.+van+Vugtauthor=B.+C.+van+de+Weerdtauthor=G.+Vaderauthor=H.+Janssenauthor=J.+Calafatauthor=R.+Klompmakerauthor=R.+M.+Wolthuisauthor=R.+H.+Medema&title=Polo-like+kinase-1+is+required+for+bipolar+spindle+formation+but+is+dispensable+for+anaphase+promoting+complex%2FCdc20+activation+and+initiation+of+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BVugt%26aufirst%3DM.%2BA.%26aulast%3Dvan%2Bde%2BWeerdt%26aufirst%3DB.%2BC.%26aulast%3DVader%26aufirst%3DG.%26aulast%3DJanssen%26aufirst%3DH.%26aulast%3DCalafat%26aufirst%3DJ.%26aulast%3DKlompmaker%26aufirst%3DR.%26aulast%3DWolthuis%26aufirst%3DR.%2BM.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DPolo-like%2520kinase-1%2520is%2520required%2520for%2520bipolar%2520spindle%2520formation%2520but%2520is%2520dispensable%2520for%2520anaphase%2520promoting%2520complex%252FCdc20%2520activation%2520and%2520initiation%2520of%2520cytokinesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D36841%26epage%3D36854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima-Morimoto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">25277</span><span class="NLM_x">–</span> <span class="NLM_lpage">25280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=25277-25280&author=H.+Nakajimaauthor=F.+Toyoshima-Morimotoauthor=E.+Taniguchiauthor=E.+Nishida&title=Identification+of+a+consensus+motif+for+Plk+%28Polo-like+kinase%29+phosphorylation+reveals+Myt1+as+a+Plk1+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DToyoshima-Morimoto%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DE.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520a%2520consensus%2520motif%2520for%2520Plk%2520%2528Polo-like%2520kinase%2529%2520phosphorylation%2520reveals%2520Myt1%2520as%2520a%2520Plk1%2520substrate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D25277%26epage%3D25280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bartholomew, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, C. F.</span><span> </span><span class="NLM_article-title">Cdc5 interacts with the Wee1 kinase in budding yeast</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1128%2FMCB.21.15.4949-4959.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=11438652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVGit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=4949-4959&author=C.+R.+Bartholomewauthor=S.+H.+Wooauthor=Y.+S.+Chungauthor=C.+Jonesauthor=C.+F.+Hardy&title=Cdc5+interacts+with+the+Wee1+kinase+in+budding+yeast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc5 interacts with the wee1 kinase in budding yeast</span></div><div class="casAuthors">Bartholomew, Clinton R.; Woo, Sung Ho; Chung, Yun Shin; Jones, Carolyn; Hardy, Christopher F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4949-4959</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Development of a multicellular organism requires that mitosis and morphogenesis be coordinated.  These processes must also be synchronized during the growth of unicellular organisms.  In the yeast Saccharomyces cerevisiae, mitosis is dependent on the prior growth of a daughter cell in the form of a bud.  Overexpression of wild-type Polo-like kinase Cdc5 or a catalytically inactive form resulted in the formation of multinucleate cells in budding yeast.  Immunofluorescence anal. of these multinucleate cells showed that mitosis and bud formation were no longer linked.  Others have shown that Swe1 is required for coupling mitosis to bud formation during a perturbed cell cycle.  When the normal pathway of bud formation is perturbed, Swe1 functions to delay mitosis through neg. regulation of Clb/Cdk.  In cells lacking Swe1, multinucleate cells are formed in response to delays in bud formation.  Affinity purifn., two-hybrid anal., and mutant characterization results suggested that Cdc5 and Swe1 interact.  From these results, we conclude that multinucleate formation in response to Cdc5 overexpression is linked to titrn. of Swe1 function.  These results also suggest that Cdc5 may be a neg. regulator of Swe1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSbDNf0I91K7Vg90H21EOLACvtfcHk0li2Ix0VGwjsZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVGit70%253D&md5=de63d5e4eace9bc27b48a51819717eb7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.15.4949-4959.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.15.4949-4959.2001%26sid%3Dliteratum%253Aachs%26aulast%3DBartholomew%26aufirst%3DC.%2BR.%26aulast%3DWoo%26aufirst%3DS.%2BH.%26aulast%3DChung%26aufirst%3DY.%2BS.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DHardy%26aufirst%3DC.%2BF.%26atitle%3DCdc5%2520interacts%2520with%2520the%2520Wee1%2520kinase%2520in%2520budding%2520yeast%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D4949%26epage%3D4959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Qian, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taieb, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maller, J. L.</span><span> </span><span class="NLM_article-title">The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in <i>Xenopus</i> oocytes</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=11408585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVSjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=1791-1799&author=Y.+W.+Qianauthor=E.+Eriksonauthor=F.+E.+Taiebauthor=J.+L.+Maller&title=The+polo-like+kinase+Plx1+is+required+for+activation+of+the+phosphatase+Cdc25C+and+cyclin+B-Cdc2+in+Xenopus+oocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes</span></div><div class="casAuthors">Qian, Yue-Wei; Erikson, Eleanor; Taieb, Frederic E.; Maller, James L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1791-1799</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">In the Xenopus oocyte system mitogen treatment triggers the G2/M transition by transiently inhibiting the cAMP-dependent protein kinase (PKA); subsequently, other signal transduction pathways are activated, including the mitogen-activated protein kinase (MAPK) and polo-like kinase pathways.  To study the interactions between these pathways, we have utilized a cell-free oocyte ext. that carries out the signaling events of oocyte maturation after addn. of the heat-stable inhibitor of PKA, PKI.  PKI stimulated the synthesis of Mos and activation of both the MAPK pathway and the Plx1/Cdc25C/cyclin B-Cdc2 pathway.  Activation of the MAPK pathway alone by glutathione S-transferase (GST)-Mos did not lead to activation of Plx1 or cyclin B-Cdc2.  Inhibition of the MAPK pathway in the ext. by the MEK1 inhibitor U0126 delayed, but did not prevent, activation of the Plx1 pathway, and inhibition of Mos synthesis by cycloheximide had a similar effect, suggesting that MAPK activation is the only relevant function of Mos.  Immunodepletion of Plx1 completely inhibited activation of Cdc25C and cyclin B-Cdc2 by PKI, indicating that Plx1 is necessary for Cdc25C activation.  In exts. contg. fully activated Plx1 and Cdc25C, inhibition of cyclin B-Cdc2 by p21Cip1 had no significant effect on either the phosphorylation of Cdc25C or the activity of Plx1.  These results demonstrate that maintenance of Plx1 and Cdc25C activity during mitosis does not require cyclin B-Cdc2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpMNCgUw3FFLVg90H21EOLACvtfcHk0li2Ix0VGwjsZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVSjtr4%253D&md5=757d7e00e122918f97ede6ae53b5763a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DY.%2BW.%26aulast%3DErikson%26aufirst%3DE.%26aulast%3DTaieb%26aufirst%3DF.%2BE.%26aulast%3DMaller%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520polo-like%2520kinase%2520Plx1%2520is%2520required%2520for%2520activation%2520of%2520the%2520phosphatase%2520Cdc25C%2520and%2520cyclin%2520B-Cdc2%2520in%2520Xenopus%2520oocytes%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2001%26volume%3D12%26spage%3D1791%26epage%3D1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wolf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doermer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtrich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutte, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmannsberger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rübsamen-Waigmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=543-549&author=G.+Wolfauthor=R.+Elezauthor=A.+Doermerauthor=U.+Holtrichauthor=H.+Ackermannauthor=H.+J.+Stutteauthor=H.+M.+Altmannsbergerauthor=H.+R%C3%BCbsamen-Waigmannauthor=K.+Strebhardt&title=Prognostic+significance+of+polo-like+kinase+%28PLK%29+expression+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DG.%26aulast%3DElez%26aufirst%3DR.%26aulast%3DDoermer%26aufirst%3DA.%26aulast%3DHoltrich%26aufirst%3DU.%26aulast%3DAckermann%26aufirst%3DH.%26aulast%3DStutte%26aufirst%3DH.%2BJ.%26aulast%3DAltmannsberger%26aufirst%3DH.%2BM.%26aulast%3DR%25C3%25BCbsamen-Waigmann%26aufirst%3DH.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DPrognostic%2520significance%2520of%2520polo-like%2520kinase%2520%2528PLK%2529%2520expression%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D543%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Weichert., W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span> </span><span class="NLM_article-title">Polo-like kinase 1 expression is a prognostic factor in human colon cancer</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5644</span><span class="NLM_x">–</span> <span class="NLM_lpage">5650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.3748%2Fwjg.v11.i36.5644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=16237758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5644-5650&author=W+Weichert.author=G.+Kristiansenauthor=M.+Schmidtauthor=V.+Gekelerauthor=A.+Noskeauthor=S.+Niesporekauthor=M.+Dietelauthor=C.+Denkert&title=Polo-like+kinase+1+expression+is+a+prognostic+factor+in+human+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 1 expression is a prognostic factor in human colon cancer</span></div><div class="casAuthors">Weichert, Wilko; Kristiansen, Glen; Schmidt, Mathias; Gekeler, Volker; Noske, Aurelia; Niesporek, Silvia; Dietel, Manfred; Denkert, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5644-5650</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">AIM: To clarify the expression patterns and prognostic implications of the mitotic regulator Polo-like kinase 1 (PLK1) in colon cancer.  METHODS: Expression of PLK1 was investigated by immunohistochem. (158 cases) and immunoblotting in tissue of colon adenomas and adenocarcinomas.  PLK1 expression patterns were correlated with clinicopathol. parameters and patient prognosis.  In addn., expression of PLK1 was evaluated by immunoblot and PCR in colon carcinoma cell lines, and coexpression of PLK1 with the proliferation marker Ki-67 was investigated.  RESULTS: Weak PLK1 expression was obsd. in normal colon mucosa and adenomas.  In contrast, 66.7% of carcinomas showed strong expression of PLK1.  Overexpression of PLK1 correlated pos. with Dukes stage (P<0.001), tumor stage (P = 0.001) and nodal status (P<0.05).  Addnl., PLK1 expression was a prognostic marker in univariate survival anal. (P<0.01) and had independent prognostic significance (RR = 3.3, P = 0.02) in patients with locoregional disease.  Expression of PLK1 mRNA and protein was detected in all cell lines investigated.  Coexpression of PLK1 and Ki-67 was obsd. in the majority of colon cancer cells, but a considerable proportion of cells showed PLK1 positivity without Ki-67 expression.  CONCLUSION: PLK1 is a new prognostic marker for colon carcinoma patients and may be involved in tumorigenesis and progression of colon cancer.  Strategies focusing on PLK1 inhibition in vivo might therefore represent a promising new therapeutic approach for this tumor entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0QpI0UhVpLVg90H21EOLACvtfcHk0lhiVKYDp31BUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyqsg%253D%253D&md5=23657ee7ef1e45ec338843c43adbf0a3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v11.i36.5644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v11.i36.5644%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert.%26aufirst%3DW%26aulast%3DKristiansen%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DNoske%26aufirst%3DA.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDenkert%26aufirst%3DC.%26atitle%3DPolo-like%2520kinase%25201%2520expression%2520is%2520a%2520prognostic%2520factor%2520in%2520human%2520colon%2520cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2005%26volume%3D11%26spage%3D5644%26epage%3D5650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loening, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span> </span><span class="NLM_article-title">Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=240-245&author=W.+Weichertauthor=M.+Schmidtauthor=V.+Gekelerauthor=C.+Denkertauthor=C.+Stephanauthor=K.+Jungauthor=S.+Loeningauthor=M.+Dietelauthor=G.+Kristiansen&title=Polo-like+kinase+1+is+overexpressed+in+prostate+cancer+and+linked+to+higher+tumor+grades"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DLoening%26aufirst%3DS.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DPolo-like%2520kinase%25201%2520is%2520overexpressed%2520in%2520prostate%2520cancer%2520and%2520linked%2520to%2520higher%2520tumor%2520grades%26jtitle%3DProstate%26date%3D2004%26volume%3D60%26spage%3D240%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauptmann, S.</span><span> </span><span class="NLM_article-title">Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1038%2Fsj.bjc.6601610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=14970859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=815-821&author=W.+Weichertauthor=C.+Denkertauthor=M.+Schmidtauthor=V.+Gekelerauthor=G.+Wolfauthor=M.+Kobelauthor=M.+Dietelauthor=S.+Hauptmann&title=Polo-like+kinase+isoform+expression+is+a+prognostic+factor+in+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma</span></div><div class="casAuthors">Weichert, W.; Denkert, C.; Schmidt, M.; Gekeler, V.; Wolf, G.; Koebel, M.; Dietel, M.; Hauptmann, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Polo-like kinase (PLK) family comprises three serine/threonine kinases, functionally involved in signal transduction pathways essential for the accomplishment of mitosis in both normal and malignant cells.  Moreover, certain PLKs have been functionally linked to cytoskeletal reorganization.  In this study, the expression of PLK1 and PLK3 was detd. immunohistochem. in tissue specimen of normal ovaries (n=9), cystadenomas (n=17), borderline tumors (n=13) and ovarian carcinomas (n=77).  PLK 1 and PLK3 expression was low in normal ovarian surface epithelium and borderline tumors, with moderately higher expression levels in cystadenomas.  In ovarian carcinomas, 26% of cases were PLK1 pos. and 50.6% of cases were PLK3 pos.  A pos. correlation of both PLK1 and PLK3 expression with indicators of mitotic frequency could be established.  The overexpression of either isoenzyme had an impact on patient prognosis with shortened survival time for patients with tumors pos. for PLK1 (P=0.02) and PLK3 (P=0.02), but only PLK1 expression remained a prognostic factor in multivariate survival anal. (P=0.03).  The results of this study, if interpreted in the context of recently published functional data, suggest that inhibition of PLKs might represent an interesting new targeted approach for chemotherapy of epithelial ovarian cancer.  Furthermore, this study suggests that PLK1 is a novel independent prognostic marker in ovarian carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLZbaRO52PLbVg90H21EOLACvtfcHk0lhiVKYDp31BUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12iurk%253D&md5=2663adc8427cfbe6be77bb65b7cd1a78</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601610%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DWolf%26aufirst%3DG.%26aulast%3DKobel%26aufirst%3DM.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DHauptmann%26aufirst%3DS.%26atitle%3DPolo-like%2520kinase%2520isoform%2520expression%2520is%2520a%2520prognostic%2520factor%2520in%2520ovarian%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span> </span><span class="NLM_article-title">Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications</span> <span class="citation_source-journal">Virchows Archiv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1007%2Fs00428-005-1212-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15785925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2005&pages=442-450&author=W.+Weichertauthor=G.+Kristiansenauthor=K.+J.+Winzerauthor=M.+Schmidtauthor=V.+Gekelerauthor=A.+Noskeauthor=B.+M.+Mullerauthor=S.+Niesporekauthor=M.+Dietelauthor=C.+Denkert&title=Polo-like+kinase+isoforms+in+breast+cancer%3A+expression+patterns+and+prognostic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications</span></div><div class="casAuthors">Weichert, Wilko; Kristiansen, Glen; Winzer, Klaus-Juergen; Schmidt, Mathias; Gekeler, Volker; Noske, Aurelia; Mueller, Berit-Maria; Niesporek, Silvia; Dietel, Manfred; Denkert, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Polo-like kinase (PLK) family members are known to be functionally involved in mitotic signaling and in cytoskeletal reorganization in both normal and malignant cells.  In this study, expression of PLK1 and PLK3 was detd. immunohistochem. in tissue specimens of 135 breast carcinomas, and expression was correlated with clinicopathol. parameters and patient prognosis.  Strong PLK isoform overexpression was obsd. in 42.2% (PLK1) and 47.4% (PLK3) of breast carcinomas when compared with non-transformed breast tissue.  A pos. correlation of PLK isoform expression with tumor grade, vascular invasion, erbB2/HER-2 expression and markers of proliferative activity was evident.  Addnl., an inverse correlation of PLK isoform expression and estrogen receptor status was obsd.  Overexpression of PLK3 but not of PLK1 was significantly linked to reduced median overall (P<0.001) and relapse-free (P=0.021) survival time.  PLK3 expression remained an independent prognostic factor for overall (RR=3.2, P=0.002) and relapse-free (RR=2.9, P=0.049) survival in multivariate survival anal.  These results suggest PLK3 as a novel independent prognostic marker in breast cancer and hint toward a role for PLK isoform overexpression in disease progression.  Therefore, in vivo inhibition of PLK family members might represent a rewarding approach in the development of new anticancer drugs for this tumor entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcqP_bOEWKUrVg90H21EOLACvtfcHk0lgsZIrmBgvjGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOrtLk%253D&md5=1fb78c61e0ed76ac3c02162308929fe9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00428-005-1212-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00428-005-1212-8%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DKristiansen%26aufirst%3DG.%26aulast%3DWinzer%26aufirst%3DK.%2BJ.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DNoske%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DB.%2BM.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDenkert%26aufirst%3DC.%26atitle%3DPolo-like%2520kinase%2520isoforms%2520in%2520breast%2520cancer%253A%2520expression%2520patterns%2520and%2520prognostic%2520implications%26jtitle%3DVirchows%2520Archiv.%26date%3D2005%26volume%3D446%26spage%3D442%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Knecht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oechler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solbach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Ilberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Prognostic Significance of Polo-like Kinase (PLK) Expression in Squamous Cell Carcinomas of the Head and Neck</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2794</span><span class="NLM_x">–</span> <span class="NLM_lpage">2797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2794-2797&author=R.+Knechtauthor=R.+Elezauthor=M.+Oechlerauthor=C.+Solbachauthor=C.+von+Ilbergauthor=K.+Strebhardt&title=Prognostic+Significance+of+Polo-like+Kinase+%28PLK%29+Expression+in+Squamous+Cell+Carcinomas+of+the+Head+and+Neck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnecht%26aufirst%3DR.%26aulast%3DElez%26aufirst%3DR.%26aulast%3DOechler%26aufirst%3DM.%26aulast%3DSolbach%26aufirst%3DC.%26aulast%3Dvon%2BIlberg%26aufirst%3DC.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DPrognostic%2520Significance%2520of%2520Polo-like%2520Kinase%2520%2528PLK%2529%2520Expression%2520in%2520Squamous%2520Cell%2520Carcinomas%2520of%2520the%2520Head%2520and%2520Neck%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2794%26epage%3D2797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Schmit, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setaluri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegelman, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, N.</span><span> </span><span class="NLM_article-title">Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2009&pages=2843-2853&author=T.+L.+Schmitauthor=W.+Zhongauthor=V.+Setaluriauthor=V.+S.+Spiegelmanauthor=N.+Ahmad&title=Targeted+Depletion+of+Polo-Like+Kinase+%28Plk%29+1+Through+Lentiviral+shRNA+or+a+Small-Molecule+Inhibitor+Causes+Mitotic+Catastrophe+and+Induction+of+Apoptosis+in+Human+Melanoma+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmit%26aufirst%3DT.%2BL.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DSetaluri%26aufirst%3DV.%26aulast%3DSpiegelman%26aufirst%3DV.%2BS.%26aulast%3DAhmad%26aufirst%3DN.%26atitle%3DTargeted%2520Depletion%2520of%2520Polo-Like%2520Kinase%2520%2528Plk%2529%25201%2520Through%2520Lentiviral%2520shRNA%2520or%2520a%2520Small-Molecule%2520Inhibitor%2520Causes%2520Mitotic%2520Catastrophe%2520and%2520Induction%2520of%2520Apoptosis%2520in%2520Human%2520Melanoma%2520Cells%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2009%26volume%3D129%26spage%3D2843%26epage%3D2853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes</span> <span class="citation_source-journal">J. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=1996&pages=1701-1713&author=H.+A.+Laneauthor=E.+A.+Nigg&title=Antibody+microinjection+reveals+an+essential+role+for+human+polo-like+kinase+1+%28Plk1%29+in+the+functional+maturation+of+mitotic+centrosomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DAntibody%2520microinjection%2520reveals%2520an%2520essential%2520role%2520for%2520human%2520polo-like%2520kinase%25201%2520%2528Plk1%2529%2520in%2520the%2520functional%2520maturation%2520of%2520mitotic%2520centrosomes%26jtitle%3DJ.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D135%26spage%3D1701%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Matthess, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaenkuch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2973</span><span class="NLM_x">–</span> <span class="NLM_lpage">2980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2973-2980&author=Y.+Matthessauthor=S.+Kappelauthor=B.+Spaenkuchauthor=B.+Zimmerauthor=M.+Kaufmannauthor=K.+Strebhardt&title=Conditional+inhibition+of+cancer+cell+proliferation+by+tetracycline-responsive%2C+H1+promoter-driven+silencing+of+PLK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthess%26aufirst%3DY.%26aulast%3DKappel%26aufirst%3DS.%26aulast%3DSpaenkuch%26aufirst%3DB.%26aulast%3DZimmer%26aufirst%3DB.%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DConditional%2520inhibition%2520of%2520cancer%2520cell%2520proliferation%2520by%2520tetracycline-responsive%252C%2520H1%2520promoter-driven%2520silencing%2520of%2520PLK1%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2973%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kageyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, T.</span><span> </span><span class="NLM_article-title">Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1172%2FJCI23043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15761500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFylt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=978-985&author=M.+Nogawaauthor=T.+Yuasaauthor=S.+Kimuraauthor=M.+Tanakaauthor=J.+Kurodaauthor=K.+Satoauthor=A.+Yokotaauthor=H.+Segawaauthor=Y.+Todaauthor=S.+Kageyamaauthor=T.+Yoshikiauthor=Y.+Okadaauthor=T.+Maekawa&title=Intravesical+administration+of+small+interfering+RNA+targeting+PLK-1+successfully+prevents+the+growth+of+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer</span></div><div class="casAuthors">Nogawa, Masaki; Yuasa, Takeshi; Kimura, Shinya; Tanaka, Motoyoshi; Kuroda, Junya; Sato, Kiyoshi; Yokota, Asumi; Segawa, Hidekazu; Toda, Yoshinobu; Kageyama, Susumu; Yoshiki, Tatsuhiro; Okada, Yusaku; Maekawa, Taira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">978-985</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The mainstay in the management of invasive bladder cancer continues to be radical cystectomy.  With regard to improvement of quality of life, however, therapies that preserve the bladder are desirable.  The authors investigated the use of intravesical PLK-1 small interfering RNA (siRNA) against bladder cancer.  Patients with bladder cancers expressing high levels of PLK-1 have a poor prognosis compared with patients with low expression.  Using siRNA/cationic liposomes, the expression of endogenous PLK-1 could be suppressed in bladder cancer cells in a time- and dose-dependent manner.  As a consequence, PLK-1 functions were disrupted.  Inhibition of bipolar spindle formation, accumulation of cyclin B1, reduced cell proliferation, and induction of apoptosis were obsd.  In order to det. the efficacy of the siRNA/liposomes in vivo, the authors established an orthotopic mouse model using a LUC-labeled bladder cancer cell line, UM-UC-3LUC.  PLK-1 siRNA was successfully transfected into the cells, reduced PLK-1 expression, and prevented the growth of bladder cancer in this mouse model.  This is the first demonstration, to the authors' knowledge, of inhibition of cancer growth in the murine bladder by intravesical siRNA/cationic liposomes.  The authors believe intravesical siRNA instillation against bladder cancer will be useful as a therapeutic tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE15pDHww5C7Vg90H21EOLACvtfcHk0lgsZIrmBgvjGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFylt7o%253D&md5=c396ea714779cdd010190364112f3d05</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI23043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI23043%26sid%3Dliteratum%253Aachs%26aulast%3DNogawa%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DSegawa%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DY.%26aulast%3DKageyama%26aufirst%3DS.%26aulast%3DYoshiki%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3DIntravesical%2520administration%2520of%2520small%2520interfering%2520RNA%2520targeting%2520PLK-1%2520successfully%2520prevents%2520the%2520growth%2520of%2520bladder%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D978%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Spankuch-Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solbach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loibl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knecht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmuller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Minckwitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3162</span><span class="NLM_x">–</span> <span class="NLM_lpage">3171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=3162-3171&author=B.+Spankuch-Schmittauthor=G.+Wolfauthor=C.+Solbachauthor=S.+Loiblauthor=R.+Knechtauthor=M.+Stegmullerauthor=G.+von+Minckwitzauthor=M.+Kaufmannauthor=K.+Strebhardt&title=Downregulation+of+human+polo-like+kinase+activity+by+antisense+oligonucleotides+induces+growth+inhibition+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpankuch-Schmitt%26aufirst%3DB.%26aulast%3DWolf%26aufirst%3DG.%26aulast%3DSolbach%26aufirst%3DC.%26aulast%3DLoibl%26aufirst%3DS.%26aulast%3DKnecht%26aufirst%3DR.%26aulast%3DStegmuller%26aufirst%3DM.%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DDownregulation%2520of%2520human%2520polo-like%2520kinase%2520activity%2520by%2520antisense%2520oligonucleotides%2520induces%2520growth%2520inhibition%2520in%2520cancer%2520cells%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D3162%26epage%3D3171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Spankuch-Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bereiter-Hahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=1863-1877&author=B.+Spankuch-Schmittauthor=J.+Bereiter-Hahnauthor=M.+Kaufmannauthor=K.+Strebhardt&title=Effect+of+RNA+silencing+of+polo-like+kinase-1+%28PLK1%29+on+apoptosis+and+spindle+formation+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpankuch-Schmitt%26aufirst%3DB.%26aulast%3DBereiter-Hahn%26aufirst%3DJ.%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DEffect%2520of%2520RNA%2520silencing%2520of%2520polo-like%2520kinase-1%2520%2528PLK1%2529%2520on%2520apoptosis%2520and%2520spindle%2520formation%2520in%2520human%2520cancer%2520cells%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2002%26volume%3D94%26spage%3D1863%26epage%3D1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, R. L.</span><span> </span><span class="NLM_article-title">Normal cells, but not cancer cells, survive severe Plk1 depletion</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2093</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1128%2FMCB.26.6.2093-2108.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=16507989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD28XislygtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2093-2108&author=X.+Liuauthor=M.+Leiauthor=R.+L.+Erikson&title=Normal+cells%2C+but+not+cancer+cells%2C+survive+severe+Plk1+depletion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Normal cells, but not cancer cells, survive severe Plk1 depletion</span></div><div class="casAuthors">Liu, Xiaoqi; Lei, Ming; Erikson, Raymond L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2093-2108</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We previously reported the phenotype of depletion of polo-like kinase 1 (Plk1) using RNA interference (RNAi) and showed that p53 is stabilized in Plk1-depleted cancer cells.  In this study, we further analyzed the Plk1 depletion-induced phenotype in both cancer cells and primary cells.  The vector-based RNAi approach was used to evaluate the role of the p53 pathway in Plk1 depletion-induced apoptosis in cancer cells with different p53 backgrounds.  Although DNA damage and cell death can occur independently of p53, p53-deficient cancer cells were much more sensitive to Plk1 depletion than cancer cells with functional p53.  Next, the lentivirus-based RNAi approach was used to generate a series of Plk1 hypomorphs.  In HeLa cells, two weak hypomorphs showed only slight G2/M arrest, a medium hypomorph arrested with 4N DNA content, followed later by apoptosis, and a strong Plk1 hypomorph underwent serious mitotic catastrophe.  In well-synchronized HeLa cells, a medium level of Plk1 depletion caused a 2-h delay of mitotic progression, and a high degree of Plk1 depletion significantly delayed mitotic entry and completely blocked cells at mitosis.  In striking contrast, normal hTERT-RPE1 and MCF10A cells were much less sensitive to Plk1 depletion than HeLa cells; no apparent cell proliferation defect or cell cycle arrest was obsd. after Plk1 depletion in these cells.  Therefore, these data further support suggestions that Plk1 may be a feasible cancer therapy target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruiHU_TInqFLVg90H21EOLACvtfcHk0lgvnTpaoNAGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislygtL4%253D&md5=409d06fe50e2ce145369c8dc86d8ce16</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.6.2093-2108.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.6.2093-2108.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DErikson%26aufirst%3DR.%2BL.%26atitle%3DNormal%2520cells%252C%2520but%2520not%2520cancer%2520cells%252C%2520survive%2520severe%2520Plk1%2520depletion%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2093%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kauselmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konietzko, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scafidi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staubli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bereiter-Hahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhl, D.</span><span> </span><span class="NLM_article-title">The polo-like protein kinases Fnk and Snk associate with a Ca<sup>(2+)</sup> and integrin-binding protein and are regulated dynamically with synaptic plasticity</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5528</span><span class="NLM_x">–</span> <span class="NLM_lpage">5539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5528-5539&author=G.+Kauselmannauthor=M.+Weilerauthor=P.+Wulffauthor=S.+Jessbergerauthor=U.+Konietzkoauthor=J.+Scafidiauthor=U.+Staubliauthor=J.+Bereiter-Hahnauthor=K.+Strebhardtauthor=D.+Kuhl&title=The+polo-like+protein+kinases+Fnk+and+Snk+associate+with+a+Ca%282%2B%29+and+integrin-binding+protein+and+are+regulated+dynamically+with+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKauselmann%26aufirst%3DG.%26aulast%3DWeiler%26aufirst%3DM.%26aulast%3DWulff%26aufirst%3DP.%26aulast%3DJessberger%26aufirst%3DS.%26aulast%3DKonietzko%26aufirst%3DU.%26aulast%3DScafidi%26aufirst%3DJ.%26aulast%3DStaubli%26aufirst%3DU.%26aulast%3DBereiter-Hahn%26aufirst%3DJ.%26aulast%3DStrebhardt%26aufirst%3DK.%26aulast%3DKuhl%26aufirst%3DD.%26atitle%3DThe%2520polo-like%2520protein%2520kinases%2520Fnk%2520and%2520Snk%2520associate%2520with%2520a%2520Ca%25282%252B%2529%2520and%2520integrin-binding%2520protein%2520and%2520are%2520regulated%2520dynamically%2520with%2520synaptic%2520plasticity%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D5528%26epage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gumireddy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosenza, S. C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">ON01910, a non-ATP-competitive small molecole inhibitor of Plk1, is a potent anticancer agent</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=275-286&author=K.+Gumireddyauthor=M.+W.+Reddyauthor=S.+C.+Cosenza&title=ON01910%2C+a+non-ATP-competitive+small+molecole+inhibitor+of+Plk1%2C+is+a+potent+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGumireddy%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DM.%2BW.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26atitle%3DON01910%252C%2520a%2520non-ATP-competitive%2520small%2520molecole%2520inhibitor%2520of%2520Plk1%252C%2520is%2520a%2520potent%2520anticancer%2520agent%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Mross, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedbom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentschler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouyrre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trommeshauser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoesl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phase, I</span><span> </span><span class="NLM_article-title">dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5511</span><span class="NLM_x">–</span> <span class="NLM_lpage">5517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1200%2FJCO.2008.16.1547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=18955456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVSktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=5511-5517&author=K.+Mrossauthor=A.+Frostauthor=S.+Steinbildauthor=S.+Hedbomauthor=J.+Rentschlerauthor=R.+Kaiserauthor=N.+Rouyrreauthor=D.+Trommeshauserauthor=C.+E.+Hoeslauthor=G.+Munzertauthor=I+Phase&title=dose+escalation+and+pharmacokinetic+study+of+BI+2536%2C+a+novel+Polo-like+kinase+1+inhibitor%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I dose escalation and pharmacokinetic study of BI 2536, a novel polo-like kinase 1 inhibitor, in patients with advanced solid tumors</span></div><div class="casAuthors">Mross, Klaus; Frost, Annette; Steinbild, Simone; Hedbom, Susanne; Rentschler, Jochen; Kaiser, Rolf; Rouyrre, Nicolas; Trommeshauser, Dirk; Hoesl, Cornelia E.; Munzert, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5511-5517</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">BI 2536 is a novel, potent, and highly specific inhibitor of polo-like kinase 1 (Plk1), which has an essential role in the regulation of mitotic progression.  The aim of this trial was to identify the max. tolerated dose (MTD) of BI 2536 and to det. the safety, pharmacokinetics, and antitumor activity in patients who had advanced solid tumors.  This phase I trial followed an open label, toxicity-guided, dose-titrn. design.  Single doses of BI 2536 (25 to 250 mg) were administered as a 1-h i.v. infusion; patients who experienced clin. benefit were eligible for addnl. treatment courses.  Safety and pharmacokinetics were investigated.  Tumor response was evaluated according to Response Evaluation Criteria in Solid Tumors Group guidelines.  The MTD was defined at 200 mg in a total of 40 patients entered; reversible neutropenia constituted the dose-limiting toxicity (DLT) and the most frequent adverse event at the MTD (grade 3 to 4; 56%).  Nausea (52%), fatigue (52%), and anorexia (44%) also were common and were mostly of mild to moderate intensity (Common Terminol. Criteria of Adverse Events ≤ grade 2).  One patient experienced a transient partial response.  At doses equal to or greater than the MTD, 23% of patients experienced disease stabilization for 3 or more months.  Dose-proportional increases in the max. plasma concn. and total exposure were obsd.  BI 2536 showed a high total clearance and high distribution into tissue.  The MTD of BI 2536 when administered as a single-dose, 1-h infusion was 200 mg; BI 2536 was well tolerated and showed a favorable pharmacokinetic profile.  Antitumor activity of BI 2536 was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6P1vjU3R8d7Vg90H21EOLACvtfcHk0lgvnTpaoNAGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVSktg%253D%253D&md5=b2a7c464ca76909221e953a266757e89</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.16.1547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.16.1547%26sid%3Dliteratum%253Aachs%26aulast%3DMross%26aufirst%3DK.%26aulast%3DFrost%26aufirst%3DA.%26aulast%3DSteinbild%26aufirst%3DS.%26aulast%3DHedbom%26aufirst%3DS.%26aulast%3DRentschler%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DRouyrre%26aufirst%3DN.%26aulast%3DTrommeshauser%26aufirst%3DD.%26aulast%3DHoesl%26aufirst%3DC.%2BE.%26aulast%3DMunzert%26aufirst%3DG.%26aulast%3DPhase%26aufirst%3DI%26atitle%3Ddose%2520escalation%2520and%2520pharmacokinetic%2520study%2520of%2520BI%25202536%252C%2520a%2520novel%2520Polo-like%2520kinase%25201%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26spage%3D5511%26epage%3D5517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Rudolph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegmaier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolf, G. A.</span><span> </span><span class="NLM_article-title">BI6727, A Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3094</span><span class="NLM_x">–</span> <span class="NLM_lpage">3102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1158%2F1078-0432.CCR-08-2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=19383823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFOrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=3094-3102&author=D.+Rudolphauthor=M.+Steegmaierauthor=M.+Hoffmannauthor=M.+Grauertauthor=A.+Baumauthor=J.+Quantauthor=C.+Haslingerauthor=P.+Garin-Chesaauthor=G.+A.+Adolf&title=BI6727%2C+A+Polo-like+kinase+inhibitor+with+improved+pharmacokinetic+profile+and+broad+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity</span></div><div class="casAuthors">Rudolph, Dorothea; Steegmaier, Martin; Hoffmann, Matthias; Grauert, Matthias; Baum, Anke; Quant, Jens; Haslinger, Christian; Garin-Chesa, Pilar; Adolf, Guenther R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3094-3102</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Antimitotic chemotherapy remains a cornerstone of multimodality treatment for locally advanced and metastatic cancers.  To identify novel mitosis-specific agents with higher selectivity than approved tubulin-binding agents (taxanes, Vinca alkaloids), we have generated inhibitors of Polo-like kinase 1, a target that functions predominantly in mitosis.  The first compd. in this series, suitable for i.v. administration, has entered clin. development.  To fully explore the potential of Polo-like kinase 1 inhibition in oncol., we have profiled addnl. compds. and now describe a novel clin. candidate.  BI 6727 is a highly potent (enzyme IC50 = 0.87 nmol/L, EC50 = 11-37 nmol/L on a panel of cancer cell lines) and selective dihydropteridinone with distinct properties.  First, BI 6727 has a pharmacokinetic profile favoring sustained exposure of tumor tissues with a high vol. of distribution and a long terminal half-life in mice (Vss = 7.6 L/kg, t1/2 = 46 h) and rats (Vss = 22 L/kg, t1/2 = 54 h).  Second, BI 6727 has physicochem. and pharmacokinetic properties that allow in vivo testing of i.v. as well as oral formulations, adding flexibility to dosing schedules.  Finally, BI 6727 shows marked antitumor activity in multiple cancer models, including a model of taxane-resistant colorectal cancer.  With oral and i.v. routes of administration, the total weekly dose of BI 6727 is most relevant for efficacy, supporting the use of a variety of well-tolerated dosing schedules.  These findings warrant further investigation of BI 6727 as a tailored antimitotic agent; clin. studies have been initiated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-YEX91EOHHLVg90H21EOLACvtfcHk0lj9RUHhA_kJ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFOrtbo%253D&md5=daed550be9d9b99ac6797c359039d295</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2445%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DD.%26aulast%3DSteegmaier%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DGrauert%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DHaslinger%26aufirst%3DC.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DAdolf%26aufirst%3DG.%2BA.%26atitle%3DBI6727%252C%2520A%2520Polo-like%2520kinase%2520inhibitor%2520with%2520improved%2520pharmacokinetic%2520profile%2520and%2520broad%2520antitumor%2520activity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D3094%26epage%3D3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sutton, D.; Diamond, M.; Faucette, L.; Giardiniere, M.; Zhang, S.; Gilmartin, A.; Salovich, J.; Cheung, M.; Kuntz, K.; Laquerre, S.; Pearl Huang, P.; Jackson, J. R.</span><span> </span><span class="NLM_article-title">Efficacy of GSK461364, a selective Plk1 inhibitor, in human tumor xenograft models</span>. <span class="NLM_conf-name">AACR Annual Meeting</span>, <span class="NLM_conf-loc">Los Angeles</span>, <span class="NLM_conf-date">Apr 14−18, 2007</span>, Vol.  <span class="NLM_volume">48</span>, <div class="note"><p class="first last">poster 5388</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sutton%2C+D.%3B+Diamond%2C+M.%3B+Faucette%2C+L.%3B+Giardiniere%2C+M.%3B+Zhang%2C+S.%3B+Gilmartin%2C+A.%3B+Salovich%2C+J.%3B+Cheung%2C+M.%3B+Kuntz%2C+K.%3B+Laquerre%2C+S.%3B+Pearl+Huang%2C+P.%3B+Jackson%2C+J.+R.+Efficacy+of+GSK461364%2C+a+selective+Plk1+inhibitor%2C+in+human+tumor+xenograft+models.+AACR+Annual+Meeting%2C+Los+Angeles%2C+Apr+14%E2%88%9218%2C+2007%2C+Vol.+48%2C+poster+5388."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DD.%26atitle%3DEfficacy%2520of%2520GSK461364%252C%2520a%2520selective%2520Plk1%2520inhibitor%252C%2520in%2520human%2520tumor%2520xenograft%2520models%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Blagden, S.; Olmons, D.; Sharma, R.; Barriuso, J.; Medani, H.; Versola, M.; Murray, S.; Smith, D. A.; Dar, M. M.; de Bono, J. S.</span><span> </span><span class="NLM_article-title">A phase I first-in-human study of the polo-like kinase 1 selective inhibitor, GSK-461364, in patients with advanced solid tumors</span>. Book of Abstracts, <span class="NLM_conf-name">EORTC-NCI-AACR</span>, <span class="NLM_conf-loc">Geneva</span>, <span class="NLM_conf-date">Oct 21−24, 2008</span>, <div class="note"><p class="first last">poster 431</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blagden%2C+S.%3B+Olmons%2C+D.%3B+Sharma%2C+R.%3B+Barriuso%2C+J.%3B+Medani%2C+H.%3B+Versola%2C+M.%3B+Murray%2C+S.%3B+Smith%2C+D.+A.%3B+Dar%2C+M.+M.%3B+de+Bono%2C+J.+S.+A+phase+I+first-in-human+study+of+the+polo-like+kinase+1+selective+inhibitor%2C+GSK-461364%2C+in+patients+with+advanced+solid+tumors.+Book+of+Abstracts%2C+EORTC-NCI-AACR%2C+Geneva%2C+Oct+21%E2%88%9224%2C+2008%2C+poster+431."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBlagden%26aufirst%3DS.%26atitle%3DA%2520phase%2520I%2520first-in-human%2520study%2520of%2520the%2520polo-like%2520kinase%25201%2520selective%2520inhibitor%252C%2520GSK-461364%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Schoffsky, P.</span><span> </span><span class="NLM_article-title">Polo-Like Kinase (PLK) Inhibitors in Preclinical and Early Clinical Development in Oncology</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffsky&title=Polo-Like+Kinase+%28PLK%29+Inhibitors+in+Preclinical+and+Early+Clinical+Development+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffsky%26aufirst%3DP.%26atitle%3DPolo-Like%2520Kinase%2520%2528PLK%2529%2520Inhibitors%2520in%2520Preclinical%2520and%2520Early%2520Clinical%2520Development%2520in%2520Oncology%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Caruso, M.; Beria, I.; Brasca, M. G.; Ferguson, R.; Posteri, H.; Valsasina, B.</span><span> </span><span class="NLM_article-title">Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors</span>. Patent WO 2008/074788,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Caruso&author=I.+Beria&author=M.+G.+Brasca&author=R.+Ferguson&author=H.+Posteri&author=B.+Valsasina&title=Substituted+pyrazolo-quinazoline+derivatives%2C+process+for+their+preparation+and+their+use+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DM.%26atitle%3DSubstituted%2520pyrazolo-quinazoline%2520derivatives%252C%2520process%2520for%2520their%2520preparation%2520and%2520their%2520use%2520as%2520kinase%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amboldi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5152</span><span class="NLM_x">–</span> <span class="NLM_lpage">5163</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5152-5163&author=M.+G.+Brascaauthor=N.+Amboldiauthor=D.+Ballinariauthor=A.+Cameronauthor=E.+Casaleauthor=G.+Cerviauthor=M.+Colomboauthor=F.+Colottaauthor=V.+Crociauthor=R.+D%E2%80%99Alessioauthor=F.+Fiorentiniauthor=A.+Isacchiauthor=C.+Mercurioauthor=W.+Morettiauthor=A.+Panzeriauthor=W.+Pastoriauthor=P.+Pevarelloauthor=F.+Quartieriauthor=F.+Rolettoauthor=G.+Traquandiauthor=P.+Vianelloauthor=A.+Vulpettiauthor=M.+Ciomei&title=Identification+of+N%2C1%2C4%2C4-Tetramethyl-8-%7B%5B4-%284-methylpiperazin-1-yl%29phenyl%5Damino%7D-4%2C5-dihydro-1H-pyrazolo%5B4%2C3-h%5Dquinazoline-3-carboxamide+%28PHA-848125%29%2C+a+Potent%2C+Orally+Available+Cyclin+Dependent+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm9006559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006559%26sid%3Dliteratum%253Aachs%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmboldi%26aufirst%3DN.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCervi%26aufirst%3DG.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DR.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DW.%26aulast%3DPanzeri%26aufirst%3DA.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DQuartieri%26aufirst%3DF.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520N%252C1%252C4%252C4-Tetramethyl-8-%257B%255B4-%25284-methylpiperazin-1-yl%2529phenyl%255Damino%257D-4%252C5-dihydro-1H-pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2520%2528PHA-848125%2529%252C%2520a%2520Potent%252C%2520Orally%2520Available%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5152%26epage%3D5163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mizuno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span> </span><span class="NLM_article-title">New practical one-pot conversion of phenols to anilines</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3629</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol051080k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=3629&author=M.+Mizunoauthor=M.+Yamano&title=New+practical+one-pot+conversion+of+phenols+to+anilines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol051080k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol051080k%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DM.%26aulast%3DYamano%26aufirst%3DM.%26atitle%3DNew%2520practical%2520one-pot%2520conversion%2520of%2520phenols%2520to%2520anilines%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D3629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohls, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheils, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span> </span><span class="NLM_article-title">Structure of the catalytic domain of human Polo-like kinase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5960</span><span class="NLM_x">–</span> <span class="NLM_lpage">5971</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi602474j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=5960-5971&author=M.+Kotheauthor=D.+Kohlsauthor=S.+Lowauthor=R.+Coliauthor=A.+C.+Chengauthor=S.+L.+Jacquesauthor=T.+L.+Johnsonauthor=C.+Lewisauthor=C.+Lohauthor=J.+Nonomiyaauthor=A.+L.+Sheilsauthor=K.+A.+Verdriesauthor=T.+A.+Wynnauthor=C.+Kuhnauthor=Y.+Ding&title=Structure+of+the+catalytic+domain+of+human+Polo-like+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi602474j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi602474j%26sid%3Dliteratum%253Aachs%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BL.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DLoh%26aufirst%3DC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DSheils%26aufirst%3DA.%2BL.%26aulast%3DVerdries%26aufirst%3DK.%2BA.%26aulast%3DWynn%26aufirst%3DT.%2BA.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520domain%2520of%2520human%2520Polo-like%2520kinase%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D5960%26epage%3D5971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">Coordinates of the Plk1 complexes with compounds <b>49</b> have been deposited in the Protein Data Base under accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KB7">3KB7</a>, together with the corresponding structure factor files.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Knight, J. D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothary, R..</span><span> </span><span class="NLM_article-title">The role of conserved water molecules in the catalytic domain of protein kinases</span> <span class="citation_source-journal">Proteins: Struct., Funct., and Bioinform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1002%2Fprot.22451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=19425109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1ertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=527-535&author=J.+D.+R.+Knightauthor=D.+Hamelbergauthor=J.+A.+McCammonauthor=R..+Kothary&title=The+role+of+conserved+water+molecules+in+the+catalytic+domain+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The role of conserved water molecules in the catalytic domain of protein kinases</span></div><div class="casAuthors">Knight, James D. R.; Hamelberg, Donald; McCammon, J. Andrew; Kothary, Rashmi</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-535</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Protein kinases are essential signaling mols. with a characteristic bilobal shape that has been studied for over 15 years.  Despite the no. of crystal structures available, little study has been directed away from the prototypical functional elements of the kinase domain.  We have performed a structural alignment of 13 active-conformation kinases and discovered the presence of six water mols. that occur in conserved locations across this group of diverse kinases.  Mol. dynamics simulations demonstrated that these waters confer a great deal of stability to their local environment and to a key catalytic residue.  Our results highlight the importance of novel elements within the greater kinase family and suggest that conserved water mols. are necessary for efficient kinase function.  Proteins 2009. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xs1DUgkovrVg90H21EOLACvtfcHk0lhp7kurIi2AvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1ertLs%253D&md5=80ed59ec30685ec16c9e21a0cdd508dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fprot.22451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22451%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DJ.%2BD.%2BR.%26aulast%3DHamelberg%26aufirst%3DD.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DKothary%26aufirst%3DR..%26atitle%3DThe%2520role%2520of%2520conserved%2520water%2520molecules%2520in%2520the%2520catalytic%2520domain%2520of%2520protein%2520kinases%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520and%2520Bioinform.%26date%3D2009%26volume%3D76%26spage%3D527%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F.</span><span> </span><span class="NLM_article-title">A helix scaffold for the assembly of active protein kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">14377</span><span class="NLM_x">–</span> <span class="NLM_lpage">14382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=14377-14382&author=A.+P.+Kornevauthor=S.+S.+Taylorauthor=L.+F.+Ten+Eyck&title=A+helix+scaffold+for+the+assembly+of+active+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26atitle%3DA%2520helix%2520scaffold%2520for%2520the%2520assembly%2520of%2520active%2520protein%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D14377%26epage%3D14382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohls, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span> </span><span class="NLM_article-title">Selectivity-determining residues in Plk1</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1111%2Fj.1747-0285.2007.00594.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=18005335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=540-546&author=M.+Kotheauthor=D.+Kohlsauthor=S.+Lowauthor=R.+Coliauthor=G.+R.+Rennieauthor=F.+Feruauthor=C.+Kuhnauthor=Y.+Ding&title=Selectivity-determining+residues+in+Plk1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity-determining residues in Plk1</span></div><div class="casAuthors">Kothe, Michael; Kohls, Darcy; Low, Simon; Coli, Rocco; Rennie, Glen R.; Feru, Frederic; Kuhn, Cyrille; Ding, Yuan-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Polo-like kinase 1 is an important regulator of cell cycle progression whose over-expression is often assocd. with oncogenesis.  Polo-like kinase 1 hence represents an attractive target for cancer intervention.  BI 2536 (Boehringer Ingelheim, Ingelheim, Germany), a Polo-like kinase 1 inhibitor currently in clin. trials, exhibits nanomolar potency against Polo-like kinase isoforms and high selectivity against other kinases.  The authors have previously published the crystal structures of the Polo-like kinase 1 domain in complex with AMPPNP and an Aurora A inhibitor.  In this work, the authors present the cocrystal structure of Polo-like kinase 1 with BI 2536.  The structure, in combination with selectivity data for BI 2536 and related compds., illustrates important features for potency and selectivity.  In particular, the authors show that the methoxy group of BI 2536 is an important specificity determinant against non-Polo-like kinases by taking advantage of a small pocket generated by Leu 132 in the hinge region of Polo-like kinase 1.  The work presented here provides a framework for structure-based drug design of Polo-like kinase 1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjA3mwWD7K0bVg90H21EOLACvtfcHk0lhp7kurIi2AvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ&md5=0f976bb98fe7d0413e8d2314abc68e2b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00594.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00594.x%26sid%3Dliteratum%253Aachs%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DRennie%26aufirst%3DG.%2BR.%26aulast%3DFeru%26aufirst%3DF.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26atitle%3DSelectivity-determining%2520residues%2520in%2520Plk1%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D540%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjebang, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badiang Alberti, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Ward, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassler, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansing, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nailor, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pobanz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, M.</span><span> </span><span class="NLM_article-title">Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1694</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1016%2Fj.bmcl.2009.01.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=19237286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1694-1697&author=K.+A.+Emmitteauthor=G.+M.+Adjebangauthor=C.+W.+Andrewsauthor=J.+G.+Badiang+Albertiauthor=R.+Bambalauthor=S.+D.+Chamberlainauthor=R.+G.+Davis-Wardauthor=H.+D.+Dicksonauthor=D.+F.+Hasslerauthor=K.+R.+Hornbergerauthor=J.+R.+Jacksonauthor=K.+W.+Kuntzauthor=T.+J.+Lansingauthor=R.+A.+Mookauthor=K.+E.+Nailorauthor=M.+A.+Pobanzauthor=S.+C.+Smithauthor=C.+Sungauthor=M.+Cheung&title=Design+of+potent+thiophene+inhibitors+of+polo-like+kinase+1+with+improved+solubility+and+reduced+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding</span></div><div class="casAuthors">Emmitte, Kyle A.; Adjebang, George M.; Andrews, C. Webb; Badiang-Alberti, Jennifer G.; Bambal, Ramesh; Chamberlain, Stanley D.; Davis-Ward, Ronda G.; Dickson, Hamilton D.; Hassler, Daniel F.; Hornberger, Keith R.; Jackson, Jeffrey R.; Kuntz, Kevin W.; Lansing, Timothy J.; Mook, Robert A.; Nailor, Kristen E.; Pobanz, Mark A.; Smith, Stephon C.; Sung, Chiu-Mei; Cheung, Mui</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1694-1697</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of thiophene PLK1 inhibitors was optimized for increased soly. and reduced protein binding through the appendage of basic amine functionality.  Interesting selectivity between PLK1 and PLK3 was also obtained through these modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLrXXbB1J4-rVg90H21EOLACvtfcHk0liOPVbkyr-bwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltrY%253D&md5=30831c589bae973ca9267dfea68971e1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.094%26sid%3Dliteratum%253Aachs%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DAdjebang%26aufirst%3DG.%2BM.%26aulast%3DAndrews%26aufirst%3DC.%2BW.%26aulast%3DBadiang%2BAlberti%26aufirst%3DJ.%2BG.%26aulast%3DBambal%26aufirst%3DR.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DDavis-Ward%26aufirst%3DR.%2BG.%26aulast%3DDickson%26aufirst%3DH.%2BD.%26aulast%3DHassler%26aufirst%3DD.%2BF.%26aulast%3DHornberger%26aufirst%3DK.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DLansing%26aufirst%3DT.%2BJ.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DNailor%26aufirst%3DK.%2BE.%26aulast%3DPobanz%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DS.%2BC.%26aulast%3DSung%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DM.%26atitle%3DDesign%2520of%2520potent%2520thiophene%2520inhibitors%2520of%2520polo-like%2520kinase%25201%2520with%2520improved%2520solubility%2520and%2520reduced%2520protein%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1694%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Yarm, F. R.</span><span> </span><span class="NLM_article-title">Plk phosphorylation regulates the microtubule-stabilizing protein TCTP</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6209</span><span class="NLM_x">–</span> <span class="NLM_lpage">6221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1128%2FMCB.22.17.6209-6221.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=12167714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1ent7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=6209-6221&author=F.+R.+Yarm&title=Plk+phosphorylation+regulates+the+microtubule-stabilizing+protein+TCTP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Plk phosphorylation regulates the microtubule-stabilizing protein TCTP</span></div><div class="casAuthors">Yarm, Frederic R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6209-6221</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mitotic polo-like kinases have been implicated in the formation and function of bipolar spindles on the basis of their resp. localizations and mutant phenotypes.  To date, this putative regulation has been limited to a kinesin-like motor protein, a centrosomal structural protein, and two microtubule-assocd. proteins (MAPs).  In this study, another spindle-regulating protein, the mammalian non-MAP microtubule-binding and -stabilizing protein, the translationally controlled tumor protein (TCTP), was identified as a putative Plk-interacting clone by a two-hybrid screen.  Plk phosphorylates TCTP on two serine residues in vitro and cofractionates with the majority of kinase activity toward TCTP in mitotic cell lysates.  In addn., these sites were demonstrated to be phosphorylated in vivo.  Overexpression of a Plk phosphorylation site-deficient mutant of TCTP induced a dramatic increase in the no. of multinucleate cells, rounded cells with condensed ball-like nuclei, and cells undergoing cell death, similar to both the reported anti-Plk antibody microinjection and the low-concn. taxol treatment phenotypes.  These results suggest that phosphorylation decreases the microtubule-stabilizing activity of TCTP and promotes the increase in microtubule dynamics that occurs after metaphase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6fc2ErGOIorVg90H21EOLACvtfcHk0liOPVbkyr-bwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1ent7Y%253D&md5=4e275fec4f18eb54c005cd6be2c9d62d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.17.6209-6221.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.17.6209-6221.2002%26sid%3Dliteratum%253Aachs%26aulast%3DYarm%26aufirst%3DF.%2BR.%26atitle%3DPlk%2520phosphorylation%2520regulates%2520the%2520microtubule-stabilizing%2520protein%2520TCTP%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D6209%26epage%3D6221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi-Sirtori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span> </span><span class="NLM_article-title">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1002%2Frcm.1368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=14966861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-517&author=M.+Colomboauthor=F.+Riccardi-Sirtoriauthor=V.+Rizzo&title=A+fully+automated+method+for+accurate+mass+determination+using+high-performance+liquid+chromatography+with+a+quadrupole%2Forthogonal+acceleration+time-of-flight+mass+spectrometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span></div><div class="casAuthors">Colombo, Maristella; Sirtori, Federico Riccardi; Rizzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A generic LC/ESI(+)-oaTOFMS method has been developed for routine automated high accuracy mass detns. of different classes of substances.  The system makes use of micro-high-performance liq. chromatog. and a hybrid quadrupole/orthogonal acceleration time-of-flight (Q-oaTOF) mass spectrometer.  Reproducible and accurate mass measurements were obtained using an electrospray dual sprayer with reserpine as ref. compd., introduced into the mass spectrometer alternating with the samples.  Expts. were performed to optimize analyte/ref. response ratio, statistical algorithm correction setting, and analyte concn.  In these expts., a clear dependence of the mass measurement error on the analyte/ref. response ratio was obsd.  The dependence of av. mass error vs. different dead time correction algorithm settings (Np factors) was also explored.  In the final automated procedure, verified for a statistically significant set of compds. (∼550) obtained from a medicinal chem. department, about 70% of the analyzed samples satisfied the acceptance criteria fixed at a max. error of ±5 ppm (mass range 150-800 Da).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5JNVhGdzjrVg90H21EOLACvtfcHk0liOPVbkyr-bwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D&md5=6f1f93c5e2fb4e24257b77f5ce6dfa37</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Frcm.1368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1368%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DRiccardi-Sirtori%26aufirst%3DF.%26aulast%3DRizzo%26aufirst%3DV.%26atitle%3DA%2520fully%2520automated%2520method%2520for%2520accurate%2520mass%2520determination%2520using%2520high-performance%2520liquid%2520chromatography%2520with%2520a%2520quadrupole%252Forthogonal%2520acceleration%2520time-of-flight%2520mass%2520spectrometer%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D18%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span> </span><span class="NLM_article-title">Integration of macromolecular diffraction data</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1696</span><span class="NLM_x">–</span> <span class="NLM_lpage">1702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=1696-1702&author=A.+G.+W.+Leslie&title=Integration+of+macromolecular+diffraction+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DIntegration%2520of%2520macromolecular%2520diffraction%2520data%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1999%26volume%3D55%26spage%3D1696%26epage%3D1702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Bailey, S.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=S.+Bailey&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DS.%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A..</span><span> </span><span class="NLM_article-title">MOLREP: an automated program for molecular replacement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1107%2FS0021889897006766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=1022-1025&author=A.+Vaginauthor=A..+Teplyakov&title=MOLREP%3A+an+automated+program+for+molecular+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">MOLREP: an automated program for molecular replacement</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement which uses effective new approaches in data processing and rotational and translational searching.  These include an automatic choice of all parameters, scaling by Patterson origin peaks and soft resoln. cutoff.  One of the cornerstones of the program is an original full-symmetry translation function combined with a packing function.  Information from the model already placed in the cell is incorporated in both translation and packing functions.  A no. of tests using exptl. data proved the ability of the program to find the correct soln. in difficult cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGXdZ-nTKxLVg90H21EOLACvtfcHk0lgSbhg5vNPazA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D&md5=96af64aedd8a8f018c3c18b57a6b4b21</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0021889897006766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897006766%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA..%26atitle%3DMOLREP%253A%2520an%2520automated%2520program%2520for%2520molecular%2520replacement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D1022%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lgSbhg5vNPazA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Lamzin, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Automated refinement of protein models</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=129-47&author=V.+S.+Lamzinauthor=K.+S.+Wilson&title=Automated+refinement+of+protein+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamzin%26aufirst%3DV.%2BS.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DAutomated%2520refinement%2520of%2520protein%2520models%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1993%26volume%3D49%26spage%3D129%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">12, Pt. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&issue=12%2C+Pt.+1&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26issue%3D12%252C%2520Pt.%25201%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piutti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritzen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warpehoski, M. A.</span><span> </span><span class="NLM_article-title">3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3367</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031145u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3367-3380&author=P.+Pevarelloauthor=M.+G.+Brascaauthor=R.+Amiciauthor=P.+Orsiniauthor=G.+Traquandiauthor=L.+Cortiauthor=C.+Piuttiauthor=P.+Sansonnaauthor=M.+Villaauthor=B.+S.+Pierceauthor=M.+Puliciauthor=P.+Giordanoauthor=K.+Martinaauthor=E.+L.+Fritzenauthor=R.+A.+Nugentauthor=E.+Casaleauthor=A.+Cameronauthor=M.+Ciomeiauthor=F.+Rolettoauthor=A.+Isacchiauthor=G.+P.+Fogliattoauthor=E.+Pesentiauthor=W.+Pastoriauthor=A.+Marsiglioauthor=K.+L.+Leachauthor=P.+M.+Clareauthor=F.+Fiorentiniauthor=M.+Varasiauthor=A.+Vulpettiauthor=M.+A.+Warpehoski&title=3-Aminopyrazole+inhibitors+of+CDK2%2Fcyclin+A+as+antitumor+agents.+1.+Lead+finding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm031145u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031145u%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DPiutti%26aufirst%3DC.%26aulast%3DSansonna%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DPulici%26aufirst%3DM.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DFritzen%26aufirst%3DE.%2BL.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DFogliatto%26aufirst%3DG.%2BP.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DP.%2BM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DWarpehoski%26aufirst%3DM.%2BA.%26atitle%3D3-Aminopyrazole%2520inhibitors%2520of%2520CDK2%252Fcyclin%2520A%2520as%2520antitumor%2520agents.%25201.%2520Lead%2520finding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3367%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Carpinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianellini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Texido, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugnoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigoni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fancelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span> </span><span class="NLM_article-title">PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3158</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1158%2F1535-7163.MCT-07-0444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=18089710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3158-3168&author=P.+Carpinelliauthor=R.+Cerutiauthor=M.+L.+Giorginiauthor=P.+Cappellaauthor=L.+Gianelliniauthor=V.+Crociauthor=A.+Degrassiauthor=G.+Texidoauthor=M.+Rocchettiauthor=P.+Vianelloauthor=L.+Rusconiauthor=P.+Storiciauthor=P.+Zugnoniauthor=C.+Arrigoniauthor=C.+Sonciniauthor=C.+Alliauthor=V.+Pattonauthor=A.+Marsiglioauthor=D.+Ballinariauthor=E.+Pesentiauthor=D.+Fancelliauthor=J.+Moll&title=PHA-739358%2C+a+potent+inhibitor+of+Aurora+kinases+with+a+selective+target+inhibition+profile+relevant+to+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer</span></div><div class="casAuthors">Carpinelli, Patrizia; Ceruti, Roberta; Giorgini, Maria Laura; Cappella, Paolo; Gianellini, Laura; Croci, Valter; Degrassi, Anna; Texido, Gemma; Rocchetti, Maurizio; Vianello, Paola; Rusconi, Luisa; Storici, Paola; Zugnoni, Paola; Arrigoni, Claudio; Soncini, Chiara; Alli, Cristina; Patton, Veronica; Marsiglio, Aurelio; Ballinari, Dario; Pesenti, Enrico; Fancelli, Daniele; Moll, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3158-3168</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PHA-739358 is a small-mol. 3-aminopyrazole deriv. with strong activity against Aurora kinases and cross-reactivities with some receptor tyrosine kinases relevant for cancer.  PHA-739358 inhibits all Aurora kinase family members and shows a dominant Aurora B kinase inhibition-related cellular phenotype and mechanism of action in cells in vitro and in vivo. p53 status-dependent endoreduplication is obsd. upon treatment of cells with PHA-739358, and phosphorylation of histone H3 in Ser10 is inhibited.  The compd. has significant antitumor activity in different xenografts and spontaneous and transgenic animal tumor models and shows a favorable pharmacokinetic and safety profile.  In vivo target modulation is obsd. as assessed by the inhibition of the phosphorylation of histone H3, which has been validated preclinically as a candidate biomarker for the clin. phase.  Pharmacokinetics/pharmacodynamics modeling was used to define drug potency and to support the prediction of active clin. doses and schedules.  We conclude that PHA-739358, which is currently tested in clin. trials, has great therapeutic potential in anticancer therapy in a wide range of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfveLDPYzNGLVg90H21EOLACvtfcHk0lgn-z-GPdFjvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3M&md5=695fc55d72717a86f96818ca23fc71b8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0444%26sid%3Dliteratum%253Aachs%26aulast%3DCarpinelli%26aufirst%3DP.%26aulast%3DCeruti%26aufirst%3DR.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DGianellini%26aufirst%3DL.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DDegrassi%26aufirst%3DA.%26aulast%3DTexido%26aufirst%3DG.%26aulast%3DRocchetti%26aufirst%3DM.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DZugnoni%26aufirst%3DP.%26aulast%3DArrigoni%26aufirst%3DC.%26aulast%3DSoncini%26aufirst%3DC.%26aulast%3DAlli%26aufirst%3DC.%26aulast%3DPatton%26aufirst%3DV.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DPHA-739358%252C%2520a%2520potent%2520inhibitor%2520of%2520Aurora%2520kinases%2520with%2520a%2520selective%2520target%2520inhibition%2520profile%2520relevant%2520to%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D3158%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Siomi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siomi, M.</span><span> </span><span class="NLM_article-title">On the road to reading the RNA-interference code</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=396-404&author=H.+Siomiauthor=M.+Siomi&title=On+the+road+to+reading+the+RNA-interference+code"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiomi%26aufirst%3DH.%26aulast%3DSiomi%26aufirst%3DM.%26atitle%3DOn%2520the%2520road%2520to%2520reading%2520the%2520RNA-interference%2520code%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D396%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Bjornsson, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einolf, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snikeris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective</span> <span class="citation_source-journal">J. Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=12751267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=443-469&author=T.+D.+Bjornssonauthor=J.+T.+Callaghanauthor=H.+J.+Einolfauthor=V.+Fischerauthor=L.+Ganauthor=S.+Grimmauthor=J.+Kaoauthor=S.+P.+Kingauthor=G.+Miwaauthor=L.+Niauthor=G.+Kumarauthor=J.+McLeodauthor=S.+R.+Obachauthor=S.+Robertsauthor=A.+Roeauthor=A.+Shahauthor=F.+Snikerisauthor=J.+T.+Sullivanauthor=D.+Tweedieauthor=J.+M.+Vegaauthor=J.+Walshauthor=S.+A.+Wrighton&title=The+conduct+of+in+vitro+and+in+vivo+drug-drug+interaction+studies%3A+A+PhRMA+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective</span></div><div class="casAuthors">Bjornsson, Thorir D.; Callaghan, John T.; Einolf, Heidi J.; Fischer, Volker; Gan, Lawrence; Grimm, Scott; Kao, John; King, S. Peter; Miwa, Gerald; Ni, Lan; Kumar, Gondi; McLeod, James; Obach, Scott R.; Roberts, Stanley; Roe, Amy; Shah, Anita; Snikeris, Fred; Sullivan, John T.; Tweedie, Donald; Vega, Jose M.; Walsh, John; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Current regulatory guidances do not address specific study designs for in vitro and in vivo drug-drug interaction studies.  There is a common desire by regulatory authorities and by industry sponsors to harmonize approaches to allow for a better assessment of the significance of findings across different studies and drugs.  There is also a growing consensus for the standardization of cytochrome P 450 (CYP) probe substrates, inhibitors, and inducers and for the development of classification systems to improve the communication of risk to health care providers and patients.  While existing guidances cover mainly CYP-mediated drug interactions, the importance of other mechanisms, such as transporters, has been recognized more recently and should also be addressed.  This paper was prepd. by the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metab. and Clin. Pharmacol. Tech. Working Groups and represents the current industry position.  The intent is to define a minimal best practice for in vitro and in vivo pharmacokinetic drug-drug interaction studies targeted to development (not discovery support) and to define a data package that can be expected by regulatory agencies in compd. registration dossiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLgVYfgRCef7Vg90H21EOLACvtfcHk0lgn-z-GPdFjvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D&md5=3c84ae2dd962249744e152383f0d6a80</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBjornsson%26aufirst%3DT.%2BD.%26aulast%3DCallaghan%26aufirst%3DJ.%2BT.%26aulast%3DEinolf%26aufirst%3DH.%2BJ.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DGrimm%26aufirst%3DS.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DS.%2BP.%26aulast%3DMiwa%26aufirst%3DG.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DMcLeod%26aufirst%3DJ.%26aulast%3DObach%26aufirst%3DS.%2BR.%26aulast%3DRoberts%26aufirst%3DS.%26aulast%3DRoe%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DSnikeris%26aufirst%3DF.%26aulast%3DSullivan%26aufirst%3DJ.%2BT.%26aulast%3DTweedie%26aufirst%3DD.%26aulast%3DVega%26aufirst%3DJ.%2BM.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520conduct%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520drug-drug%2520interaction%2520studies%253A%2520A%2520PhRMA%2520perspective%26jtitle%3DJ.%2520Clin.%2520Pharm.%26date%3D2003%26volume%3D43%26spage%3D443%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':[],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunchen  Yuan</span>, <span class="hlFld-ContribAuthor ">Guangliang  Tu</span>, and <span class="hlFld-ContribAuthor ">Yingsheng  Zhao</span>  . </span><span class="cited-content_cbyCitation_article-title">Rhodium(III)-Catalyzed Selective Monoarylation of β or γ C(sp3)–H Bonds Assisted by a Trimethylpyrazole Group. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (2)
                                     , 356-359. <a href="https://doi.org/10.1021/acs.orglett.6b03522" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03522%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRhodium%252528III%252529-Catalyzed%252BSelective%252BMonoarylation%252Bof%252B%2525CE%2525B2%252Bor%252B%2525CE%2525B3%252BC%252528sp3%252529%2525E2%252580%252593H%252BBonds%252BAssisted%252Bby%252Ba%252BTrimethylpyrazole%252BGroup%26aulast%3DYuan%26aufirst%3DChunchen%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D28112016%26date%3D30122016%26date%3D20012017%26volume%3D19%26issue%3D2%26spage%3D356%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Menichincheri</span>, <span class="hlFld-ContribAuthor ">Elena  Ardini</span>, <span class="hlFld-ContribAuthor ">Paola  Magnaghi</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Patrizia  Banfi</span>, <span class="hlFld-ContribAuthor ">Roberto  Bossi</span>, <span class="hlFld-ContribAuthor ">Laura  Buffa</span>, <span class="hlFld-ContribAuthor ">Giulia  Canevari</span>, <span class="hlFld-ContribAuthor ">Lucio  Ceriani</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Luca  Corti</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Marina  Fasolini</span>, <span class="hlFld-ContribAuthor ">Eduard  Felder</span>, <span class="hlFld-ContribAuthor ">Claudio  Fiorelli</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Andrea Lombardi  Borgia</span>, <span class="hlFld-ContribAuthor ">Chiara  Marchionni</span>, <span class="hlFld-ContribAuthor ">Marcella  Nesi</span>, <span class="hlFld-ContribAuthor ">Christian  Orrenius</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Luisa  Rusconi</span>, <span class="hlFld-ContribAuthor ">Maria Beatrice  Saccardo</span>, <span class="hlFld-ContribAuthor ">Ermes  Vanotti</span>, <span class="hlFld-ContribAuthor ">Ettore  Perrone</span>, and <span class="hlFld-ContribAuthor ">Paolo  Orsini</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3392-3408. <a href="https://doi.org/10.1021/acs.jmedchem.6b00064" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BEntrectinib%25253A%252BA%252BNew%252B3-Aminoindazole%252BAs%252Ba%252BPotent%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%25252C%252Bc-ros%252BOncogene%252B1%252BKinase%252B%252528ROS1%252529%25252C%252Band%252BPan-Tropomyosin%252BReceptor%252BKinases%252B%252528Pan-TRKs%252529%252Binhibitor%26aulast%3DMenichincheri%26aufirst%3DMaria%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14012016%26date%3D30032016%26date%3D14042016%26date%3D22032016%26volume%3D59%26issue%3D7%26spage%3D3392%26epage%3D3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluca  Papeo</span>, <span class="hlFld-ContribAuthor ">Helena  Posteri</span>, <span class="hlFld-ContribAuthor ">Daniela  Borghi</span>, <span class="hlFld-ContribAuthor ">Alina A.  Busel</span>, <span class="hlFld-ContribAuthor ">Francesco  Caprera</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Marina  Ciomei</span>, <span class="hlFld-ContribAuthor ">Alessandra  Cirla</span>, <span class="hlFld-ContribAuthor ">Emiliana  Corti</span>, <span class="hlFld-ContribAuthor ">Matteo  D’Anello</span>, <span class="hlFld-ContribAuthor ">Marina  Fasolini</span>, <span class="hlFld-ContribAuthor ">Barbara  Forte</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Alexander  Khvat</span>, <span class="hlFld-ContribAuthor ">Mikhail Y.  Krasavin</span>, <span class="hlFld-ContribAuthor ">Rosita  Lupi</span>, <span class="hlFld-ContribAuthor ">Paolo  Orsini</span>, <span class="hlFld-ContribAuthor ">Rita  Perego</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Daniele  Pezzetta</span>, <span class="hlFld-ContribAuthor ">Sonia  Rainoldi</span>, <span class="hlFld-ContribAuthor ">Federico  Riccardi-Sirtori</span>, <span class="hlFld-ContribAuthor ">Alessandra  Scolaro</span>, <span class="hlFld-ContribAuthor ">Francesco  Sola</span>, <span class="hlFld-ContribAuthor ">Fabio  Zuccotto</span>, <span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, and <span class="hlFld-ContribAuthor ">Alessia  Montagnoli</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6875-6898. <a href="https://doi.org/10.1021/acs.jmedchem.5b00680" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00680%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%25255B1-%2525284%25252C4-Difluorocyclohexyl%252529piperidin-4-yl%25255D-6-fluoro-3-oxo-2%25252C3-dihydro-1H-isoindole-4-carboxamide%252B%252528NMS-P118%252529%25253A%252BA%252BPotent%25252C%252BOrally%252BAvailable%25252C%252Band%252BHighly%252BSelective%252BPARP-1%252BInhibitor%252Bfor%252BCancer%252BTherapy%26aulast%3DPapeo%26aufirst%3DGianluca%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D04052015%26date%3D26082015%26date%3D10092015%26date%3D29072015%26volume%3D58%26issue%3D17%26spage%3D6875%26epage%3D6898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Polucci</span>, <span class="hlFld-ContribAuthor ">Paola  Magnaghi</span>, <span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>, <span class="hlFld-ContribAuthor ">Daniela  Asa</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Alessandra  Badari</span>, <span class="hlFld-ContribAuthor ">Jay  Bertrand</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Silvia  Cauteruccio</span>, <span class="hlFld-ContribAuthor ">Alessandra  Cirla</span>, <span class="hlFld-ContribAuthor ">Liviana  Cozzi</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Peter K.  Jackson</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>, <span class="hlFld-ContribAuthor ">Beatrice  Malgesini</span>, <span class="hlFld-ContribAuthor ">Stefano  Nuvoloni</span>, <span class="hlFld-ContribAuthor ">Christian  Orrenius</span>, <span class="hlFld-ContribAuthor ">Federico Riccardi  Sirtori</span>, <span class="hlFld-ContribAuthor ">Laura  Riceputi</span>, <span class="hlFld-ContribAuthor ">Simona  Rizzi</span>, <span class="hlFld-ContribAuthor ">Beatrice  Trucchi</span>, <span class="hlFld-ContribAuthor ">Tom  O’Brien</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, and <span class="hlFld-ContribAuthor ">Roberto  D’Alessio</span>  . </span><span class="cited-content_cbyCitation_article-title">Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure–Activity Relationships. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (2)
                                     , 437-450. <a href="https://doi.org/10.1021/jm3013213" title="DOI URL">https://doi.org/10.1021/jm3013213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3013213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3013213%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAlkylsulfanyl-1%25252C2%25252C4-triazoles%25252C%252Ba%252BNew%252BClass%252Bof%252BAllosteric%252BValosine%252BContaining%252BProtein%252BInhibitors.%252BSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%26aulast%3DPolucci%26aufirst%3DPaolo%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D13092012%26date%3D04012013%26date%3D24012013%26date%3D17122012%26volume%3D56%26issue%3D2%26spage%3D437%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott W.  Bagley</span>, <span class="hlFld-ContribAuthor ">James A.  Southers</span>, <span class="hlFld-ContribAuthor ">Shawn  Cabral</span>, <span class="hlFld-ContribAuthor ">Colin R.  Rose</span>, <span class="hlFld-ContribAuthor ">David J.  Bernhardson</span>, <span class="hlFld-ContribAuthor ">David J.  Edmonds</span>, <span class="hlFld-ContribAuthor ">Jana  Polivkova</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Yang</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Kung</span>, <span class="hlFld-ContribAuthor ">David A.  Griffith</span>, and <span class="hlFld-ContribAuthor ">Scott J.  Bader</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 7-Oxo-dihydrospiro[indazole-5,4′-piperidine] Acetyl-CoA Carboxylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>77 </em>
                                    (3)
                                     , 1497-1506. <a href="https://doi.org/10.1021/jo202377g" title="DOI URL">https://doi.org/10.1021/jo202377g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo202377g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo202377g%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B7-Oxo-dihydrospiro%25255Bindazole-5%25252C4%2525E2%252580%2525B2-piperidine%25255D%252BAcetyl-CoA%252BCarboxylase%252BInhibitors%26aulast%3DBagley%26aufirst%3DScott%2BW.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D17112011%26date%3D25012012%26date%3D03022012%26date%3D12012012%26volume%3D77%26issue%3D3%26spage%3D1497%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew O.  Duffey</span>, <span class="hlFld-ContribAuthor ">Tricia J.  Vos</span>, <span class="hlFld-ContribAuthor ">Ruth  Adams</span>, <span class="hlFld-ContribAuthor ">Jennifer  Alley</span>, <span class="hlFld-ContribAuthor ">Justin  Anthony</span>, <span class="hlFld-ContribAuthor ">Cynthia  Barrett</span>, <span class="hlFld-ContribAuthor ">Indu  Bharathan</span>, <span class="hlFld-ContribAuthor ">Douglas  Bowman</span>, <span class="hlFld-ContribAuthor ">Nancy J.  Bump</span>, <span class="hlFld-ContribAuthor ">Ryan  Chau</span>, <span class="hlFld-ContribAuthor ">Courtney  Cullis</span>, <span class="hlFld-ContribAuthor ">Denise L.  Driscoll</span>, <span class="hlFld-ContribAuthor ">Amy  Elder</span>, <span class="hlFld-ContribAuthor ">Nancy  Forsyth</span>, <span class="hlFld-ContribAuthor ">Jonathan  Frazer</span>, <span class="hlFld-ContribAuthor ">Jianping  Guo</span>, <span class="hlFld-ContribAuthor ">Luyi  Guo</span>, <span class="hlFld-ContribAuthor ">Marc L.  Hyer</span>, <span class="hlFld-ContribAuthor ">David  Janowick</span>, <span class="hlFld-ContribAuthor ">Bheemashankar  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Su-Jen  Lai</span>, <span class="hlFld-ContribAuthor ">Kerri  Lasky</span>, <span class="hlFld-ContribAuthor ">Gang  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Debra  Liao</span>, <span class="hlFld-ContribAuthor ">Jeremy  Little</span>, <span class="hlFld-ContribAuthor ">Bo  Peng</span>, <span class="hlFld-ContribAuthor ">Mark G.  Qian</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Mansoureh  Rezaei</span>, <span class="hlFld-ContribAuthor ">Margaret Porter  Scott</span>, <span class="hlFld-ContribAuthor ">Todd B.  Sells</span>, <span class="hlFld-ContribAuthor ">Vaishali  Shinde</span>, <span class="hlFld-ContribAuthor ">Qiuju Judy  Shi</span>, <span class="hlFld-ContribAuthor ">Michael D.  Sintchak</span>, <span class="hlFld-ContribAuthor ">Francois  Soucy</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Sprott</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Stroud</span>, <span class="hlFld-ContribAuthor ">Michelle  Nestor</span>, <span class="hlFld-ContribAuthor ">Irache  Visiers</span>, <span class="hlFld-ContribAuthor ">Gabriel  Weatherhead</span>, <span class="hlFld-ContribAuthor ">Yingchun  Ye</span>, and <span class="hlFld-ContribAuthor ">Natalie  D’Amore</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (1)
                                     , 197-208. <a href="https://doi.org/10.1021/jm2011172" title="DOI URL">https://doi.org/10.1021/jm2011172</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2011172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2011172%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BBenzolactam-Derived%252BInhibitor%252Bof%252BPolo-Like%252BKinase%252B1%252B%252528MLN0905%252529%26aulast%3DDuffey%26aufirst%3DMatthew%2BO.%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D19082011%26date%3D05122011%26date%3D12012012%26date%3D09112011%26volume%3D55%26issue%3D1%26spage%3D197%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Jana  Sopková-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2536. <a href="https://doi.org/10.3390/molecules26092536" title="DOI URL">https://doi.org/10.3390/molecules26092536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092536%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDevelopment%252Bof%252BNovel%252BPotential%252BPleiotropic%252BCompounds%252Bof%252BInterest%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTreatment%252Bthrough%252BRigidification%252BStrategy%26aulast%3DLecoutey%26aufirst%3DC%25C3%25A9dric%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youri  Oh</span>, <span class="hlFld-ContribAuthor ">Hoyong  Jung</span>, <span class="hlFld-ContribAuthor ">Hyejin  Kim</span>, <span class="hlFld-ContribAuthor ">Jihyun  Baek</span>, <span class="hlFld-ContribAuthor ">Joonhong  Jun</span>, <span class="hlFld-ContribAuthor ">Hyunwook  Cho</span>, <span class="hlFld-ContribAuthor ">Daseul  Im</span>, <span class="hlFld-ContribAuthor ">Jung-Mi  Hah</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of a Novel PLK1 Inhibitor Scaffold Using a Hybridized 3D-QSAR Model. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 3865. <a href="https://doi.org/10.3390/ijms22083865" title="DOI URL">https://doi.org/10.3390/ijms22083865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22083865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22083865%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252Ba%252BNovel%252BPLK1%252BInhibitor%252BScaffold%252BUsing%252Ba%252BHybridized%252B3D-QSAR%252BModel%26aulast%3DOh%26aufirst%3DYouri%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D3865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Firdoos Ahmad  Sofi</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Drugs and Biorelevant N-heterocycles Employing Recent Advances in C-N Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2020,</strong> <em>24 </em>
                                    (20)
                                     , 2293-2340. <a href="https://doi.org/10.2174/1385272824999200909114144" title="DOI URL">https://doi.org/10.2174/1385272824999200909114144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272824999200909114144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272824999200909114144%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BDrugs%252Band%252BBiorelevant%252BN-heterocycles%252BEmploying%252BRecent%252BAdvances%252Bin%252BC-N%252BBond%252BFormation%26aulast%3DSofi%26aufirst%3DFirdoos%2BAhmad%26date%3D2020%26volume%3D24%26issue%3D20%26spage%3D2293%26epage%3D2340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chelsea E.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Mackenzie J.  MacAuley</span>, <span class="hlFld-ContribAuthor ">Frederick S.  Vizeacoumar</span>, <span class="hlFld-ContribAuthor ">Omar  Abuhussein</span>, <span class="hlFld-ContribAuthor ">Andrew  Freywald</span>, <span class="hlFld-ContribAuthor ">Franco J.  Vizeacoumar</span>. </span><span class="cited-content_cbyCitation_article-title">The CINs of Polo-Like Kinase 1 in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 2953. <a href="https://doi.org/10.3390/cancers12102953" title="DOI URL">https://doi.org/10.3390/cancers12102953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12102953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12102953%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BCINs%252Bof%252BPolo-Like%252BKinase%252B1%252Bin%252BCancer%26aulast%3DCunningham%26aufirst%3DChelsea%2BE.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D2953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Hu</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunlei  Tang</span>, <span class="hlFld-ContribAuthor ">Bainian  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in Synthesis and Bioactivity Evaluation of Pyrazoloquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (2)
                                     , 104-113. <a href="https://doi.org/10.2174/1570180815666181017120100" title="DOI URL">https://doi.org/10.2174/1570180815666181017120100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180815666181017120100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180815666181017120100%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DProgress%252Bin%252BSynthesis%252Band%252BBioactivity%252BEvaluation%252Bof%252BPyrazoloquinazolines%26aulast%3DZhao%26aufirst%3DHui%26date%3D2020%26volume%3D17%26issue%3D2%26spage%3D104%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shutao  Wang</span>, <span class="hlFld-ContribAuthor ">Muxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengnan  Jiang</span>, <span class="hlFld-ContribAuthor ">Junli  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaguo  Li</span>, <span class="hlFld-ContribAuthor ">Chenchen  Li</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 247-268. <a href="https://doi.org/10.1016/j.ejmech.2019.04.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bdesign%252Band%252Banticancer%252Bactivities%252Bof%252Bsmall-molecule%252Bmonopolar%252Bspindle%252B1%252Binhibitors%25253A%252BA%252BMedicinal%252Bchemistry%252Bperspective%26aulast%3DWang%26aufirst%3DShutao%26date%3D2019%26volume%3D175%26spage%3D247%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Hu</span>, <span class="hlFld-ContribAuthor ">Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Youzhi  Wang</span>, <span class="hlFld-ContribAuthor ">Zhan  Liu</span>, <span class="hlFld-ContribAuthor ">Bainian  Feng</span>, <span class="hlFld-ContribAuthor ">Chunlei  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel 5,6-dihydropyrimido[4,5-f]quinazoline derivatives as potent CDK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (20)
                                     , 3385-3390. <a href="https://doi.org/10.1016/j.bmcl.2018.08.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.08.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.08.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B5%25252C6-dihydropyrimido%25255B4%25252C5-f%25255Dquinazoline%252Bderivatives%252Bas%252Bpotent%252BCDK2%252Binhibitors%26aulast%3DHu%26aufirst%3DXiaoxia%26date%3D2018%26volume%3D28%26issue%3D20%26spage%3D3385%26epage%3D3390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Hu</span>, <span class="hlFld-ContribAuthor ">Kai  Cao</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Kuantao  Zhao</span>, <span class="hlFld-ContribAuthor ">Chunlei  Tang</span>, <span class="hlFld-ContribAuthor ">Bainian  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as potent and selective CDK4/6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 935-945. <a href="https://doi.org/10.1016/j.ejmech.2018.08.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252B4%25252C5-dihydro-1H-pyrazolo%25255B4%25252C3-h%25255Dquinazoline%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BCDK4%25252F6%252Binhibitors%26aulast%3DZhao%26aufirst%3DHui%26date%3D2018%26volume%3D157%26spage%3D935%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Alagarsamy</span>, <span class="hlFld-ContribAuthor ">K.  Chitra</span>, <span class="hlFld-ContribAuthor ">G.  Saravanan</span>, <span class="hlFld-ContribAuthor ">V. Raja  Solomon</span>, <span class="hlFld-ContribAuthor ">M.T.  Sulthana</span>, <span class="hlFld-ContribAuthor ">B.  Narendhar</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of quinazolines: Pharmacological significance and recent developments. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 628-685. <a href="https://doi.org/10.1016/j.ejmech.2018.03.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bquinazolines%25253A%252BPharmacological%252Bsignificance%252Band%252Brecent%252Bdevelopments%26aulast%3DAlagarsamy%26aufirst%3DV.%26date%3D2018%26volume%3D151%26spage%3D628%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akshada J.  Joshi</span>, <span class="hlFld-ContribAuthor ">Heena R.  Bhojwani</span>, <span class="hlFld-ContribAuthor ">Urmila J.  Joshi</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to select the best pharmacophore model: a case study in pyrazoloquinazoline class of PLK-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2018,</strong> <em>27 </em>
                                    (1)
                                     , 234-260. <a href="https://doi.org/10.1007/s00044-017-2057-9" title="DOI URL">https://doi.org/10.1007/s00044-017-2057-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-2057-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-2057-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DStrategies%252Bto%252Bselect%252Bthe%252Bbest%252Bpharmacophore%252Bmodel%25253A%252Ba%252Bcase%252Bstudy%252Bin%252Bpyrazoloquinazoline%252Bclass%252Bof%252BPLK-1%252Binhibitors%26aulast%3DJoshi%26aufirst%3DAkshada%2BJ.%26date%3D2018%26date%3D2017%26volume%3D27%26issue%3D1%26spage%3D234%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-Ge  Li</span>, <span class="hlFld-ContribAuthor ">Kai-Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Chi  Gong</span>, <span class="hlFld-ContribAuthor ">Yu  Bao</span>, <span class="hlFld-ContribAuthor ">Ning-Bo  Qin</span>, <span class="hlFld-ContribAuthor ">Da-Hong  Li</span>, <span class="hlFld-ContribAuthor ">Zhan-Lin  Li</span>, <span class="hlFld-ContribAuthor ">Jiao  Bai</span>, <span class="hlFld-ContribAuthor ">Hui-Ming  Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic quinazoline alkaloids from the seeds of Peganum harmala. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (2)
                                     , 103-106. <a href="https://doi.org/10.1016/j.bmcl.2017.12.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCytotoxic%252Bquinazoline%252Balkaloids%252Bfrom%252Bthe%252Bseeds%252Bof%252BPeganum%252Bharmala%26aulast%3DLi%26aufirst%3DSheng-Ge%26date%3D2018%26volume%3D28%26issue%3D2%26spage%3D103%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiko  Iikubo</span>, <span class="hlFld-ContribAuthor ">Yutaka  Kondoh</span>, <span class="hlFld-ContribAuthor ">Itsuro  Shimada</span>, <span class="hlFld-ContribAuthor ">Takahiro  Matsuya</span>, <span class="hlFld-ContribAuthor ">Kenichi  Mori</span>, <span class="hlFld-ContribAuthor ">Yoko  Ueno</span>, <span class="hlFld-ContribAuthor ">Minoru  Okada</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-{2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N′-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2018,</strong> <em>66 </em>
                                    (3)
                                     , 251-262. <a href="https://doi.org/10.1248/cpb.c17-00784" title="DOI URL">https://doi.org/10.1248/cpb.c17-00784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c17-00784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c17-00784%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DDiscovery%252Bof%252BN-%25257B2-Methoxy-4-%25255B4-%2525284-methylpiperazin-1-yl%252529piperidin-1-yl%25255Dphenyl%25257D-N%2525E2%252580%2525B2-%25255B2-%252528propane-2-sulfonyl%252529phenyl%25255D-1%25252C3%25252C5-triazine-2%25252C4-diamine%252B%252528ASP3026%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BInhibitor%26aulast%3DIikubo%26aufirst%3DKazuhiko%26date%3D2018%26volume%3D66%26issue%3D3%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Mei-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structurally diversified synthesis of 2,3-dihydroquinazolin-4-(1H)-ones from 2-aminobenzamides and 1,2-dicarbonyl compounds in ionic liquids catalyzed by iodine. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (5)
                                     , 2985-3005. <a href="https://doi.org/10.1007/s11164-016-2807-1" title="DOI URL">https://doi.org/10.1007/s11164-016-2807-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2807-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2807-1%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DStructurally%252Bdiversified%252Bsynthesis%252Bof%252B2%25252C3-dihydroquinazolin-4-%2525281H%252529-ones%252Bfrom%252B2-aminobenzamides%252Band%252B1%25252C2-dicarbonyl%252Bcompounds%252Bin%252Bionic%252Bliquids%252Bcatalyzed%252Bby%252Biodine%26aulast%3DWang%26aufirst%3DJie%26date%3D2017%26date%3D2016%26volume%3D43%26issue%3D5%26spage%3D2985%26epage%3D3005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Van den Bossche</span>, <span class="hlFld-ContribAuthor ">F.  Lardon</span>, <span class="hlFld-ContribAuthor ">V.  Deschoolmeester</span>, <span class="hlFld-ContribAuthor ">I.  De Pauw</span>, <span class="hlFld-ContribAuthor ">J.B.  Vermorken</span>, <span class="hlFld-ContribAuthor ">P.  Specenier</span>, <span class="hlFld-ContribAuthor ">P.  Pauwels</span>, <span class="hlFld-ContribAuthor ">M.  Peeters</span>, <span class="hlFld-ContribAuthor ">A.  Wouters</span>. </span><span class="cited-content_cbyCitation_article-title">Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2016,</strong> <em>36 </em>
                                    (4)
                                     , 749-786. <a href="https://doi.org/10.1002/med.21392" title="DOI URL">https://doi.org/10.1002/med.21392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21392%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DSpotlight%252Bon%252BVolasertib%25253A%252BPreclinical%252Band%252BClinical%252BEvaluation%252Bof%252Ba%252BPromising%252BPlk1%252BInhibitor%26aulast%3DVan%2Bden%2BBossche%26aufirst%3DJ.%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D4%26spage%3D749%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosie Elizabeth Ann  Gutteridge</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Ndiaye</span>, <span class="hlFld-ContribAuthor ">Xiaoqi  Liu</span>, <span class="hlFld-ContribAuthor ">Nihal  Ahmad</span>. </span><span class="cited-content_cbyCitation_article-title">Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2016,</strong> <em>15 </em>
                                    (7)
                                     , 1427-1435. <a href="https://doi.org/10.1158/1535-7163.MCT-15-0897" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-15-0897</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-15-0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-15-0897%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DPlk1%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BFrom%252BLaboratory%252Bto%252BClinics%26aulast%3DGutteridge%26aufirst%3DRosie%2BElizabeth%2BAnn%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D7%26spage%3D1427%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiv  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashish Ranjan  Sharma</span>, <span class="hlFld-ContribAuthor ">Garima  Sharma</span>, <span class="hlFld-ContribAuthor ">Chiranjib  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Jaebong  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">PLK-1: Angel or devil for cell cycle progression. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2016,</strong> <em>1865 </em>
                                    (2)
                                     , 190-203. <a href="https://doi.org/10.1016/j.bbcan.2016.02.003" title="DOI URL">https://doi.org/10.1016/j.bbcan.2016.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2016.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2016.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DPLK-1%25253A%252BAngel%252Bor%252Bdevil%252Bfor%252Bcell%252Bcycle%252Bprogression%26aulast%3DKumar%26aufirst%3DShiv%26date%3D2016%26volume%3D1865%26issue%3D2%26spage%3D190%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Posch</span>, <span class="hlFld-ContribAuthor ">Brian D.  Cholewa</span>, <span class="hlFld-ContribAuthor ">Igor  Vujic</span>, <span class="hlFld-ContribAuthor ">Martina  Sanlorenzo</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Ma</span>, <span class="hlFld-ContribAuthor ">Sarasa T.  Kim</span>, <span class="hlFld-ContribAuthor ">Sonja  Kleffel</span>, <span class="hlFld-ContribAuthor ">Tobias  Schatton</span>, <span class="hlFld-ContribAuthor ">Klemens  Rappersberger</span>, <span class="hlFld-ContribAuthor ">Rosie  Gutteridge</span>, <span class="hlFld-ContribAuthor ">Nihal  Ahmad</span>, <span class="hlFld-ContribAuthor ">Susana  Ortiz-Urda</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2015,</strong> <em>135 </em>
                                    (10)
                                     , 2475-2483. <a href="https://doi.org/10.1038/jid.2015.198" title="DOI URL">https://doi.org/10.1038/jid.2015.198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/jid.2015.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fjid.2015.198%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DCombined%252BInhibition%252Bof%252BMEK%252Band%252BPlk1%252BHas%252BSynergistic%252BAntitumor%252BActivity%252Bin%252BNRAS%252BMutant%252BMelanoma%26aulast%3DPosch%26aufirst%3DChristian%26date%3D2015%26volume%3D135%26issue%3D10%26spage%3D2475%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mansi  Garg</span>, <span class="hlFld-ContribAuthor ">Monika  Chauhan</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Jimi Marin  Alex</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazoloquinazolines: Synthetic strategies and bioactivities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 444-461. <a href="https://doi.org/10.1016/j.ejmech.2014.11.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.11.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.11.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.11.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazoloquinazolines%25253A%252BSynthetic%252Bstrategies%252Band%252Bbioactivities%26aulast%3DGarg%26aufirst%3DMansi%26date%3D2015%26volume%3D97%26spage%3D444%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zong-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Shu-Yong  Song</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">He-Lin  Lu</span>, <span class="hlFld-ContribAuthor ">Brian  Lieberman</span>, <span class="hlFld-ContribAuthor ">Yun-Sheng  Huang</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of tetrahydroindazole derivatives as sigma-2 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (7)
                                     , 1463-1471. <a href="https://doi.org/10.1016/j.bmc.2015.02.012" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Btetrahydroindazole%252Bderivatives%252Bas%252Bsigma-2%252Breceptor%252Bligands%26aulast%3DWu%26aufirst%3DZong-Wen%26date%3D2015%26volume%3D23%26issue%3D7%26spage%3D1463%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiv  Kumar</span>, <span class="hlFld-ContribAuthor ">Jaebong  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2015,</strong> <em>2015 </em>, 1-21. <a href="https://doi.org/10.1155/2015/705745" title="DOI URL">https://doi.org/10.1155/2015/705745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/705745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F705745%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DPLK-1%252BTargeted%252BInhibitors%252Band%252BTheir%252BPotential%252Bagainst%252BTumorigenesis%26aulast%3DKumar%26aufirst%3DShiv%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Carrasco-Gomez</span>, <span class="hlFld-ContribAuthor ">Sarah  Keppner-Witter</span>, <span class="hlFld-ContribAuthor ">Martina  Hieke</span>, <span class="hlFld-ContribAuthor ">Lisa  Lange</span>, <span class="hlFld-ContribAuthor ">Gisbert  Schneider</span>, <span class="hlFld-ContribAuthor ">Manfred  Schubert-Zsilavecz</span>, <span class="hlFld-ContribAuthor ">Ewgenij  Proschak</span>, <span class="hlFld-ContribAuthor ">Birgit  Spänkuch</span>. </span><span class="cited-content_cbyCitation_article-title">Vanillin-derived antiproliferative compounds influence Plk1 activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (21)
                                     , 5063-5069. <a href="https://doi.org/10.1016/j.bmcl.2014.09.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.09.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.09.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVanillin-derived%252Bantiproliferative%252Bcompounds%252Binfluence%252BPlk1%252Bactivity%26aulast%3DCarrasco-Gomez%26aufirst%3DRoberto%26date%3D2014%26volume%3D24%26issue%3D21%26spage%3D5063%26epage%3D5069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Bao-Xiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 311-340. <a href="https://doi.org/10.1016/j.ejmech.2014.07.102" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.102%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bof%252Bthe%252Bsynthesis%252Bof%252Bcondensed%252Bpyrazole%252Bderivatives%252B%252528from%252B2010%252Bto%252Bmid-2013%252529%26aulast%3DLi%26aufirst%3DMeng%26date%3D2014%26volume%3D85%26spage%3D311%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Sun</span>, <span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Feng-Jiao  Guo</span>, <span class="hlFld-ContribAuthor ">Xin-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-  Han</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Gui-Hua  Sheng</span>, <span class="hlFld-ContribAuthor ">Shao-Song  Qian</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatic diacylhydrazine derivatives as a new class of polo-like kinase 1 (PLK1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>81 </em>, 420-426. <a href="https://doi.org/10.1016/j.ejmech.2014.05.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.05.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.05.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAromatic%252Bdiacylhydrazine%252Bderivatives%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Bpolo-like%252Bkinase%252B1%252B%252528PLK1%252529%252Binhibitors%26aulast%3DSun%26aufirst%3DJuan%26date%3D2014%26volume%3D81%26spage%3D420%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simpal  Chauhan</span>, <span class="hlFld-ContribAuthor ">Sarvesh  Paliwal</span>, <span class="hlFld-ContribAuthor ">Rajani  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Activity of Pyrazole via Different Biological Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (10)
                                     , 1333-1374. <a href="https://doi.org/10.1080/00397911.2013.837186" title="DOI URL">https://doi.org/10.1080/00397911.2013.837186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2013.837186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2013.837186%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DAnticancer%252BActivity%252Bof%252BPyrazole%252Bvia%252BDifferent%252BBiological%252BMechanisms%26aulast%3DChauhan%26aufirst%3DSimpal%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D10%26spage%3D1333%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Mei-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Ling  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper(I)-catalyzed synthesis of 1-arylpyrazolo[5,1-b]quinazolin-9(1H)-one via intramolecular alkyne hydroamination. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (18)
                                     , 2889-2893. <a href="https://doi.org/10.1016/j.tet.2014.03.048" title="DOI URL">https://doi.org/10.1016/j.tet.2014.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCopper%252528I%252529-catalyzed%252Bsynthesis%252Bof%252B1-arylpyrazolo%25255B5%25252C1-b%25255Dquinazolin-9%2525281H%252529-one%252Bvia%252Bintramolecular%252Balkyne%252Bhydroamination%26aulast%3DChen%26aufirst%3DDong-Sheng%26date%3D2014%26volume%3D70%26issue%3D18%26spage%3D2889%26epage%3D2893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Jing  Zhou</span>, <span class="hlFld-ContribAuthor ">Mei-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Ling  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-catalyzed synthesis of 2-arylpyrazolo[5,1-b]quinazolin-9(3H)-one derivatives in ionic liquids via domino reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (21)
                                     , 3440-3446. <a href="https://doi.org/10.1016/j.tet.2014.03.075" title="DOI URL">https://doi.org/10.1016/j.tet.2014.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DIodine-catalyzed%252Bsynthesis%252Bof%252B2-arylpyrazolo%25255B5%25252C1-b%25255Dquinazolin-9%2525283H%252529-one%252Bderivatives%252Bin%252Bionic%252Bliquids%252Bvia%252Bdomino%252Breaction%26aulast%3DZhou%26aufirst%3DYu-Jing%26date%3D2014%26volume%3D70%26issue%3D21%26spage%3D3440%26epage%3D3446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongguang  Li</span>, <span class="hlFld-ContribAuthor ">Chi-Fai  Chan</span>, <span class="hlFld-ContribAuthor ">Wai-Lun  Chan</span>, <span class="hlFld-ContribAuthor ">Sam  Lear</span>, <span class="hlFld-ContribAuthor ">Steven L.  Cobb</span>, <span class="hlFld-ContribAuthor ">Nai-Ki  Mak</span>, <span class="hlFld-ContribAuthor ">Terrence Chi-Kong  Lau</span>, <span class="hlFld-ContribAuthor ">Rongfeng  Lan</span>, <span class="hlFld-ContribAuthor ">Wai-Kwok  Wong</span>, <span class="hlFld-ContribAuthor ">Ka-Leung  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Monitoring and inhibition of Plk1: amphiphilic porphyrin conjugated Plk1 specific peptides for its imaging and anti-tumor function. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (31)
                                     , 5876-5882. <a href="https://doi.org/10.1039/C4OB00853G" title="DOI URL">https://doi.org/10.1039/C4OB00853G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00853G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00853G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DMonitoring%252Band%252Binhibition%252Bof%252BPlk1%25253A%252Bamphiphilic%252Bporphyrin%252Bconjugated%252BPlk1%252Bspecific%252Bpeptides%252Bfor%252Bits%252Bimaging%252Band%252Banti-tumor%252Bfunction%26aulast%3DLi%26aufirst%3DHongguang%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D31%26spage%3D5876%26epage%3D5882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Casuscelli</span>, <span class="hlFld-ContribAuthor ">Elena  Ardini</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Giovanni  Cervi</span>, <span class="hlFld-ContribAuthor ">Matteo  D’Anello</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Daniela  Faiardi</span>, <span class="hlFld-ContribAuthor ">Ronald D.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Gianpaolo  Fogliatto</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Aurelio  Marsiglio</span>, <span class="hlFld-ContribAuthor ">Danilo G.  Mirizzi</span>, <span class="hlFld-ContribAuthor ">Marisa  Montemartini</span>, <span class="hlFld-ContribAuthor ">Christian  Orrenius</span>, <span class="hlFld-ContribAuthor ">Gianluca  Papeo</span>, <span class="hlFld-ContribAuthor ">Claudia  Piutti</span>, <span class="hlFld-ContribAuthor ">Barbara  Salom</span>, <span class="hlFld-ContribAuthor ">Eduard R.  Felder</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (23)
                                     , 7364-7380. <a href="https://doi.org/10.1016/j.bmc.2013.09.054" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bpyrrolo%25255B1%25252C2-a%25255Dpyrazinones%252Bleads%252Bto%252Bnovel%252Band%252Bselective%252Binhibitors%252Bof%252BPIM%252Bkinases%26aulast%3DCasuscelli%26aufirst%3DFrancesco%26date%3D2013%26volume%3D21%26issue%3D23%26spage%3D7364%26epage%3D7380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanliang  Sun</span>, <span class="hlFld-ContribAuthor ">Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">De novo
              design of PLK1 inhibitors based on 2-amino aromatic heterocyclic scaffold: 3D-QSAR and molecular fragment replacement. </span><span class="cited-content_cbyCitation_journal-name">Molecular Simulation</span><span> <strong>2013,</strong> <em>39 </em>
                                    (12)
                                     , 975-987. <a href="https://doi.org/10.1080/08927022.2013.784761" title="DOI URL">https://doi.org/10.1080/08927022.2013.784761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08927022.2013.784761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08927022.2013.784761%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Simulation%26atitle%3DDe%252Bnovo%252Bdesign%252Bof%252BPLK1%252Binhibitors%252Bbased%252Bon%252B2-amino%252Baromatic%252Bheterocyclic%252Bscaffold%25253A%252B3D-QSAR%252Band%252Bmolecular%252Bfragment%252Breplacement%26aulast%3DSun%26aufirst%3DShanliang%26date%3D2013%26volume%3D39%26issue%3D12%26spage%3D975%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lufen  He</span>, <span class="hlFld-ContribAuthor ">Lu  Zhou</span>, <span class="hlFld-ContribAuthor ">Taijin  Wang</span>, <span class="hlFld-ContribAuthor ">Zicheng  Li</span>, <span class="hlFld-ContribAuthor ">Xiangyang  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potent virtual leads to design novel PLK1 inhibitors: pharmacophore modelling, virtual screening and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Simulation</span><span> <strong>2013,</strong> <em>39 </em>
                                    (8)
                                     , 640-652. <a href="https://doi.org/10.1080/08927022.2012.758849" title="DOI URL">https://doi.org/10.1080/08927022.2012.758849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08927022.2012.758849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08927022.2012.758849%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Simulation%26atitle%3DIdentification%252Bof%252Bpotent%252Bvirtual%252Bleads%252Bto%252Bdesign%252Bnovel%252BPLK1%252Binhibitors%25253A%252Bpharmacophore%252Bmodelling%25252C%252Bvirtual%252Bscreening%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DHe%26aufirst%3DLufen%26date%3D2013%26volume%3D39%26issue%3D8%26spage%3D640%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Genest</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Jana Sopkova-de  Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Céline  Ballandonne</span>, <span class="hlFld-ContribAuthor ">Sabrina  Butt-Gueulle</span>, <span class="hlFld-ContribAuthor ">Remi  Legay</span>, <span class="hlFld-ContribAuthor ">Marc  Since</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel indano- and thiaindano-pyrazoles with potential interest for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (6)
                                     , 925. <a href="https://doi.org/10.1039/c3md00041a" title="DOI URL">https://doi.org/10.1039/c3md00041a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3md00041a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3md00041a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bindano-%252Band%252Bthiaindano-pyrazoles%252Bwith%252Bpotential%252Binterest%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DGenest%26aufirst%3DDavid%26date%3D2013%26volume%3D4%26issue%3D6%26spage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Sun</span>, <span class="hlFld-ContribAuthor ">Yuan  Ren</span>, <span class="hlFld-ContribAuthor ">Yunbo  Lou</span>, <span class="hlFld-ContribAuthor ">Jun  Zhou</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Dengwen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2012,</strong> <em>13 </em>
                                    (12)
                                     , 1214-1220. <a href="https://doi.org/10.4161/cbt.21412" title="DOI URL">https://doi.org/10.4161/cbt.21412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/cbt.21412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fcbt.21412%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DValidation%252Bof%252BPolo-like%252Bkinase%252B1%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252Bpancreatic%252Bcancer%252Bcells%26aulast%3DZhang%26aufirst%3DChao%26date%3D2012%26date%3D2014%26volume%3D13%26issue%3D12%26spage%3D1214%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elen Gomes  Pereira</span>, <span class="hlFld-ContribAuthor ">Miguel Ângelo Martins  Moreira</span>, <span class="hlFld-ContribAuthor ">Ernesto Raúl  Caffarena</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular interactions of c-ABL mutants in complex with imatinib/nilotinib: a computational study using linear interaction energy (LIE) calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (9)
                                     , 4333-4341. <a href="https://doi.org/10.1007/s00894-012-1436-x" title="DOI URL">https://doi.org/10.1007/s00894-012-1436-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-012-1436-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-012-1436-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DMolecular%252Binteractions%252Bof%252Bc-ABL%252Bmutants%252Bin%252Bcomplex%252Bwith%252Bimatinib%25252Fnilotinib%25253A%252Ba%252Bcomputational%252Bstudy%252Busing%252Blinear%252Binteraction%252Benergy%252B%252528LIE%252529%252Bcalculations%26aulast%3DPereira%26aufirst%3DElen%2BGomes%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D9%26spage%3D4333%26epage%3D4341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Valsasina</span>, <span class="hlFld-ContribAuthor ">Italo  Beria</span>, <span class="hlFld-ContribAuthor ">Cristina  Alli</span>, <span class="hlFld-ContribAuthor ">Rachele  Alzani</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Paolo  Cappella</span>, <span class="hlFld-ContribAuthor ">Michele  Caruso</span>, <span class="hlFld-ContribAuthor ">Alessia  Casolaro</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciavolella</span>, <span class="hlFld-ContribAuthor ">Ulisse  Cucchi</span>, <span class="hlFld-ContribAuthor ">Anna  De Ponti</span>, <span class="hlFld-ContribAuthor ">Eduard  Felder</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Laura M.  Gianellini</span>, <span class="hlFld-ContribAuthor ">Maria L.  Giorgini</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Jaqueline  Lansen</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Simona  Rizzi</span>, <span class="hlFld-ContribAuthor ">Maurizio  Rocchetti</span>, <span class="hlFld-ContribAuthor ">Francesco  Sola</span>, <span class="hlFld-ContribAuthor ">Jürgen  Moll</span>. </span><span class="cited-content_cbyCitation_article-title">NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2012,</strong> <em>11 </em>
                                    (4)
                                     , 1006-1016. <a href="https://doi.org/10.1158/1535-7163.MCT-11-0765" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-0765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-0765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-0765%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DNMS-P937%25252C%252Ban%252BOrally%252BAvailable%25252C%252BSpecific%252BSmall-Molecule%252BPolo-like%252BKinase%252B1%252BInhibitor%252Bwith%252BAntitumor%252BActivity%252Bin%252BSolid%252Band%252BHematologic%252BMalignancies%26aulast%3DValsasina%26aufirst%3DBarbara%26date%3D2012%26date%3D2012%26volume%3D11%26issue%3D4%26spage%3D1006%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>, <span class="hlFld-ContribAuthor ">Adriano  Guiotto</span>, <span class="hlFld-ContribAuthor ">Adriana  Chilin</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (3)
                                     , 223-252. <a href="https://doi.org/10.1517/13543776.2012.665876" title="DOI URL">https://doi.org/10.1517/13543776.2012.665876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.665876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.665876%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DQuinazoline%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%25253A%252Ba%252Bpatent%252Breview%252B%2525282007%252B%2525E2%252580%252593%252B2010%252529%26aulast%3DMarzaro%26aufirst%3DGiovanni%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D3%26spage%3D223%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Caruso</span>, <span class="hlFld-ContribAuthor ">Barbara  Valsasina</span>, <span class="hlFld-ContribAuthor ">Dario  Ballinari</span>, <span class="hlFld-ContribAuthor ">Jay  Bertrand</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Marina  Caldarelli</span>, <span class="hlFld-ContribAuthor ">Paolo  Cappella</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Laura M.  Gianellini</span>, <span class="hlFld-ContribAuthor ">Alessandra  Scolaro</span>, <span class="hlFld-ContribAuthor ">Italo  Beria</span>. </span><span class="cited-content_cbyCitation_article-title">5-(2-Amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 96-101. <a href="https://doi.org/10.1016/j.bmcl.2011.11.065" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.065%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D5-%2525282-Amino-pyrimidin-4-yl%252529-1H-pyrrole%252Band%252B2-%2525282-amino-pyrimidin-4-yl%252529-1%25252C5%25252C6%25252C7-tetrahydro-pyrrolo%25255B3%25252C2-c%25255Dpyridin-4-one%252Bderivatives%252Bas%252Bnew%252Bclasses%252Bof%252Bselective%252Band%252Borally%252Bavailable%252BPolo-like%252Bkinase%252B1%252Binhibitors%26aulast%3DCaruso%26aufirst%3DMichele%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D96%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Hai-Chun  Liu</span>, <span class="hlFld-ContribAuthor ">Ya-Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Hao-Liang  Yuan</span>, <span class="hlFld-ContribAuthor ">Shan-Liang  Sun</span>, <span class="hlFld-ContribAuthor ">Yi-Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Pei  Yang</span>, <span class="hlFld-ContribAuthor ">Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2011,</strong> <em>12 </em>
                                    (12)
                                     , 8713-8739. <a href="https://doi.org/10.3390/ijms12128713" title="DOI URL">https://doi.org/10.3390/ijms12128713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms12128713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms12128713%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCombined%252BPharmacophore%252BModeling%25252C%252BDocking%25252C%252Band%252B3D-QSAR%252BStudies%252Bof%252BPLK1%252BInhibitors%26aulast%3DLu%26aufirst%3DShuai%26date%3D2011%26date%3D2011%26volume%3D12%26issue%3D12%26spage%3D8713%26epage%3D8739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravichandran N.  Murugan</span>, <span class="hlFld-ContribAuthor ">Jung-Eun  Park</span>, <span class="hlFld-ContribAuthor ">Eun-Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Song Yub  Shin</span>, <span class="hlFld-ContribAuthor ">Chaejoon  Cheong</span>, <span class="hlFld-ContribAuthor ">Kyung S.  Lee</span>, <span class="hlFld-ContribAuthor ">Jeong Kyu  Bang</span>. </span><span class="cited-content_cbyCitation_article-title">Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity. </span><span class="cited-content_cbyCitation_journal-name">Molecules and Cells</span><span> <strong>2011,</strong> <em>32 </em>
                                    (3)
                                     , 209-220. <a href="https://doi.org/10.1007/s10059-011-0126-3" title="DOI URL">https://doi.org/10.1007/s10059-011-0126-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10059-011-0126-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10059-011-0126-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%2520and%2520Cells%26atitle%3DPlk1-targeted%252Bsmall%252Bmolecule%252Binhibitors%25253A%252Bmolecular%252Bbasis%252Bfor%252Btheir%252Bpotency%252Band%252Bspecificity%26aulast%3DMurugan%26aufirst%3DRavichandran%2BN.%26date%3D2011%26date%3D2011%26volume%3D32%26issue%3D3%26spage%3D209%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Caldarelli</span>, <span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>, <span class="hlFld-ContribAuthor ">Teresa  Disingrini</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Marco  Guanci</span>, <span class="hlFld-ContribAuthor ">Stefano  Nuvoloni</span>, <span class="hlFld-ContribAuthor ">Helena  Posteri</span>, <span class="hlFld-ContribAuthor ">Francesca  Quartieri</span>, <span class="hlFld-ContribAuthor ">Marco  Silvagni</span>, <span class="hlFld-ContribAuthor ">Riccardo  Colombo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (15)
                                     , 4507-4511. <a href="https://doi.org/10.1016/j.bmcl.2011.05.122" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.05.122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.05.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.05.122%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252Bnew%252Bpyrazolo%25255B4%25252C3-h%25255Dquinazoline-3-carboxamide%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BMPS1%252Bkinase%252Binhibitors%26aulast%3DCaldarelli%26aufirst%3DMarina%26date%3D2011%26volume%3D21%26issue%3D15%26spage%3D4507%26epage%3D4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Campbell  McInnes</span>, <span class="hlFld-ContribAuthor ">Michael D.  Wyatt</span>. </span><span class="cited-content_cbyCitation_article-title">PLK1 as an oncology target: current status and future potential. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2011,</strong> <em>16 </em>
                                    (13-14)
                                     , 619-625. <a href="https://doi.org/10.1016/j.drudis.2011.05.002" title="DOI URL">https://doi.org/10.1016/j.drudis.2011.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2011.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2011.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DPLK1%252Bas%252Ban%252Boncology%252Btarget%25253A%252Bcurrent%252Bstatus%252Band%252Bfuture%252Bpotential%26aulast%3DMcInnes%26aufirst%3DCampbell%26date%3D2011%26volume%3D16%26issue%3D13-14%26spage%3D619%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel C  Christoph</span>, <span class="hlFld-ContribAuthor ">Martin  Schuler</span>. </span><span class="cited-content_cbyCitation_article-title">Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2011,</strong> <em>11 </em>
                                    (7)
                                     , 1117-1132. <a href="https://doi.org/10.1586/era.11.61" title="DOI URL">https://doi.org/10.1586/era.11.61</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/era.11.61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2Fera.11.61%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DPolo-like%252Bkinase%252B1%252Binhibitors%252Bin%252Bmono-%252Band%252Bcombination%252Btherapies%25253A%252Ba%252Bnew%252Bstrategy%252Bfor%252Btreating%252Bmalignancies%26aulast%3DChristoph%26aufirst%3DDaniel%2BC%26date%3D2011%26date%3D2014%26volume%3D11%26issue%3D7%26spage%3D1117%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Italo  Beria</span>, <span class="hlFld-ContribAuthor ">Roberto T.  Bossi</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Michele  Caruso</span>, <span class="hlFld-ContribAuthor ">Walter  Ceccarelli</span>, <span class="hlFld-ContribAuthor ">Gabriele  Fachin</span>, <span class="hlFld-ContribAuthor ">Marina  Fasolini</span>, <span class="hlFld-ContribAuthor ">Barbara  Forte</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Daniele  Pezzetta</span>, <span class="hlFld-ContribAuthor ">Helena  Posteri</span>, <span class="hlFld-ContribAuthor ">Alessandra  Scolaro</span>, <span class="hlFld-ContribAuthor ">Stefania Re  Depaolini</span>, <span class="hlFld-ContribAuthor ">Barbara  Valsasina</span>. </span><span class="cited-content_cbyCitation_article-title">NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (10)
                                     , 2969-2974. <a href="https://doi.org/10.1016/j.bmcl.2011.03.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.03.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.03.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNMS-P937%25252C%252Ba%252B4%25252C5-dihydro-1H-pyrazolo%25255B4%25252C3-h%25255Dquinazoline%252Bderivative%252Bas%252Bpotent%252Band%252Bselective%252BPolo-like%252Bkinase%252B1%252Binhibitor%26aulast%3DBeria%26aufirst%3DItalo%26date%3D2011%26volume%3D21%26issue%3D10%26spage%3D2969%26epage%3D2974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael M.  Miller</span>, <span class="hlFld-ContribAuthor ">Albert J.  DelMonte</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 371-402. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00013-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00013-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00013-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00013-9%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DMiller%26aufirst%3DMichael%2BM.%26date%3D2011%26spage%3D371%26epage%3D402%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhupesh S.  Samant</span>, <span class="hlFld-ContribAuthor ">George W.  Kabalka</span>. </span><span class="cited-content_cbyCitation_article-title">A novel catalytic process for trifluoromethylation of bromoaromatic compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2011,</strong> <em>47 </em>
                                    (25)
                                     , 7236. <a href="https://doi.org/10.1039/c1cc12098k" title="DOI URL">https://doi.org/10.1039/c1cc12098k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1cc12098k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1cc12098k%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bnovel%252Bcatalytic%252Bprocess%252Bfor%252Btrifluoromethylation%252Bof%252Bbromoaromatic%252Bcompounds%26aulast%3DSamant%26aufirst%3DBhupesh%2BS.%26date%3D2011%26volume%3D47%26issue%3D25%26spage%3D7236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Italo  Beria</span>, <span class="hlFld-ContribAuthor ">Barbara  Valsasina</span>, <span class="hlFld-ContribAuthor ">Maria Gabriella  Brasca</span>, <span class="hlFld-ContribAuthor ">Walter  Ceccarelli</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Sabrina  Cribioli</span>, <span class="hlFld-ContribAuthor ">Gabriele  Fachin</span>, <span class="hlFld-ContribAuthor ">Ronald D.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Laura M.  Gianellini</span>, <span class="hlFld-ContribAuthor ">Maria L.  Giorgini</span>, <span class="hlFld-ContribAuthor ">Jurgen K.  Moll</span>, <span class="hlFld-ContribAuthor ">Helena  Posteri</span>, <span class="hlFld-ContribAuthor ">Daniele  Pezzetta</span>, <span class="hlFld-ContribAuthor ">Fulvia  Roletto</span>, <span class="hlFld-ContribAuthor ">Francesco  Sola</span>, <span class="hlFld-ContribAuthor ">Dania  Tesei</span>, <span class="hlFld-ContribAuthor ">Michele  Caruso</span>. </span><span class="cited-content_cbyCitation_article-title">4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (22)
                                     , 6489-6494. <a href="https://doi.org/10.1016/j.bmcl.2010.09.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.09.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.09.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.09.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4%25252C5-Dihydro-1H-pyrazolo%25255B4%25252C3-h%25255Dquinazolines%252Bas%252Bpotent%252Band%252Bselective%252BPolo-like%252Bkinase%252B1%252B%252528PLK1%252529%252Binhibitors%26aulast%3DBeria%26aufirst%3DItalo%26date%3D2010%26volume%3D20%26issue%3D22%26spage%3D6489%26epage%3D6494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Ai</span>, <span class="hlFld-ContribAuthor ">Shao-Teng  Wang</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Fa-Jun  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Modeling Studies of 4,5-Dihydro-1H-pyrazolo[4,3-h] quinazoline Derivatives as Potent CDK2/Cyclin A Inhibitors Using 3D-QSAR and Docking. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2010,</strong> <em>11 </em>
                                    (10)
                                     , 3705-3724. <a href="https://doi.org/10.3390/ijms11103705" title="DOI URL">https://doi.org/10.3390/ijms11103705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms11103705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms11103705%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMolecular%252BModeling%252BStudies%252Bof%252B4%25252C5-Dihydro-1H-pyrazolo%25255B4%25252C3-h%25255D%252Bquinazoline%252BDerivatives%252Bas%252BPotent%252BCDK2%25252FCyclin%252BA%252BInhibitors%252BUsing%252B3D-QSAR%252Band%252BDocking%26aulast%3DAi%26aufirst%3DYong%26date%3D2010%26date%3D2010%26volume%3D11%26issue%3D10%26spage%3D3705%26epage%3D3724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klaus  Strebhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2010,</strong> <em>9 </em>
                                    (8)
                                     , 643-660. <a href="https://doi.org/10.1038/nrd3184" title="DOI URL">https://doi.org/10.1038/nrd3184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd3184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd3184%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DMultifaceted%252Bpolo-like%252Bkinases%25253A%252Bdrug%252Btargets%252Band%252Bantitargets%252Bfor%252Bcancer%252Btherapy%26aulast%3DStrebhardt%26aufirst%3DKlaus%26date%3D2010%26volume%3D9%26issue%3D8%26spage%3D643%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Angiolini</span>, <span class="hlFld-ContribAuthor ">Patrizia  Banfi</span>, <span class="hlFld-ContribAuthor ">Elena  Casale</span>, <span class="hlFld-ContribAuthor ">Francesco  Casuscelli</span>, <span class="hlFld-ContribAuthor ">Claudio  Fiorelli</span>, <span class="hlFld-ContribAuthor ">Maria B.  Saccardo</span>, <span class="hlFld-ContribAuthor ">Marco  Silvagni</span>, <span class="hlFld-ContribAuthor ">Fabio  Zuccotto</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimization of potent PDK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (14)
                                     , 4095-4099. <a href="https://doi.org/10.1016/j.bmcl.2010.05.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.05.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.05.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Boptimization%252Bof%252Bpotent%252BPDK1%252Binhibitors%26aulast%3DAngiolini%26aufirst%3DMauro%26date%3D2010%26volume%3D20%26issue%3D14%26spage%3D4095%26epage%3D4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HTS pyrazoloquinazoline hit <b>1a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds modified at the position <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesis of intermediate <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0017.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Enaminone Intermediates <b>5a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) hydrazine R<sub>1</sub>NHNH<sub>2</sub> (<b>6a</b>−<b>c</b>), AcOH glacial, rt, 36−55%; (b) hydrazine hydrate, EtOH, reflux, 70%; (c) tritylchloride, TEA, DCM, rt, 72%; (d) DMF-DIPA, DMF, 60 °C, 54−71%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0018.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 1-Substituted 4,5-Dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline derivatives <b>1a</b>−<b>c</b>, <b>1e</b>, <b>1f</b>−<b>i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) phenylguanidine carbonate, DMF, 110 °C, 67−72%; (b) 1.5 M KOH/EtOH, reflux, quant; (c) EDC, HOBt·NH<sub>3</sub>, DMF, DIPEA, rt, 56−78%; (d) TFA, DCM, rt, 80%; (e) DTBAD, Ph<sub>3</sub>P polyimer-bound, alcohol R<sub>1</sub>−OH (<b>8a</b>−<b>d</b>), THF, rt, 24−62%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0019.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4,5-Dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline Derivatives <b>19</b>−<b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Pd(OAc)<sub>2</sub>, (±)-BINAP, K<sub>2</sub>CO<sub>3</sub>, amines (<b>50</b>−<b>76</b>; <b>85a</b>−<b>e</b>), DMF, 80 °C, 7−77%.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0020.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2′ Anilino Derivatives <b>79</b> and <b>81</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) Pd(OAc)<sub>2</sub>, (±)-BINAP, K<sub>2</sub>CO<sub>3</sub>, <i>N</i>-Boc-<i>o</i>-phenylenediamine, 61%; (b) 4N HCl/dioxane, DCM, rt, 96%; (c) acetyl chloride, DIPEA, rt, 72%; (d) 30% NH<sub>4</sub>OH, EtOH, sealed tube, 70 °C, 17−64%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0021.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Amino Intermediates <b>85a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) acetic anhydride, rt, 42−51%; (b) Pd<sub>2</sub>(dba)<sub>3</sub>, 1 M LiN(TMS)<sub>2</sub>/THF, 4-methylpiperazine, 2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl, reflux, 53−91%; (c) HCl conc, EtOH, reflux, 45%-quant; (d) 4-methylpiperazine, Pd(OAc)<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, 2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl, THF, reflux, 55%; (e) 4-methylpiperazine, 120 °C sealed tube, 68%; (f) cyclohexene, 10% Pd/C, HCl conc, THF/H<sub>2</sub>O/EtOH, 70 °C, 95%; (g) 10% Pd/C, H<sub>2</sub>, 35 psi, MeOH, 90%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0022.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Amino Intermediate <b>85e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 4-methylpiperazine, 130 °C, quant; (b) NaOH, DMA, 2-bromo-2-methylpropanamide, rt. then NaOH, 100 °C, 30%.</p></p></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>49</b> bound to Plk1. Hydrogen bonds are shown as red dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hydrogen bonding network that links compound <b>49</b> to the regulatory spine residues His105 and Phe195.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding pocket of the methylpiperazino substituent of <b>49</b>, shown as a Connolly surface. The indicated distance for the interaction between Glu140 and <b>49</b> is in Ångstroms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Flow cytometry analysis of <b>49</b> in A2780 cells. Cells were treated for 24 h with different doses of <b>49</b> (0.05 μM, 0.5 μM and 5 μM). DNA profile of untreated (C) and Nocodazole (N) treated cells are also reported.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0013.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Western blot analysis of <b>49</b> on A2780 cells. Cells were treated with <b>49</b> at two different doses (0.1 and 0.2 μM) for 24 h. Shown are untreated (C) and Nocodazole (N) treated cells. The Plk specific marker (pSer46 TCTP) as well as mitotic markers (pSer10 Histone H3 and pThr199 NPM) were evaluated. Total TCTP was used as loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0014.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Flow cytometry and Western blot analysis of A2780 (A) or HCT116 (B) cells treated for 24 h with 0.5 μM or 1.5 μM of <b>49</b> and after additional 24 h in the absence of compound. Expression of GAPDH was used as loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0015.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Aberrant monopolar spindles upon inhibition of Plk1. Immunofluorescence pictures of representative U2OS cells during mitosis. Control (A), siRNA targeting Plk1 (NM005030, sense strand 5′-CGAGCUGCUUAAUGACGAG) as assessed 72 h after transfection (B), and treatment with 0.3 μM of compound <b>49</b> for 72 h (C). Blue, DNA; red, pSer10 histone H3; green, α-tubulin. Images were taken with an objective 40× by using a confocal laser mounted on a Zeiss microscopy (Radiance 2000, Biorad).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/medium/jm-2009-01713n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0016.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>49</b> shows antitumor activity (TGI = 82%) in rodent BALB/c nu/nu mice carrying subcutaneous HCT116 human colon adenocarcinoma. Mice were treated with either vehicle or <b>49</b> by oral administration (schedule 90 mg/kg 1, 2 daily × 4 cycles). Data are represented as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm901713n/production/images/large/jm-2009-01713n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901713n&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Donaldson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. M.</span><span> </span><span class="NLM_article-title">The mitotic roles of Polo-like kinase</span> <span class="citation_source-journal">J. Cell. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2357</span><span class="NLM_x">–</span> <span class="NLM_lpage">2358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=11559744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFamt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2001&pages=2357-2358&author=M.+M.+Donaldsonauthor=A.+A.+Tavaresauthor=I.+M.+Haganauthor=E.+A.+Niggauthor=D.+M.+Glover&title=The+mitotic+roles+of+Polo-like+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The mitotic roles of Polo-like kinase</span></div><div class="casAuthors">Donaldson, Mary M.; Tavares, Alvaro A. M.; Hagan, Iain M.; Nigg, Erich A.; Glover, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2357-2358</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review and discussion, with 2 refs.  Topics discussed include mitotic entry, centrosome sepn. and maturation, the metaphase-anaphase transition and mitotic exit, and the septum-inducing network and cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_GZ2EhNqzV7Vg90H21EOLACvtfcHk0lj2DaEYTWXkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFamt7s%253D&md5=7a7e70d672283fe57c1cac21aef5f151</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonaldson%26aufirst%3DM.%2BM.%26aulast%3DTavares%26aufirst%3DA.%2BA.%26aulast%3DHagan%26aufirst%3DI.%2BM.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26aulast%3DGlover%26aufirst%3DD.%2BM.%26atitle%3DThe%2520mitotic%2520roles%2520of%2520Polo-like%2520kinase%26jtitle%3DJ.%2520Cell.%2520Sci.%26date%3D2001%26volume%3D114%26spage%3D2357%26epage%3D2358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Glover, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, I. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, A. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases: a team that plays throughout mitosis</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1101%2Fgad.12.24.3777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=9869630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFCqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=3777-3787&author=D.+M.+Gloverauthor=I.+M+Haganauthor=A.+A.+Tavares&title=Polo-like+kinases%3A+a+team+that+plays+throughout+mitosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: a team that plays throughout mitosis</span></div><div class="casAuthors">Glover, David M.; Hagan, Iain M.; Tavares, Alvaro A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3777-3787</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with 73 refs. on role of polo-like serine-threonine kinases in regulating centromere behavior and mitosis in organisms from yeast to human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLL0Rl9j0JbVg90H21EOLACvtfcHk0lj2DaEYTWXkIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFCqsQ%253D%253D&md5=6d56713565a4c60897729a2e9e90622a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.24.3777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.24.3777%26sid%3Dliteratum%253Aachs%26aulast%3DGlover%26aufirst%3DD.%2BM.%26aulast%3DHagan%26aufirst%3DI.%2BM%26aulast%3DTavares%26aufirst%3DA.%2BA.%26atitle%3DPolo-like%2520kinases%253A%2520a%2520team%2520that%2520plays%2520throughout%2520mitosis%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D3777%26epage%3D3787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases: positive regulators of cell division from start to finish</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1016%2FS0955-0674%2898%2980121-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=9914175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK1MXitVOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1998&pages=776-783&author=E.+A.+Nigg&title=Polo-like+kinases%3A+positive+regulators+of+cell+division+from+start+to+finish"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases: positive regulators of cell division from start to finish</span></div><div class="casAuthors">Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">776-783</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">A review with 66 refs.  Present in organisms ranging from yeast to man, homologs of the Drosophila Polo kinase control multiple stages of cell division.  At the onset of mitosis, Polo-like kinases (Plks) function in centrosome maturation and bipolar spindle formation, and they contribute to the activation of cyclindependent kinase (Cdk) 1-cyclin B.  Subsequently, they are required for the inactivation of Cdk1 and exit from mitosis.  In the absence of Plk function, mitotic cyclins fail to be destroyed, indicating that Plks are important regulators of the anaphase-promoting complex/cyclosome (APC/C), a key component of the ubiquitin-dependent proteolytic degrdn. pathway.  Finally, recent evidence implicates Plks in the temporal and spatial coordination of cytokinesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq31f1X5czvprVg90H21EOLACvtfcHk0lj96NKAi4ETNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVOltQ%253D%253D&md5=7dd85a1b4b9c90bfff971530db76533b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2898%2980121-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252898%252980121-X%26sid%3Dliteratum%253Aachs%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%253A%2520positive%2520regulators%2520of%2520cell%2520division%2520from%2520start%2520to%2520finish%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1998%26volume%3D10%26spage%3D776%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kumagai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunphy, W. G.</span><span> </span><span class="NLM_article-title">Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from <i>Xenopus</i> egg extracts</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=1377-1380&author=A.+Kumagaiauthor=W.+G.+Dunphy&title=Purification+and+molecular+cloning+of+Plx1%2C+a+Cdc25-regulatory+kinase+from+Xenopus+egg+extracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumagai%26aufirst%3DA.%26aulast%3DDunphy%26aufirst%3DW.%2BG.%26atitle%3DPurification%2520and%2520molecular%2520cloning%2520of%2520Plx1%252C%2520a%2520Cdc25-regulatory%2520kinase%2520from%2520Xenopus%2520egg%2520extracts%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D1377%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Barr, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sillje, H. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Polo-like kinases and the orchestration of cell cycle division</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1038%2Fnrm1401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15173822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=429-440&author=F.+A.+Barrauthor=H.+H+Silljeauthor=E.+A.+Nigg&title=Polo-like+kinases+and+the+orchestration+of+cell+cycle+division"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinases and the orchestration of cell division</span></div><div class="casAuthors">Barr, Francis A.; Sillje, Herman H. W.; Nigg, Erich A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-441</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Polo-like kinases (Plks) are increasingly recognized as key regulators of mitosis, meiosis and cytokinesis.  In agreement with a broad range of proposed functions during cell division, Plks are subject to complex temporal and spatial control.  Recent findings are uncovering the mechanisms of Plk regulation, notably their targeting to different cellular structures through interactions with phosphorylated docking proteins.  Moreover, information is emerging on the substrate specificity of Plks and the role of individual substrates in M-phase progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLN4E8Z5Hjq7Vg90H21EOLACvtfcHk0lj96NKAi4ETNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVarsLk%253D&md5=8c11ac86d8b157dfa74ab95841e9eba0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm1401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1401%26sid%3Dliteratum%253Aachs%26aulast%3DBarr%26aufirst%3DF.%2BA.%26aulast%3DSillje%26aufirst%3DH.%2BH%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DPolo-like%2520kinases%2520and%2520the%2520orchestration%2520of%2520cell%2520cycle%2520division%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D429%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">van Vugt, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Weerdt, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vader, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calafat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klompmaker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolthuis, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span> </span><span class="NLM_article-title">Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">36841</span><span class="NLM_x">–</span> <span class="NLM_lpage">36854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=36841-36854&author=M.+A.+van+Vugtauthor=B.+C.+van+de+Weerdtauthor=G.+Vaderauthor=H.+Janssenauthor=J.+Calafatauthor=R.+Klompmakerauthor=R.+M.+Wolthuisauthor=R.+H.+Medema&title=Polo-like+kinase-1+is+required+for+bipolar+spindle+formation+but+is+dispensable+for+anaphase+promoting+complex%2FCdc20+activation+and+initiation+of+cytokinesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BVugt%26aufirst%3DM.%2BA.%26aulast%3Dvan%2Bde%2BWeerdt%26aufirst%3DB.%2BC.%26aulast%3DVader%26aufirst%3DG.%26aulast%3DJanssen%26aufirst%3DH.%26aulast%3DCalafat%26aufirst%3DJ.%26aulast%3DKlompmaker%26aufirst%3DR.%26aulast%3DWolthuis%26aufirst%3DR.%2BM.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26atitle%3DPolo-like%2520kinase-1%2520is%2520required%2520for%2520bipolar%2520spindle%2520formation%2520but%2520is%2520dispensable%2520for%2520anaphase%2520promoting%2520complex%252FCdc20%2520activation%2520and%2520initiation%2520of%2520cytokinesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D36841%26epage%3D36854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima-Morimoto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">25277</span><span class="NLM_x">–</span> <span class="NLM_lpage">25280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=25277-25280&author=H.+Nakajimaauthor=F.+Toyoshima-Morimotoauthor=E.+Taniguchiauthor=E.+Nishida&title=Identification+of+a+consensus+motif+for+Plk+%28Polo-like+kinase%29+phosphorylation+reveals+Myt1+as+a+Plk1+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DToyoshima-Morimoto%26aufirst%3DF.%26aulast%3DTaniguchi%26aufirst%3DE.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520a%2520consensus%2520motif%2520for%2520Plk%2520%2528Polo-like%2520kinase%2529%2520phosphorylation%2520reveals%2520Myt1%2520as%2520a%2520Plk1%2520substrate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D25277%26epage%3D25280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bartholomew, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, C. F.</span><span> </span><span class="NLM_article-title">Cdc5 interacts with the Wee1 kinase in budding yeast</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4949</span><span class="NLM_x">–</span> <span class="NLM_lpage">4959</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1128%2FMCB.21.15.4949-4959.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=11438652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVGit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=4949-4959&author=C.+R.+Bartholomewauthor=S.+H.+Wooauthor=Y.+S.+Chungauthor=C.+Jonesauthor=C.+F.+Hardy&title=Cdc5+interacts+with+the+Wee1+kinase+in+budding+yeast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cdc5 interacts with the wee1 kinase in budding yeast</span></div><div class="casAuthors">Bartholomew, Clinton R.; Woo, Sung Ho; Chung, Yun Shin; Jones, Carolyn; Hardy, Christopher F. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4949-4959</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Development of a multicellular organism requires that mitosis and morphogenesis be coordinated.  These processes must also be synchronized during the growth of unicellular organisms.  In the yeast Saccharomyces cerevisiae, mitosis is dependent on the prior growth of a daughter cell in the form of a bud.  Overexpression of wild-type Polo-like kinase Cdc5 or a catalytically inactive form resulted in the formation of multinucleate cells in budding yeast.  Immunofluorescence anal. of these multinucleate cells showed that mitosis and bud formation were no longer linked.  Others have shown that Swe1 is required for coupling mitosis to bud formation during a perturbed cell cycle.  When the normal pathway of bud formation is perturbed, Swe1 functions to delay mitosis through neg. regulation of Clb/Cdk.  In cells lacking Swe1, multinucleate cells are formed in response to delays in bud formation.  Affinity purifn., two-hybrid anal., and mutant characterization results suggested that Cdc5 and Swe1 interact.  From these results, we conclude that multinucleate formation in response to Cdc5 overexpression is linked to titrn. of Swe1 function.  These results also suggest that Cdc5 may be a neg. regulator of Swe1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSbDNf0I91K7Vg90H21EOLACvtfcHk0lj96NKAi4ETNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVGit70%253D&md5=de63d5e4eace9bc27b48a51819717eb7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.15.4949-4959.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.15.4949-4959.2001%26sid%3Dliteratum%253Aachs%26aulast%3DBartholomew%26aufirst%3DC.%2BR.%26aulast%3DWoo%26aufirst%3DS.%2BH.%26aulast%3DChung%26aufirst%3DY.%2BS.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DHardy%26aufirst%3DC.%2BF.%26atitle%3DCdc5%2520interacts%2520with%2520the%2520Wee1%2520kinase%2520in%2520budding%2520yeast%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D4949%26epage%3D4959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Qian, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taieb, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maller, J. L.</span><span> </span><span class="NLM_article-title">The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in <i>Xenopus</i> oocytes</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=11408585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVSjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=1791-1799&author=Y.+W.+Qianauthor=E.+Eriksonauthor=F.+E.+Taiebauthor=J.+L.+Maller&title=The+polo-like+kinase+Plx1+is+required+for+activation+of+the+phosphatase+Cdc25C+and+cyclin+B-Cdc2+in+Xenopus+oocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes</span></div><div class="casAuthors">Qian, Yue-Wei; Erikson, Eleanor; Taieb, Frederic E.; Maller, James L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1791-1799</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">In the Xenopus oocyte system mitogen treatment triggers the G2/M transition by transiently inhibiting the cAMP-dependent protein kinase (PKA); subsequently, other signal transduction pathways are activated, including the mitogen-activated protein kinase (MAPK) and polo-like kinase pathways.  To study the interactions between these pathways, we have utilized a cell-free oocyte ext. that carries out the signaling events of oocyte maturation after addn. of the heat-stable inhibitor of PKA, PKI.  PKI stimulated the synthesis of Mos and activation of both the MAPK pathway and the Plx1/Cdc25C/cyclin B-Cdc2 pathway.  Activation of the MAPK pathway alone by glutathione S-transferase (GST)-Mos did not lead to activation of Plx1 or cyclin B-Cdc2.  Inhibition of the MAPK pathway in the ext. by the MEK1 inhibitor U0126 delayed, but did not prevent, activation of the Plx1 pathway, and inhibition of Mos synthesis by cycloheximide had a similar effect, suggesting that MAPK activation is the only relevant function of Mos.  Immunodepletion of Plx1 completely inhibited activation of Cdc25C and cyclin B-Cdc2 by PKI, indicating that Plx1 is necessary for Cdc25C activation.  In exts. contg. fully activated Plx1 and Cdc25C, inhibition of cyclin B-Cdc2 by p21Cip1 had no significant effect on either the phosphorylation of Cdc25C or the activity of Plx1.  These results demonstrate that maintenance of Plx1 and Cdc25C activity during mitosis does not require cyclin B-Cdc2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpMNCgUw3FFLVg90H21EOLACvtfcHk0lhfvK5h7ppgbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVSjtr4%253D&md5=757d7e00e122918f97ede6ae53b5763a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DY.%2BW.%26aulast%3DErikson%26aufirst%3DE.%26aulast%3DTaieb%26aufirst%3DF.%2BE.%26aulast%3DMaller%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520polo-like%2520kinase%2520Plx1%2520is%2520required%2520for%2520activation%2520of%2520the%2520phosphatase%2520Cdc25C%2520and%2520cyclin%2520B-Cdc2%2520in%2520Xenopus%2520oocytes%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2001%26volume%3D12%26spage%3D1791%26epage%3D1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wolf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doermer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtrich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutte, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmannsberger, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rübsamen-Waigmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=543-549&author=G.+Wolfauthor=R.+Elezauthor=A.+Doermerauthor=U.+Holtrichauthor=H.+Ackermannauthor=H.+J.+Stutteauthor=H.+M.+Altmannsbergerauthor=H.+R%C3%BCbsamen-Waigmannauthor=K.+Strebhardt&title=Prognostic+significance+of+polo-like+kinase+%28PLK%29+expression+in+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DG.%26aulast%3DElez%26aufirst%3DR.%26aulast%3DDoermer%26aufirst%3DA.%26aulast%3DHoltrich%26aufirst%3DU.%26aulast%3DAckermann%26aufirst%3DH.%26aulast%3DStutte%26aufirst%3DH.%2BJ.%26aulast%3DAltmannsberger%26aufirst%3DH.%2BM.%26aulast%3DR%25C3%25BCbsamen-Waigmann%26aufirst%3DH.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DPrognostic%2520significance%2520of%2520polo-like%2520kinase%2520%2528PLK%2529%2520expression%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D543%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Weichert., W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span> </span><span class="NLM_article-title">Polo-like kinase 1 expression is a prognostic factor in human colon cancer</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5644</span><span class="NLM_x">–</span> <span class="NLM_lpage">5650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.3748%2Fwjg.v11.i36.5644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=16237758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=5644-5650&author=W+Weichert.author=G.+Kristiansenauthor=M.+Schmidtauthor=V.+Gekelerauthor=A.+Noskeauthor=S.+Niesporekauthor=M.+Dietelauthor=C.+Denkert&title=Polo-like+kinase+1+expression+is+a+prognostic+factor+in+human+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase 1 expression is a prognostic factor in human colon cancer</span></div><div class="casAuthors">Weichert, Wilko; Kristiansen, Glen; Schmidt, Mathias; Gekeler, Volker; Noske, Aurelia; Niesporek, Silvia; Dietel, Manfred; Denkert, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5644-5650</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">AIM: To clarify the expression patterns and prognostic implications of the mitotic regulator Polo-like kinase 1 (PLK1) in colon cancer.  METHODS: Expression of PLK1 was investigated by immunohistochem. (158 cases) and immunoblotting in tissue of colon adenomas and adenocarcinomas.  PLK1 expression patterns were correlated with clinicopathol. parameters and patient prognosis.  In addn., expression of PLK1 was evaluated by immunoblot and PCR in colon carcinoma cell lines, and coexpression of PLK1 with the proliferation marker Ki-67 was investigated.  RESULTS: Weak PLK1 expression was obsd. in normal colon mucosa and adenomas.  In contrast, 66.7% of carcinomas showed strong expression of PLK1.  Overexpression of PLK1 correlated pos. with Dukes stage (P<0.001), tumor stage (P = 0.001) and nodal status (P<0.05).  Addnl., PLK1 expression was a prognostic marker in univariate survival anal. (P<0.01) and had independent prognostic significance (RR = 3.3, P = 0.02) in patients with locoregional disease.  Expression of PLK1 mRNA and protein was detected in all cell lines investigated.  Coexpression of PLK1 and Ki-67 was obsd. in the majority of colon cancer cells, but a considerable proportion of cells showed PLK1 positivity without Ki-67 expression.  CONCLUSION: PLK1 is a new prognostic marker for colon carcinoma patients and may be involved in tumorigenesis and progression of colon cancer.  Strategies focusing on PLK1 inhibition in vivo might therefore represent a promising new therapeutic approach for this tumor entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob0QpI0UhVpLVg90H21EOLACvtfcHk0lhfvK5h7ppgbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyqsg%253D%253D&md5=23657ee7ef1e45ec338843c43adbf0a3</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v11.i36.5644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v11.i36.5644%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert.%26aufirst%3DW%26aulast%3DKristiansen%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DNoske%26aufirst%3DA.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDenkert%26aufirst%3DC.%26atitle%3DPolo-like%2520kinase%25201%2520expression%2520is%2520a%2520prognostic%2520factor%2520in%2520human%2520colon%2520cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2005%26volume%3D11%26spage%3D5644%26epage%3D5650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loening, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span> </span><span class="NLM_article-title">Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=240-245&author=W.+Weichertauthor=M.+Schmidtauthor=V.+Gekelerauthor=C.+Denkertauthor=C.+Stephanauthor=K.+Jungauthor=S.+Loeningauthor=M.+Dietelauthor=G.+Kristiansen&title=Polo-like+kinase+1+is+overexpressed+in+prostate+cancer+and+linked+to+higher+tumor+grades"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DLoening%26aufirst%3DS.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DPolo-like%2520kinase%25201%2520is%2520overexpressed%2520in%2520prostate%2520cancer%2520and%2520linked%2520to%2520higher%2520tumor%2520grades%26jtitle%3DProstate%26date%3D2004%26volume%3D60%26spage%3D240%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauptmann, S.</span><span> </span><span class="NLM_article-title">Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1038%2Fsj.bjc.6601610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=14970859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12iurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=815-821&author=W.+Weichertauthor=C.+Denkertauthor=M.+Schmidtauthor=V.+Gekelerauthor=G.+Wolfauthor=M.+Kobelauthor=M.+Dietelauthor=S.+Hauptmann&title=Polo-like+kinase+isoform+expression+is+a+prognostic+factor+in+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma</span></div><div class="casAuthors">Weichert, W.; Denkert, C.; Schmidt, M.; Gekeler, V.; Wolf, G.; Koebel, M.; Dietel, M.; Hauptmann, S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">815-821</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Polo-like kinase (PLK) family comprises three serine/threonine kinases, functionally involved in signal transduction pathways essential for the accomplishment of mitosis in both normal and malignant cells.  Moreover, certain PLKs have been functionally linked to cytoskeletal reorganization.  In this study, the expression of PLK1 and PLK3 was detd. immunohistochem. in tissue specimen of normal ovaries (n=9), cystadenomas (n=17), borderline tumors (n=13) and ovarian carcinomas (n=77).  PLK 1 and PLK3 expression was low in normal ovarian surface epithelium and borderline tumors, with moderately higher expression levels in cystadenomas.  In ovarian carcinomas, 26% of cases were PLK1 pos. and 50.6% of cases were PLK3 pos.  A pos. correlation of both PLK1 and PLK3 expression with indicators of mitotic frequency could be established.  The overexpression of either isoenzyme had an impact on patient prognosis with shortened survival time for patients with tumors pos. for PLK1 (P=0.02) and PLK3 (P=0.02), but only PLK1 expression remained a prognostic factor in multivariate survival anal. (P=0.03).  The results of this study, if interpreted in the context of recently published functional data, suggest that inhibition of PLKs might represent an interesting new targeted approach for chemotherapy of epithelial ovarian cancer.  Furthermore, this study suggests that PLK1 is a novel independent prognostic marker in ovarian carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLZbaRO52PLbVg90H21EOLACvtfcHk0lgidetCUqSBNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12iurk%253D&md5=2663adc8427cfbe6be77bb65b7cd1a78</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601610%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DWolf%26aufirst%3DG.%26aulast%3DKobel%26aufirst%3DM.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DHauptmann%26aufirst%3DS.%26atitle%3DPolo-like%2520kinase%2520isoform%2520expression%2520is%2520a%2520prognostic%2520factor%2520in%2520ovarian%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span> </span><span class="NLM_article-title">Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications</span> <span class="citation_source-journal">Virchows Archiv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1007%2Fs00428-005-1212-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15785925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2005&pages=442-450&author=W.+Weichertauthor=G.+Kristiansenauthor=K.+J.+Winzerauthor=M.+Schmidtauthor=V.+Gekelerauthor=A.+Noskeauthor=B.+M.+Mullerauthor=S.+Niesporekauthor=M.+Dietelauthor=C.+Denkert&title=Polo-like+kinase+isoforms+in+breast+cancer%3A+expression+patterns+and+prognostic+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications</span></div><div class="casAuthors">Weichert, Wilko; Kristiansen, Glen; Winzer, Klaus-Juergen; Schmidt, Mathias; Gekeler, Volker; Noske, Aurelia; Mueller, Berit-Maria; Niesporek, Silvia; Dietel, Manfred; Denkert, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Polo-like kinase (PLK) family members are known to be functionally involved in mitotic signaling and in cytoskeletal reorganization in both normal and malignant cells.  In this study, expression of PLK1 and PLK3 was detd. immunohistochem. in tissue specimens of 135 breast carcinomas, and expression was correlated with clinicopathol. parameters and patient prognosis.  Strong PLK isoform overexpression was obsd. in 42.2% (PLK1) and 47.4% (PLK3) of breast carcinomas when compared with non-transformed breast tissue.  A pos. correlation of PLK isoform expression with tumor grade, vascular invasion, erbB2/HER-2 expression and markers of proliferative activity was evident.  Addnl., an inverse correlation of PLK isoform expression and estrogen receptor status was obsd.  Overexpression of PLK3 but not of PLK1 was significantly linked to reduced median overall (P<0.001) and relapse-free (P=0.021) survival time.  PLK3 expression remained an independent prognostic factor for overall (RR=3.2, P=0.002) and relapse-free (RR=2.9, P=0.049) survival in multivariate survival anal.  These results suggest PLK3 as a novel independent prognostic marker in breast cancer and hint toward a role for PLK isoform overexpression in disease progression.  Therefore, in vivo inhibition of PLK family members might represent a rewarding approach in the development of new anticancer drugs for this tumor entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcqP_bOEWKUrVg90H21EOLACvtfcHk0lgidetCUqSBNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOrtLk%253D&md5=1fb78c61e0ed76ac3c02162308929fe9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00428-005-1212-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00428-005-1212-8%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DKristiansen%26aufirst%3DG.%26aulast%3DWinzer%26aufirst%3DK.%2BJ.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DNoske%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DB.%2BM.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDenkert%26aufirst%3DC.%26atitle%3DPolo-like%2520kinase%2520isoforms%2520in%2520breast%2520cancer%253A%2520expression%2520patterns%2520and%2520prognostic%2520implications%26jtitle%3DVirchows%2520Archiv.%26date%3D2005%26volume%3D446%26spage%3D442%26epage%3D450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Knecht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oechler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solbach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Ilberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Prognostic Significance of Polo-like Kinase (PLK) Expression in Squamous Cell Carcinomas of the Head and Neck</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2794</span><span class="NLM_x">–</span> <span class="NLM_lpage">2797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2794-2797&author=R.+Knechtauthor=R.+Elezauthor=M.+Oechlerauthor=C.+Solbachauthor=C.+von+Ilbergauthor=K.+Strebhardt&title=Prognostic+Significance+of+Polo-like+Kinase+%28PLK%29+Expression+in+Squamous+Cell+Carcinomas+of+the+Head+and+Neck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnecht%26aufirst%3DR.%26aulast%3DElez%26aufirst%3DR.%26aulast%3DOechler%26aufirst%3DM.%26aulast%3DSolbach%26aufirst%3DC.%26aulast%3Dvon%2BIlberg%26aufirst%3DC.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DPrognostic%2520Significance%2520of%2520Polo-like%2520Kinase%2520%2528PLK%2529%2520Expression%2520in%2520Squamous%2520Cell%2520Carcinomas%2520of%2520the%2520Head%2520and%2520Neck%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2794%26epage%3D2797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Schmit, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setaluri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegelman, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, N.</span><span> </span><span class="NLM_article-title">Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2009&pages=2843-2853&author=T.+L.+Schmitauthor=W.+Zhongauthor=V.+Setaluriauthor=V.+S.+Spiegelmanauthor=N.+Ahmad&title=Targeted+Depletion+of+Polo-Like+Kinase+%28Plk%29+1+Through+Lentiviral+shRNA+or+a+Small-Molecule+Inhibitor+Causes+Mitotic+Catastrophe+and+Induction+of+Apoptosis+in+Human+Melanoma+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmit%26aufirst%3DT.%2BL.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DSetaluri%26aufirst%3DV.%26aulast%3DSpiegelman%26aufirst%3DV.%2BS.%26aulast%3DAhmad%26aufirst%3DN.%26atitle%3DTargeted%2520Depletion%2520of%2520Polo-Like%2520Kinase%2520%2528Plk%2529%25201%2520Through%2520Lentiviral%2520shRNA%2520or%2520a%2520Small-Molecule%2520Inhibitor%2520Causes%2520Mitotic%2520Catastrophe%2520and%2520Induction%2520of%2520Apoptosis%2520in%2520Human%2520Melanoma%2520Cells%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2009%26volume%3D129%26spage%3D2843%26epage%3D2853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lane, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigg, E. A.</span><span> </span><span class="NLM_article-title">Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes</span> <span class="citation_source-journal">J. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=1996&pages=1701-1713&author=H.+A.+Laneauthor=E.+A.+Nigg&title=Antibody+microinjection+reveals+an+essential+role+for+human+polo-like+kinase+1+%28Plk1%29+in+the+functional+maturation+of+mitotic+centrosomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DNigg%26aufirst%3DE.%2BA.%26atitle%3DAntibody%2520microinjection%2520reveals%2520an%2520essential%2520role%2520for%2520human%2520polo-like%2520kinase%25201%2520%2528Plk1%2529%2520in%2520the%2520functional%2520maturation%2520of%2520mitotic%2520centrosomes%26jtitle%3DJ.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D135%26spage%3D1701%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Matthess, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaenkuch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2973</span><span class="NLM_x">–</span> <span class="NLM_lpage">2980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=2973-2980&author=Y.+Matthessauthor=S.+Kappelauthor=B.+Spaenkuchauthor=B.+Zimmerauthor=M.+Kaufmannauthor=K.+Strebhardt&title=Conditional+inhibition+of+cancer+cell+proliferation+by+tetracycline-responsive%2C+H1+promoter-driven+silencing+of+PLK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthess%26aufirst%3DY.%26aulast%3DKappel%26aufirst%3DS.%26aulast%3DSpaenkuch%26aufirst%3DB.%26aulast%3DZimmer%26aufirst%3DB.%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DConditional%2520inhibition%2520of%2520cancer%2520cell%2520proliferation%2520by%2520tetracycline-responsive%252C%2520H1%2520promoter-driven%2520silencing%2520of%2520PLK1%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D2973%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuasa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kageyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, T.</span><span> </span><span class="NLM_article-title">Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1172%2FJCI23043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15761500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFylt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=978-985&author=M.+Nogawaauthor=T.+Yuasaauthor=S.+Kimuraauthor=M.+Tanakaauthor=J.+Kurodaauthor=K.+Satoauthor=A.+Yokotaauthor=H.+Segawaauthor=Y.+Todaauthor=S.+Kageyamaauthor=T.+Yoshikiauthor=Y.+Okadaauthor=T.+Maekawa&title=Intravesical+administration+of+small+interfering+RNA+targeting+PLK-1+successfully+prevents+the+growth+of+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer</span></div><div class="casAuthors">Nogawa, Masaki; Yuasa, Takeshi; Kimura, Shinya; Tanaka, Motoyoshi; Kuroda, Junya; Sato, Kiyoshi; Yokota, Asumi; Segawa, Hidekazu; Toda, Yoshinobu; Kageyama, Susumu; Yoshiki, Tatsuhiro; Okada, Yusaku; Maekawa, Taira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">978-985</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The mainstay in the management of invasive bladder cancer continues to be radical cystectomy.  With regard to improvement of quality of life, however, therapies that preserve the bladder are desirable.  The authors investigated the use of intravesical PLK-1 small interfering RNA (siRNA) against bladder cancer.  Patients with bladder cancers expressing high levels of PLK-1 have a poor prognosis compared with patients with low expression.  Using siRNA/cationic liposomes, the expression of endogenous PLK-1 could be suppressed in bladder cancer cells in a time- and dose-dependent manner.  As a consequence, PLK-1 functions were disrupted.  Inhibition of bipolar spindle formation, accumulation of cyclin B1, reduced cell proliferation, and induction of apoptosis were obsd.  In order to det. the efficacy of the siRNA/liposomes in vivo, the authors established an orthotopic mouse model using a LUC-labeled bladder cancer cell line, UM-UC-3LUC.  PLK-1 siRNA was successfully transfected into the cells, reduced PLK-1 expression, and prevented the growth of bladder cancer in this mouse model.  This is the first demonstration, to the authors' knowledge, of inhibition of cancer growth in the murine bladder by intravesical siRNA/cationic liposomes.  The authors believe intravesical siRNA instillation against bladder cancer will be useful as a therapeutic tool.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE15pDHww5C7Vg90H21EOLACvtfcHk0lgriYWuJFBuAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFylt7o%253D&md5=c396ea714779cdd010190364112f3d05</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI23043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI23043%26sid%3Dliteratum%253Aachs%26aulast%3DNogawa%26aufirst%3DM.%26aulast%3DYuasa%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DSegawa%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DY.%26aulast%3DKageyama%26aufirst%3DS.%26aulast%3DYoshiki%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3DIntravesical%2520administration%2520of%2520small%2520interfering%2520RNA%2520targeting%2520PLK-1%2520successfully%2520prevents%2520the%2520growth%2520of%2520bladder%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D978%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Spankuch-Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solbach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loibl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knecht, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmuller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Minckwitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3162</span><span class="NLM_x">–</span> <span class="NLM_lpage">3171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=3162-3171&author=B.+Spankuch-Schmittauthor=G.+Wolfauthor=C.+Solbachauthor=S.+Loiblauthor=R.+Knechtauthor=M.+Stegmullerauthor=G.+von+Minckwitzauthor=M.+Kaufmannauthor=K.+Strebhardt&title=Downregulation+of+human+polo-like+kinase+activity+by+antisense+oligonucleotides+induces+growth+inhibition+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpankuch-Schmitt%26aufirst%3DB.%26aulast%3DWolf%26aufirst%3DG.%26aulast%3DSolbach%26aufirst%3DC.%26aulast%3DLoibl%26aufirst%3DS.%26aulast%3DKnecht%26aufirst%3DR.%26aulast%3DStegmuller%26aufirst%3DM.%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DDownregulation%2520of%2520human%2520polo-like%2520kinase%2520activity%2520by%2520antisense%2520oligonucleotides%2520induces%2520growth%2520inhibition%2520in%2520cancer%2520cells%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D3162%26epage%3D3171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Spankuch-Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bereiter-Hahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span> </span><span class="NLM_article-title">Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=1863-1877&author=B.+Spankuch-Schmittauthor=J.+Bereiter-Hahnauthor=M.+Kaufmannauthor=K.+Strebhardt&title=Effect+of+RNA+silencing+of+polo-like+kinase-1+%28PLK1%29+on+apoptosis+and+spindle+formation+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpankuch-Schmitt%26aufirst%3DB.%26aulast%3DBereiter-Hahn%26aufirst%3DJ.%26aulast%3DKaufmann%26aufirst%3DM.%26aulast%3DStrebhardt%26aufirst%3DK.%26atitle%3DEffect%2520of%2520RNA%2520silencing%2520of%2520polo-like%2520kinase-1%2520%2528PLK1%2529%2520on%2520apoptosis%2520and%2520spindle%2520formation%2520in%2520human%2520cancer%2520cells%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2002%26volume%3D94%26spage%3D1863%26epage%3D1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, R. L.</span><span> </span><span class="NLM_article-title">Normal cells, but not cancer cells, survive severe Plk1 depletion</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2093</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1128%2FMCB.26.6.2093-2108.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=16507989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD28XislygtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2093-2108&author=X.+Liuauthor=M.+Leiauthor=R.+L.+Erikson&title=Normal+cells%2C+but+not+cancer+cells%2C+survive+severe+Plk1+depletion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Normal cells, but not cancer cells, survive severe Plk1 depletion</span></div><div class="casAuthors">Liu, Xiaoqi; Lei, Ming; Erikson, Raymond L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2093-2108</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We previously reported the phenotype of depletion of polo-like kinase 1 (Plk1) using RNA interference (RNAi) and showed that p53 is stabilized in Plk1-depleted cancer cells.  In this study, we further analyzed the Plk1 depletion-induced phenotype in both cancer cells and primary cells.  The vector-based RNAi approach was used to evaluate the role of the p53 pathway in Plk1 depletion-induced apoptosis in cancer cells with different p53 backgrounds.  Although DNA damage and cell death can occur independently of p53, p53-deficient cancer cells were much more sensitive to Plk1 depletion than cancer cells with functional p53.  Next, the lentivirus-based RNAi approach was used to generate a series of Plk1 hypomorphs.  In HeLa cells, two weak hypomorphs showed only slight G2/M arrest, a medium hypomorph arrested with 4N DNA content, followed later by apoptosis, and a strong Plk1 hypomorph underwent serious mitotic catastrophe.  In well-synchronized HeLa cells, a medium level of Plk1 depletion caused a 2-h delay of mitotic progression, and a high degree of Plk1 depletion significantly delayed mitotic entry and completely blocked cells at mitosis.  In striking contrast, normal hTERT-RPE1 and MCF10A cells were much less sensitive to Plk1 depletion than HeLa cells; no apparent cell proliferation defect or cell cycle arrest was obsd. after Plk1 depletion in these cells.  Therefore, these data further support suggestions that Plk1 may be a feasible cancer therapy target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruiHU_TInqFLVg90H21EOLACvtfcHk0lgriYWuJFBuAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislygtL4%253D&md5=409d06fe50e2ce145369c8dc86d8ce16</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FMCB.26.6.2093-2108.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.26.6.2093-2108.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DErikson%26aufirst%3DR.%2BL.%26atitle%3DNormal%2520cells%252C%2520but%2520not%2520cancer%2520cells%252C%2520survive%2520severe%2520Plk1%2520depletion%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D2093%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kauselmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konietzko, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scafidi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staubli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bereiter-Hahn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strebhardt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhl, D.</span><span> </span><span class="NLM_article-title">The polo-like protein kinases Fnk and Snk associate with a Ca<sup>(2+)</sup> and integrin-binding protein and are regulated dynamically with synaptic plasticity</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5528</span><span class="NLM_x">–</span> <span class="NLM_lpage">5539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5528-5539&author=G.+Kauselmannauthor=M.+Weilerauthor=P.+Wulffauthor=S.+Jessbergerauthor=U.+Konietzkoauthor=J.+Scafidiauthor=U.+Staubliauthor=J.+Bereiter-Hahnauthor=K.+Strebhardtauthor=D.+Kuhl&title=The+polo-like+protein+kinases+Fnk+and+Snk+associate+with+a+Ca%282%2B%29+and+integrin-binding+protein+and+are+regulated+dynamically+with+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKauselmann%26aufirst%3DG.%26aulast%3DWeiler%26aufirst%3DM.%26aulast%3DWulff%26aufirst%3DP.%26aulast%3DJessberger%26aufirst%3DS.%26aulast%3DKonietzko%26aufirst%3DU.%26aulast%3DScafidi%26aufirst%3DJ.%26aulast%3DStaubli%26aufirst%3DU.%26aulast%3DBereiter-Hahn%26aufirst%3DJ.%26aulast%3DStrebhardt%26aufirst%3DK.%26aulast%3DKuhl%26aufirst%3DD.%26atitle%3DThe%2520polo-like%2520protein%2520kinases%2520Fnk%2520and%2520Snk%2520associate%2520with%2520a%2520Ca%25282%252B%2529%2520and%2520integrin-binding%2520protein%2520and%2520are%2520regulated%2520dynamically%2520with%2520synaptic%2520plasticity%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D5528%26epage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gumireddy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosenza, S. C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">ON01910, a non-ATP-competitive small molecole inhibitor of Plk1, is a potent anticancer agent</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=275-286&author=K.+Gumireddyauthor=M.+W.+Reddyauthor=S.+C.+Cosenza&title=ON01910%2C+a+non-ATP-competitive+small+molecole+inhibitor+of+Plk1%2C+is+a+potent+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGumireddy%26aufirst%3DK.%26aulast%3DReddy%26aufirst%3DM.%2BW.%26aulast%3DCosenza%26aufirst%3DS.%2BC.%26atitle%3DON01910%252C%2520a%2520non-ATP-competitive%2520small%2520molecole%2520inhibitor%2520of%2520Plk1%252C%2520is%2520a%2520potent%2520anticancer%2520agent%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Mross, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedbom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentschler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouyrre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trommeshauser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoesl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munzert, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phase, I</span><span> </span><span class="NLM_article-title">dose escalation and pharmacokinetic study of BI 2536, a novel Polo-like kinase 1 inhibitor, in patients with advanced solid tumors</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5511</span><span class="NLM_x">–</span> <span class="NLM_lpage">5517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1200%2FJCO.2008.16.1547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=18955456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVSktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=5511-5517&author=K.+Mrossauthor=A.+Frostauthor=S.+Steinbildauthor=S.+Hedbomauthor=J.+Rentschlerauthor=R.+Kaiserauthor=N.+Rouyrreauthor=D.+Trommeshauserauthor=C.+E.+Hoeslauthor=G.+Munzertauthor=I+Phase&title=dose+escalation+and+pharmacokinetic+study+of+BI+2536%2C+a+novel+Polo-like+kinase+1+inhibitor%2C+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I dose escalation and pharmacokinetic study of BI 2536, a novel polo-like kinase 1 inhibitor, in patients with advanced solid tumors</span></div><div class="casAuthors">Mross, Klaus; Frost, Annette; Steinbild, Simone; Hedbom, Susanne; Rentschler, Jochen; Kaiser, Rolf; Rouyrre, Nicolas; Trommeshauser, Dirk; Hoesl, Cornelia E.; Munzert, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5511-5517</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">BI 2536 is a novel, potent, and highly specific inhibitor of polo-like kinase 1 (Plk1), which has an essential role in the regulation of mitotic progression.  The aim of this trial was to identify the max. tolerated dose (MTD) of BI 2536 and to det. the safety, pharmacokinetics, and antitumor activity in patients who had advanced solid tumors.  This phase I trial followed an open label, toxicity-guided, dose-titrn. design.  Single doses of BI 2536 (25 to 250 mg) were administered as a 1-h i.v. infusion; patients who experienced clin. benefit were eligible for addnl. treatment courses.  Safety and pharmacokinetics were investigated.  Tumor response was evaluated according to Response Evaluation Criteria in Solid Tumors Group guidelines.  The MTD was defined at 200 mg in a total of 40 patients entered; reversible neutropenia constituted the dose-limiting toxicity (DLT) and the most frequent adverse event at the MTD (grade 3 to 4; 56%).  Nausea (52%), fatigue (52%), and anorexia (44%) also were common and were mostly of mild to moderate intensity (Common Terminol. Criteria of Adverse Events ≤ grade 2).  One patient experienced a transient partial response.  At doses equal to or greater than the MTD, 23% of patients experienced disease stabilization for 3 or more months.  Dose-proportional increases in the max. plasma concn. and total exposure were obsd.  BI 2536 showed a high total clearance and high distribution into tissue.  The MTD of BI 2536 when administered as a single-dose, 1-h infusion was 200 mg; BI 2536 was well tolerated and showed a favorable pharmacokinetic profile.  Antitumor activity of BI 2536 was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6P1vjU3R8d7Vg90H21EOLACvtfcHk0lg2dox71TRLsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVSktg%253D%253D&md5=b2a7c464ca76909221e953a266757e89</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1200%2FJCO.2008.16.1547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2008.16.1547%26sid%3Dliteratum%253Aachs%26aulast%3DMross%26aufirst%3DK.%26aulast%3DFrost%26aufirst%3DA.%26aulast%3DSteinbild%26aufirst%3DS.%26aulast%3DHedbom%26aufirst%3DS.%26aulast%3DRentschler%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DR.%26aulast%3DRouyrre%26aufirst%3DN.%26aulast%3DTrommeshauser%26aufirst%3DD.%26aulast%3DHoesl%26aufirst%3DC.%2BE.%26aulast%3DMunzert%26aufirst%3DG.%26aulast%3DPhase%26aufirst%3DI%26atitle%3Ddose%2520escalation%2520and%2520pharmacokinetic%2520study%2520of%2520BI%25202536%252C%2520a%2520novel%2520Polo-like%2520kinase%25201%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26spage%3D5511%26epage%3D5517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Rudolph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steegmaier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolf, G. A.</span><span> </span><span class="NLM_article-title">BI6727, A Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3094</span><span class="NLM_x">–</span> <span class="NLM_lpage">3102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1158%2F1078-0432.CCR-08-2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=19383823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFOrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=3094-3102&author=D.+Rudolphauthor=M.+Steegmaierauthor=M.+Hoffmannauthor=M.+Grauertauthor=A.+Baumauthor=J.+Quantauthor=C.+Haslingerauthor=P.+Garin-Chesaauthor=G.+A.+Adolf&title=BI6727%2C+A+Polo-like+kinase+inhibitor+with+improved+pharmacokinetic+profile+and+broad+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity</span></div><div class="casAuthors">Rudolph, Dorothea; Steegmaier, Martin; Hoffmann, Matthias; Grauert, Matthias; Baum, Anke; Quant, Jens; Haslinger, Christian; Garin-Chesa, Pilar; Adolf, Guenther R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3094-3102</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Antimitotic chemotherapy remains a cornerstone of multimodality treatment for locally advanced and metastatic cancers.  To identify novel mitosis-specific agents with higher selectivity than approved tubulin-binding agents (taxanes, Vinca alkaloids), we have generated inhibitors of Polo-like kinase 1, a target that functions predominantly in mitosis.  The first compd. in this series, suitable for i.v. administration, has entered clin. development.  To fully explore the potential of Polo-like kinase 1 inhibition in oncol., we have profiled addnl. compds. and now describe a novel clin. candidate.  BI 6727 is a highly potent (enzyme IC50 = 0.87 nmol/L, EC50 = 11-37 nmol/L on a panel of cancer cell lines) and selective dihydropteridinone with distinct properties.  First, BI 6727 has a pharmacokinetic profile favoring sustained exposure of tumor tissues with a high vol. of distribution and a long terminal half-life in mice (Vss = 7.6 L/kg, t1/2 = 46 h) and rats (Vss = 22 L/kg, t1/2 = 54 h).  Second, BI 6727 has physicochem. and pharmacokinetic properties that allow in vivo testing of i.v. as well as oral formulations, adding flexibility to dosing schedules.  Finally, BI 6727 shows marked antitumor activity in multiple cancer models, including a model of taxane-resistant colorectal cancer.  With oral and i.v. routes of administration, the total weekly dose of BI 6727 is most relevant for efficacy, supporting the use of a variety of well-tolerated dosing schedules.  These findings warrant further investigation of BI 6727 as a tailored antimitotic agent; clin. studies have been initiated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-YEX91EOHHLVg90H21EOLACvtfcHk0lg2dox71TRLsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFOrtbo%253D&md5=daed550be9d9b99ac6797c359039d295</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2445%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DD.%26aulast%3DSteegmaier%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DGrauert%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DHaslinger%26aufirst%3DC.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DAdolf%26aufirst%3DG.%2BA.%26atitle%3DBI6727%252C%2520A%2520Polo-like%2520kinase%2520inhibitor%2520with%2520improved%2520pharmacokinetic%2520profile%2520and%2520broad%2520antitumor%2520activity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D3094%26epage%3D3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sutton, D.; Diamond, M.; Faucette, L.; Giardiniere, M.; Zhang, S.; Gilmartin, A.; Salovich, J.; Cheung, M.; Kuntz, K.; Laquerre, S.; Pearl Huang, P.; Jackson, J. R.</span><span> </span><span class="NLM_article-title">Efficacy of GSK461364, a selective Plk1 inhibitor, in human tumor xenograft models</span>. <span class="NLM_conf-name">AACR Annual Meeting</span>, <span class="NLM_conf-loc">Los Angeles</span>, <span class="NLM_conf-date">Apr 14−18, 2007</span>, Vol.  <span class="NLM_volume">48</span>, <div class="note"><p class="first last">poster 5388</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sutton%2C+D.%3B+Diamond%2C+M.%3B+Faucette%2C+L.%3B+Giardiniere%2C+M.%3B+Zhang%2C+S.%3B+Gilmartin%2C+A.%3B+Salovich%2C+J.%3B+Cheung%2C+M.%3B+Kuntz%2C+K.%3B+Laquerre%2C+S.%3B+Pearl+Huang%2C+P.%3B+Jackson%2C+J.+R.+Efficacy+of+GSK461364%2C+a+selective+Plk1+inhibitor%2C+in+human+tumor+xenograft+models.+AACR+Annual+Meeting%2C+Los+Angeles%2C+Apr+14%E2%88%9218%2C+2007%2C+Vol.+48%2C+poster+5388."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DD.%26atitle%3DEfficacy%2520of%2520GSK461364%252C%2520a%2520selective%2520Plk1%2520inhibitor%252C%2520in%2520human%2520tumor%2520xenograft%2520models%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Blagden, S.; Olmons, D.; Sharma, R.; Barriuso, J.; Medani, H.; Versola, M.; Murray, S.; Smith, D. A.; Dar, M. M.; de Bono, J. S.</span><span> </span><span class="NLM_article-title">A phase I first-in-human study of the polo-like kinase 1 selective inhibitor, GSK-461364, in patients with advanced solid tumors</span>. Book of Abstracts, <span class="NLM_conf-name">EORTC-NCI-AACR</span>, <span class="NLM_conf-loc">Geneva</span>, <span class="NLM_conf-date">Oct 21−24, 2008</span>, <div class="note"><p class="first last">poster 431</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Blagden%2C+S.%3B+Olmons%2C+D.%3B+Sharma%2C+R.%3B+Barriuso%2C+J.%3B+Medani%2C+H.%3B+Versola%2C+M.%3B+Murray%2C+S.%3B+Smith%2C+D.+A.%3B+Dar%2C+M.+M.%3B+de+Bono%2C+J.+S.+A+phase+I+first-in-human+study+of+the+polo-like+kinase+1+selective+inhibitor%2C+GSK-461364%2C+in+patients+with+advanced+solid+tumors.+Book+of+Abstracts%2C+EORTC-NCI-AACR%2C+Geneva%2C+Oct+21%E2%88%9224%2C+2008%2C+poster+431."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBlagden%26aufirst%3DS.%26atitle%3DA%2520phase%2520I%2520first-in-human%2520study%2520of%2520the%2520polo-like%2520kinase%25201%2520selective%2520inhibitor%252C%2520GSK-461364%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Schoffsky, P.</span><span> </span><span class="NLM_article-title">Polo-Like Kinase (PLK) Inhibitors in Preclinical and Early Clinical Development in Oncology</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=559-570&author=P.+Schoffsky&title=Polo-Like+Kinase+%28PLK%29+Inhibitors+in+Preclinical+and+Early+Clinical+Development+in+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchoffsky%26aufirst%3DP.%26atitle%3DPolo-Like%2520Kinase%2520%2528PLK%2529%2520Inhibitors%2520in%2520Preclinical%2520and%2520Early%2520Clinical%2520Development%2520in%2520Oncology%26jtitle%3DOncologist%26date%3D2009%26volume%3D14%26spage%3D559%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Caruso, M.; Beria, I.; Brasca, M. G.; Ferguson, R.; Posteri, H.; Valsasina, B.</span><span> </span><span class="NLM_article-title">Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors</span>. Patent WO 2008/074788,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+Caruso&author=I.+Beria&author=M.+G.+Brasca&author=R.+Ferguson&author=H.+Posteri&author=B.+Valsasina&title=Substituted+pyrazolo-quinazoline+derivatives%2C+process+for+their+preparation+and+their+use+as+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DM.%26atitle%3DSubstituted%2520pyrazolo-quinazoline%2520derivatives%252C%2520process%2520for%2520their%2520preparation%2520and%2520their%2520use%2520as%2520kinase%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amboldi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5152</span><span class="NLM_x">–</span> <span class="NLM_lpage">5163</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5152-5163&author=M.+G.+Brascaauthor=N.+Amboldiauthor=D.+Ballinariauthor=A.+Cameronauthor=E.+Casaleauthor=G.+Cerviauthor=M.+Colomboauthor=F.+Colottaauthor=V.+Crociauthor=R.+D%E2%80%99Alessioauthor=F.+Fiorentiniauthor=A.+Isacchiauthor=C.+Mercurioauthor=W.+Morettiauthor=A.+Panzeriauthor=W.+Pastoriauthor=P.+Pevarelloauthor=F.+Quartieriauthor=F.+Rolettoauthor=G.+Traquandiauthor=P.+Vianelloauthor=A.+Vulpettiauthor=M.+Ciomei&title=Identification+of+N%2C1%2C4%2C4-Tetramethyl-8-%7B%5B4-%284-methylpiperazin-1-yl%29phenyl%5Damino%7D-4%2C5-dihydro-1H-pyrazolo%5B4%2C3-h%5Dquinazoline-3-carboxamide+%28PHA-848125%29%2C+a+Potent%2C+Orally+Available+Cyclin+Dependent+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm9006559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006559%26sid%3Dliteratum%253Aachs%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmboldi%26aufirst%3DN.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCervi%26aufirst%3DG.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DR.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DW.%26aulast%3DPanzeri%26aufirst%3DA.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DQuartieri%26aufirst%3DF.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520N%252C1%252C4%252C4-Tetramethyl-8-%257B%255B4-%25284-methylpiperazin-1-yl%2529phenyl%255Damino%257D-4%252C5-dihydro-1H-pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2520%2528PHA-848125%2529%252C%2520a%2520Potent%252C%2520Orally%2520Available%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5152%26epage%3D5163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mizuno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, M.</span><span> </span><span class="NLM_article-title">New practical one-pot conversion of phenols to anilines</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3629</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol051080k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=3629&author=M.+Mizunoauthor=M.+Yamano&title=New+practical+one-pot+conversion+of+phenols+to+anilines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fol051080k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol051080k%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DM.%26aulast%3DYamano%26aufirst%3DM.%26atitle%3DNew%2520practical%2520one-pot%2520conversion%2520of%2520phenols%2520to%2520anilines%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D3629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohls, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheils, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdries, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span> </span><span class="NLM_article-title">Structure of the catalytic domain of human Polo-like kinase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5960</span><span class="NLM_x">–</span> <span class="NLM_lpage">5971</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi602474j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=5960-5971&author=M.+Kotheauthor=D.+Kohlsauthor=S.+Lowauthor=R.+Coliauthor=A.+C.+Chengauthor=S.+L.+Jacquesauthor=T.+L.+Johnsonauthor=C.+Lewisauthor=C.+Lohauthor=J.+Nonomiyaauthor=A.+L.+Sheilsauthor=K.+A.+Verdriesauthor=T.+A.+Wynnauthor=C.+Kuhnauthor=Y.+Ding&title=Structure+of+the+catalytic+domain+of+human+Polo-like+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi602474j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi602474j%26sid%3Dliteratum%253Aachs%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DJohnson%26aufirst%3DT.%2BL.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DLoh%26aufirst%3DC.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DSheils%26aufirst%3DA.%2BL.%26aulast%3DVerdries%26aufirst%3DK.%2BA.%26aulast%3DWynn%26aufirst%3DT.%2BA.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520domain%2520of%2520human%2520Polo-like%2520kinase%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D5960%26epage%3D5971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">Coordinates of the Plk1 complexes with compounds <b>49</b> have been deposited in the Protein Data Base under accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KB7">3KB7</a>, together with the corresponding structure factor files.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Knight, J. D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothary, R..</span><span> </span><span class="NLM_article-title">The role of conserved water molecules in the catalytic domain of protein kinases</span> <span class="citation_source-journal">Proteins: Struct., Funct., and Bioinform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1002%2Fprot.22451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=19425109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1ertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=527-535&author=J.+D.+R.+Knightauthor=D.+Hamelbergauthor=J.+A.+McCammonauthor=R..+Kothary&title=The+role+of+conserved+water+molecules+in+the+catalytic+domain+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The role of conserved water molecules in the catalytic domain of protein kinases</span></div><div class="casAuthors">Knight, James D. R.; Hamelberg, Donald; McCammon, J. Andrew; Kothary, Rashmi</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-535</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Protein kinases are essential signaling mols. with a characteristic bilobal shape that has been studied for over 15 years.  Despite the no. of crystal structures available, little study has been directed away from the prototypical functional elements of the kinase domain.  We have performed a structural alignment of 13 active-conformation kinases and discovered the presence of six water mols. that occur in conserved locations across this group of diverse kinases.  Mol. dynamics simulations demonstrated that these waters confer a great deal of stability to their local environment and to a key catalytic residue.  Our results highlight the importance of novel elements within the greater kinase family and suggest that conserved water mols. are necessary for efficient kinase function.  Proteins 2009. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xs1DUgkovrVg90H21EOLACvtfcHk0lh8loW4j8DxVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1ertLs%253D&md5=80ed59ec30685ec16c9e21a0cdd508dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fprot.22451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22451%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DJ.%2BD.%2BR.%26aulast%3DHamelberg%26aufirst%3DD.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DKothary%26aufirst%3DR..%26atitle%3DThe%2520role%2520of%2520conserved%2520water%2520molecules%2520in%2520the%2520catalytic%2520domain%2520of%2520protein%2520kinases%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520and%2520Bioinform.%26date%3D2009%26volume%3D76%26spage%3D527%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F.</span><span> </span><span class="NLM_article-title">A helix scaffold for the assembly of active protein kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">14377</span><span class="NLM_x">–</span> <span class="NLM_lpage">14382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=14377-14382&author=A.+P.+Kornevauthor=S.+S.+Taylorauthor=L.+F.+Ten+Eyck&title=A+helix+scaffold+for+the+assembly+of+active+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26atitle%3DA%2520helix%2520scaffold%2520for%2520the%2520assembly%2520of%2520active%2520protein%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D14377%26epage%3D14382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohls, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span> </span><span class="NLM_article-title">Selectivity-determining residues in Plk1</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1111%2Fj.1747-0285.2007.00594.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=18005335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=540-546&author=M.+Kotheauthor=D.+Kohlsauthor=S.+Lowauthor=R.+Coliauthor=G.+R.+Rennieauthor=F.+Feruauthor=C.+Kuhnauthor=Y.+Ding&title=Selectivity-determining+residues+in+Plk1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity-determining residues in Plk1</span></div><div class="casAuthors">Kothe, Michael; Kohls, Darcy; Low, Simon; Coli, Rocco; Rennie, Glen R.; Feru, Frederic; Kuhn, Cyrille; Ding, Yuan-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">540-546</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Polo-like kinase 1 is an important regulator of cell cycle progression whose over-expression is often assocd. with oncogenesis.  Polo-like kinase 1 hence represents an attractive target for cancer intervention.  BI 2536 (Boehringer Ingelheim, Ingelheim, Germany), a Polo-like kinase 1 inhibitor currently in clin. trials, exhibits nanomolar potency against Polo-like kinase isoforms and high selectivity against other kinases.  The authors have previously published the crystal structures of the Polo-like kinase 1 domain in complex with AMPPNP and an Aurora A inhibitor.  In this work, the authors present the cocrystal structure of Polo-like kinase 1 with BI 2536.  The structure, in combination with selectivity data for BI 2536 and related compds., illustrates important features for potency and selectivity.  In particular, the authors show that the methoxy group of BI 2536 is an important specificity determinant against non-Polo-like kinases by taking advantage of a small pocket generated by Leu 132 in the hinge region of Polo-like kinase 1.  The work presented here provides a framework for structure-based drug design of Polo-like kinase 1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjA3mwWD7K0bVg90H21EOLACvtfcHk0lip68l0gZ7Lmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhsbrJ&md5=0f976bb98fe7d0413e8d2314abc68e2b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00594.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00594.x%26sid%3Dliteratum%253Aachs%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DKohls%26aufirst%3DD.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DRennie%26aufirst%3DG.%2BR.%26aulast%3DFeru%26aufirst%3DF.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26atitle%3DSelectivity-determining%2520residues%2520in%2520Plk1%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D540%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjebang, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badiang Alberti, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis-Ward, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassler, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuntz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansing, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mook, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nailor, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pobanz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, M.</span><span> </span><span class="NLM_article-title">Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1694</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1016%2Fj.bmcl.2009.01.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=19237286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1694-1697&author=K.+A.+Emmitteauthor=G.+M.+Adjebangauthor=C.+W.+Andrewsauthor=J.+G.+Badiang+Albertiauthor=R.+Bambalauthor=S.+D.+Chamberlainauthor=R.+G.+Davis-Wardauthor=H.+D.+Dicksonauthor=D.+F.+Hasslerauthor=K.+R.+Hornbergerauthor=J.+R.+Jacksonauthor=K.+W.+Kuntzauthor=T.+J.+Lansingauthor=R.+A.+Mookauthor=K.+E.+Nailorauthor=M.+A.+Pobanzauthor=S.+C.+Smithauthor=C.+Sungauthor=M.+Cheung&title=Design+of+potent+thiophene+inhibitors+of+polo-like+kinase+1+with+improved+solubility+and+reduced+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding</span></div><div class="casAuthors">Emmitte, Kyle A.; Adjebang, George M.; Andrews, C. Webb; Badiang-Alberti, Jennifer G.; Bambal, Ramesh; Chamberlain, Stanley D.; Davis-Ward, Ronda G.; Dickson, Hamilton D.; Hassler, Daniel F.; Hornberger, Keith R.; Jackson, Jeffrey R.; Kuntz, Kevin W.; Lansing, Timothy J.; Mook, Robert A.; Nailor, Kristen E.; Pobanz, Mark A.; Smith, Stephon C.; Sung, Chiu-Mei; Cheung, Mui</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1694-1697</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of thiophene PLK1 inhibitors was optimized for increased soly. and reduced protein binding through the appendage of basic amine functionality.  Interesting selectivity between PLK1 and PLK3 was also obtained through these modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLrXXbB1J4-rVg90H21EOLACvtfcHk0lip68l0gZ7Lmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltrY%253D&md5=30831c589bae973ca9267dfea68971e1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.094%26sid%3Dliteratum%253Aachs%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DAdjebang%26aufirst%3DG.%2BM.%26aulast%3DAndrews%26aufirst%3DC.%2BW.%26aulast%3DBadiang%2BAlberti%26aufirst%3DJ.%2BG.%26aulast%3DBambal%26aufirst%3DR.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DDavis-Ward%26aufirst%3DR.%2BG.%26aulast%3DDickson%26aufirst%3DH.%2BD.%26aulast%3DHassler%26aufirst%3DD.%2BF.%26aulast%3DHornberger%26aufirst%3DK.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKuntz%26aufirst%3DK.%2BW.%26aulast%3DLansing%26aufirst%3DT.%2BJ.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DNailor%26aufirst%3DK.%2BE.%26aulast%3DPobanz%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DS.%2BC.%26aulast%3DSung%26aufirst%3DC.%26aulast%3DCheung%26aufirst%3DM.%26atitle%3DDesign%2520of%2520potent%2520thiophene%2520inhibitors%2520of%2520polo-like%2520kinase%25201%2520with%2520improved%2520solubility%2520and%2520reduced%2520protein%2520binding%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1694%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Yarm, F. R.</span><span> </span><span class="NLM_article-title">Plk phosphorylation regulates the microtubule-stabilizing protein TCTP</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6209</span><span class="NLM_x">–</span> <span class="NLM_lpage">6221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1128%2FMCB.22.17.6209-6221.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=12167714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1ent7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=6209-6221&author=F.+R.+Yarm&title=Plk+phosphorylation+regulates+the+microtubule-stabilizing+protein+TCTP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Plk phosphorylation regulates the microtubule-stabilizing protein TCTP</span></div><div class="casAuthors">Yarm, Frederic R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6209-6221</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mitotic polo-like kinases have been implicated in the formation and function of bipolar spindles on the basis of their resp. localizations and mutant phenotypes.  To date, this putative regulation has been limited to a kinesin-like motor protein, a centrosomal structural protein, and two microtubule-assocd. proteins (MAPs).  In this study, another spindle-regulating protein, the mammalian non-MAP microtubule-binding and -stabilizing protein, the translationally controlled tumor protein (TCTP), was identified as a putative Plk-interacting clone by a two-hybrid screen.  Plk phosphorylates TCTP on two serine residues in vitro and cofractionates with the majority of kinase activity toward TCTP in mitotic cell lysates.  In addn., these sites were demonstrated to be phosphorylated in vivo.  Overexpression of a Plk phosphorylation site-deficient mutant of TCTP induced a dramatic increase in the no. of multinucleate cells, rounded cells with condensed ball-like nuclei, and cells undergoing cell death, similar to both the reported anti-Plk antibody microinjection and the low-concn. taxol treatment phenotypes.  These results suggest that phosphorylation decreases the microtubule-stabilizing activity of TCTP and promotes the increase in microtubule dynamics that occurs after metaphase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6fc2ErGOIorVg90H21EOLACvtfcHk0lip68l0gZ7Lmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1ent7Y%253D&md5=4e275fec4f18eb54c005cd6be2c9d62d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.17.6209-6221.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.17.6209-6221.2002%26sid%3Dliteratum%253Aachs%26aulast%3DYarm%26aufirst%3DF.%2BR.%26atitle%3DPlk%2520phosphorylation%2520regulates%2520the%2520microtubule-stabilizing%2520protein%2520TCTP%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D6209%26epage%3D6221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi-Sirtori, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span> </span><span class="NLM_article-title">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1002%2Frcm.1368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=14966861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=511-517&author=M.+Colomboauthor=F.+Riccardi-Sirtoriauthor=V.+Rizzo&title=A+fully+automated+method+for+accurate+mass+determination+using+high-performance+liquid+chromatography+with+a+quadrupole%2Forthogonal+acceleration+time-of-flight+mass+spectrometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer</span></div><div class="casAuthors">Colombo, Maristella; Sirtori, Federico Riccardi; Rizzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">511-517</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A generic LC/ESI(+)-oaTOFMS method has been developed for routine automated high accuracy mass detns. of different classes of substances.  The system makes use of micro-high-performance liq. chromatog. and a hybrid quadrupole/orthogonal acceleration time-of-flight (Q-oaTOF) mass spectrometer.  Reproducible and accurate mass measurements were obtained using an electrospray dual sprayer with reserpine as ref. compd., introduced into the mass spectrometer alternating with the samples.  Expts. were performed to optimize analyte/ref. response ratio, statistical algorithm correction setting, and analyte concn.  In these expts., a clear dependence of the mass measurement error on the analyte/ref. response ratio was obsd.  The dependence of av. mass error vs. different dead time correction algorithm settings (Np factors) was also explored.  In the final automated procedure, verified for a statistically significant set of compds. (∼550) obtained from a medicinal chem. department, about 70% of the analyzed samples satisfied the acceptance criteria fixed at a max. error of ±5 ppm (mass range 150-800 Da).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5JNVhGdzjrVg90H21EOLACvtfcHk0liu3T5aVmSmzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1equr8%253D&md5=6f1f93c5e2fb4e24257b77f5ce6dfa37</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Frcm.1368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.1368%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DRiccardi-Sirtori%26aufirst%3DF.%26aulast%3DRizzo%26aufirst%3DV.%26atitle%3DA%2520fully%2520automated%2520method%2520for%2520accurate%2520mass%2520determination%2520using%2520high-performance%2520liquid%2520chromatography%2520with%2520a%2520quadrupole%252Forthogonal%2520acceleration%2520time-of-flight%2520mass%2520spectrometer%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2004%26volume%3D18%26spage%3D511%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span> </span><span class="NLM_article-title">Integration of macromolecular diffraction data</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1696</span><span class="NLM_x">–</span> <span class="NLM_lpage">1702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=1696-1702&author=A.+G.+W.+Leslie&title=Integration+of+macromolecular+diffraction+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26atitle%3DIntegration%2520of%2520macromolecular%2520diffraction%2520data%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1999%26volume%3D55%26spage%3D1696%26epage%3D1702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Bailey, S.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=S.+Bailey&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DS.%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A..</span><span> </span><span class="NLM_article-title">MOLREP: an automated program for molecular replacement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1107%2FS0021889897006766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=1022-1025&author=A.+Vaginauthor=A..+Teplyakov&title=MOLREP%3A+an+automated+program+for+molecular+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">MOLREP: an automated program for molecular replacement</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement which uses effective new approaches in data processing and rotational and translational searching.  These include an automatic choice of all parameters, scaling by Patterson origin peaks and soft resoln. cutoff.  One of the cornerstones of the program is an original full-symmetry translation function combined with a packing function.  Information from the model already placed in the cell is incorporated in both translation and packing functions.  A no. of tests using exptl. data proved the ability of the program to find the correct soln. in difficult cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGXdZ-nTKxLVg90H21EOLACvtfcHk0liu3T5aVmSmzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D&md5=96af64aedd8a8f018c3c18b57a6b4b21</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0021889897006766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897006766%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA..%26atitle%3DMOLREP%253A%2520an%2520automated%2520program%2520for%2520molecular%2520replacement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D1022%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0liu3T5aVmSmzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Lamzin, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Automated refinement of protein models</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=129-47&author=V.+S.+Lamzinauthor=K.+S.+Wilson&title=Automated+refinement+of+protein+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamzin%26aufirst%3DV.%2BS.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DAutomated%2520refinement%2520of%2520protein%2520models%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1993%26volume%3D49%26spage%3D129%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">12, Pt. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&issue=12%2C+Pt.+1&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26issue%3D12%252C%2520Pt.%25201%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Pevarello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasca, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traquandi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piutti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sansonna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritzen, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nugent, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciomei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roletto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastori, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warpehoski, M. A.</span><span> </span><span class="NLM_article-title">3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3367</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031145u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3367-3380&author=P.+Pevarelloauthor=M.+G.+Brascaauthor=R.+Amiciauthor=P.+Orsiniauthor=G.+Traquandiauthor=L.+Cortiauthor=C.+Piuttiauthor=P.+Sansonnaauthor=M.+Villaauthor=B.+S.+Pierceauthor=M.+Puliciauthor=P.+Giordanoauthor=K.+Martinaauthor=E.+L.+Fritzenauthor=R.+A.+Nugentauthor=E.+Casaleauthor=A.+Cameronauthor=M.+Ciomeiauthor=F.+Rolettoauthor=A.+Isacchiauthor=G.+P.+Fogliattoauthor=E.+Pesentiauthor=W.+Pastoriauthor=A.+Marsiglioauthor=K.+L.+Leachauthor=P.+M.+Clareauthor=F.+Fiorentiniauthor=M.+Varasiauthor=A.+Vulpettiauthor=M.+A.+Warpehoski&title=3-Aminopyrazole+inhibitors+of+CDK2%2Fcyclin+A+as+antitumor+agents.+1.+Lead+finding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm031145u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031145u%26sid%3Dliteratum%253Aachs%26aulast%3DPevarello%26aufirst%3DP.%26aulast%3DBrasca%26aufirst%3DM.%2BG.%26aulast%3DAmici%26aufirst%3DR.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DTraquandi%26aufirst%3DG.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DPiutti%26aufirst%3DC.%26aulast%3DSansonna%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DPulici%26aufirst%3DM.%26aulast%3DGiordano%26aufirst%3DP.%26aulast%3DMartina%26aufirst%3DK.%26aulast%3DFritzen%26aufirst%3DE.%2BL.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DA.%26aulast%3DCiomei%26aufirst%3DM.%26aulast%3DRoletto%26aufirst%3DF.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DFogliatto%26aufirst%3DG.%2BP.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DPastori%26aufirst%3DW.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DLeach%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DP.%2BM.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DVarasi%26aufirst%3DM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DWarpehoski%26aufirst%3DM.%2BA.%26atitle%3D3-Aminopyrazole%2520inhibitors%2520of%2520CDK2%252Fcyclin%2520A%2520as%2520antitumor%2520agents.%25201.%2520Lead%2520finding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3367%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Carpinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianellini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degrassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Texido, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugnoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigoni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soncini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsiglio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fancelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span> </span><span class="NLM_article-title">PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3158</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901713n&amp;key=10.1158%2F1535-7163.MCT-07-0444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=18089710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3158-3168&author=P.+Carpinelliauthor=R.+Cerutiauthor=M.+L.+Giorginiauthor=P.+Cappellaauthor=L.+Gianelliniauthor=V.+Crociauthor=A.+Degrassiauthor=G.+Texidoauthor=M.+Rocchettiauthor=P.+Vianelloauthor=L.+Rusconiauthor=P.+Storiciauthor=P.+Zugnoniauthor=C.+Arrigoniauthor=C.+Sonciniauthor=C.+Alliauthor=V.+Pattonauthor=A.+Marsiglioauthor=D.+Ballinariauthor=E.+Pesentiauthor=D.+Fancelliauthor=J.+Moll&title=PHA-739358%2C+a+potent+inhibitor+of+Aurora+kinases+with+a+selective+target+inhibition+profile+relevant+to+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer</span></div><div class="casAuthors">Carpinelli, Patrizia; Ceruti, Roberta; Giorgini, Maria Laura; Cappella, Paolo; Gianellini, Laura; Croci, Valter; Degrassi, Anna; Texido, Gemma; Rocchetti, Maurizio; Vianello, Paola; Rusconi, Luisa; Storici, Paola; Zugnoni, Paola; Arrigoni, Claudio; Soncini, Chiara; Alli, Cristina; Patton, Veronica; Marsiglio, Aurelio; Ballinari, Dario; Pesenti, Enrico; Fancelli, Daniele; Moll, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3158-3168</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PHA-739358 is a small-mol. 3-aminopyrazole deriv. with strong activity against Aurora kinases and cross-reactivities with some receptor tyrosine kinases relevant for cancer.  PHA-739358 inhibits all Aurora kinase family members and shows a dominant Aurora B kinase inhibition-related cellular phenotype and mechanism of action in cells in vitro and in vivo. p53 status-dependent endoreduplication is obsd. upon treatment of cells with PHA-739358, and phosphorylation of histone H3 in Ser10 is inhibited.  The compd. has significant antitumor activity in different xenografts and spontaneous and transgenic animal tumor models and shows a favorable pharmacokinetic and safety profile.  In vivo target modulation is obsd. as assessed by the inhibition of the phosphorylation of histone H3, which has been validated preclinically as a candidate biomarker for the clin. phase.  Pharmacokinetics/pharmacodynamics modeling was used to define drug potency and to support the prediction of active clin. doses and schedules.  We conclude that PHA-739358, which is currently tested in clin. trials, has great therapeutic potential in anticancer therapy in a wide range of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfveLDPYzNGLVg90H21EOLACvtfcHk0liBgIjtG-UIlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsr3M&md5=695fc55d72717a86f96818ca23fc71b8</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0444%26sid%3Dliteratum%253Aachs%26aulast%3DCarpinelli%26aufirst%3DP.%26aulast%3DCeruti%26aufirst%3DR.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DGianellini%26aufirst%3DL.%26aulast%3DCroci%26aufirst%3DV.%26aulast%3DDegrassi%26aufirst%3DA.%26aulast%3DTexido%26aufirst%3DG.%26aulast%3DRocchetti%26aufirst%3DM.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DZugnoni%26aufirst%3DP.%26aulast%3DArrigoni%26aufirst%3DC.%26aulast%3DSoncini%26aufirst%3DC.%26aulast%3DAlli%26aufirst%3DC.%26aulast%3DPatton%26aufirst%3DV.%26aulast%3DMarsiglio%26aufirst%3DA.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DFancelli%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DPHA-739358%252C%2520a%2520potent%2520inhibitor%2520of%2520Aurora%2520kinases%2520with%2520a%2520selective%2520target%2520inhibition%2520profile%2520relevant%2520to%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D3158%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Siomi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siomi, M.</span><span> </span><span class="NLM_article-title">On the road to reading the RNA-interference code</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">457</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=396-404&author=H.+Siomiauthor=M.+Siomi&title=On+the+road+to+reading+the+RNA-interference+code"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiomi%26aufirst%3DH.%26aulast%3DSiomi%26aufirst%3DM.%26atitle%3DOn%2520the%2520road%2520to%2520reading%2520the%2520RNA-interference%2520code%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D396%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Bjornsson, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einolf, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miwa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snikeris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweedie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective</span> <span class="citation_source-journal">J. Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm901713n&amp;key=12751267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm901713n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=443-469&author=T.+D.+Bjornssonauthor=J.+T.+Callaghanauthor=H.+J.+Einolfauthor=V.+Fischerauthor=L.+Ganauthor=S.+Grimmauthor=J.+Kaoauthor=S.+P.+Kingauthor=G.+Miwaauthor=L.+Niauthor=G.+Kumarauthor=J.+McLeodauthor=S.+R.+Obachauthor=S.+Robertsauthor=A.+Roeauthor=A.+Shahauthor=F.+Snikerisauthor=J.+T.+Sullivanauthor=D.+Tweedieauthor=J.+M.+Vegaauthor=J.+Walshauthor=S.+A.+Wrighton&title=The+conduct+of+in+vitro+and+in+vivo+drug-drug+interaction+studies%3A+A+PhRMA+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective</span></div><div class="casAuthors">Bjornsson, Thorir D.; Callaghan, John T.; Einolf, Heidi J.; Fischer, Volker; Gan, Lawrence; Grimm, Scott; Kao, John; King, S. Peter; Miwa, Gerald; Ni, Lan; Kumar, Gondi; McLeod, James; Obach, Scott R.; Roberts, Stanley; Roe, Amy; Shah, Anita; Snikeris, Fred; Sullivan, John T.; Tweedie, Donald; Vega, Jose M.; Walsh, John; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443-469</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Current regulatory guidances do not address specific study designs for in vitro and in vivo drug-drug interaction studies.  There is a common desire by regulatory authorities and by industry sponsors to harmonize approaches to allow for a better assessment of the significance of findings across different studies and drugs.  There is also a growing consensus for the standardization of cytochrome P 450 (CYP) probe substrates, inhibitors, and inducers and for the development of classification systems to improve the communication of risk to health care providers and patients.  While existing guidances cover mainly CYP-mediated drug interactions, the importance of other mechanisms, such as transporters, has been recognized more recently and should also be addressed.  This paper was prepd. by the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metab. and Clin. Pharmacol. Tech. Working Groups and represents the current industry position.  The intent is to define a minimal best practice for in vitro and in vivo pharmacokinetic drug-drug interaction studies targeted to development (not discovery support) and to define a data package that can be expected by regulatory agencies in compd. registration dossiers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLgVYfgRCef7Vg90H21EOLACvtfcHk0liBgIjtG-UIlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVShsbs%253D&md5=3c84ae2dd962249744e152383f0d6a80</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBjornsson%26aufirst%3DT.%2BD.%26aulast%3DCallaghan%26aufirst%3DJ.%2BT.%26aulast%3DEinolf%26aufirst%3DH.%2BJ.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DGrimm%26aufirst%3DS.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DS.%2BP.%26aulast%3DMiwa%26aufirst%3DG.%26aulast%3DNi%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DMcLeod%26aufirst%3DJ.%26aulast%3DObach%26aufirst%3DS.%2BR.%26aulast%3DRoberts%26aufirst%3DS.%26aulast%3DRoe%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DSnikeris%26aufirst%3DF.%26aulast%3DSullivan%26aufirst%3DJ.%2BT.%26aulast%3DTweedie%26aufirst%3DD.%26aulast%3DVega%26aufirst%3DJ.%2BM.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520conduct%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520drug-drug%2520interaction%2520studies%253A%2520A%2520PhRMA%2520perspective%26jtitle%3DJ.%2520Clin.%2520Pharm.%26date%3D2003%26volume%3D43%26spage%3D443%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KB7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KB7','PDB','3KB7'); return false;">PDB: 3KB7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i117"><a href="/doi/suppl/10.1021/jm901713n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82438"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic studies of compound <b>49</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901713n/suppl_file/jm901713n_si_001.pdf">jm901713n_si_001.pdf (49.78 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901713n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm901713n%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901713n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b6d59fc8bd1a3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
